
<html lang="en"     class="pb-page"  data-request-id="afc668a7-2887-4e14-b48f-cdd762751ce3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm2013453;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-3;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors" /></meta><meta name="dc.Creator" content="Antonio  Garofalo" /></meta><meta name="dc.Creator" content="Amaury  Farce" /></meta><meta name="dc.Creator" content="Séverine  Ravez" /></meta><meta name="dc.Creator" content="Amélie  Lemoine" /></meta><meta name="dc.Creator" content="Perrine  Six" /></meta><meta name="dc.Creator" content="Philippe  Chavatte" /></meta><meta name="dc.Creator" content="Laurence  Goossens" /></meta><meta name="dc.Creator" content="Patrick  Depreux" /></meta><meta name="dc.Description" content="In our continuing search for medicinal agents to treat proliferative diseases, quinazoline derivatives were synthesized and evaluated pharmacologically as epithelial growth factor receptor and vasc..." /></meta><meta name="Description" content="In our continuing search for medicinal agents to treat proliferative diseases, quinazoline derivatives were synthesized and evaluated pharmacologically as epithelial growth factor receptor and vasc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 25, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2013453" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2013453" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2013453" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2013453" /></link>
        
    
    

<title>Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2013453" /></meta><meta property="og:title" content="Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0004.jpeg" /></meta><meta property="og:description" content="In our continuing search for medicinal agents to treat proliferative diseases, quinazoline derivatives were synthesized and evaluated pharmacologically as epithelial growth factor receptor and vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitors. A quantitative structure–activity relationship analysis was conducted to rationalize the structure–activity relationship and to predict how similar the inhibitor-binding profiles of two protein kinases are likely to be on the basis of the docking of lead coumpounds into the ATP-binding site. This model was used to direct the synthesis of new compounds. A series of N-(aromatic)-N′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}urea were identified as potent and selective inhibitors of the tyrosine kinase activity of VEGFR-2 (fetal liver kinase 1, kinase insert domain-containing receptor). An efficient route was developed that enabled the synthesis of a wide variety of analogues with substitution on several positions of the template. Substitution of diarylurea, competitive with ATP, afforded several analogues with low nanomolar inhibition of enzymatic activity of VEGFR-2. In this paper, we describe the synthesis, structure–activity relationships, and pharmacological characterization of the series." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2013453"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2013453">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2013453&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2013453&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2013453&amp;href=/doi/10.1021/jm2013453" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1189-1204</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2012112" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201346g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Garofalo">Antonio Garofalo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amaury++Farce">Amaury Farce</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A9verine++Ravez">Séverine Ravez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Am%C3%A9lie++Lemoine">Amélie Lemoine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Perrine++Six">Perrine Six</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Chavatte">Philippe Chavatte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurence++Goossens">Laurence Goossens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Depreux">Patrick Depreux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Univ. Lille Nord de France, F-59000 Lille, France</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL) and <sup>§</sup>Laboratoire de Chimie Thérapeutique, UFR de Pharmacie, Univ. Lille 2 Droit et Santé (UDSL), EA4481, F-59006 Lille, France</span></div><div class="corresp-info"><strong>*</strong>Phone: +33 (0)3 20 96 40 40. Fax: +33 (0)3 20 96 49 06. E-mail: <a href="/cdn-cgi/l/email-protection#21404c405453580f47405342440c1361544f48570c4d484d4d44130f4753"><span class="__cf_email__" data-cfemail="a8c9c5c9dddad186cec9dacbcd859ae8ddc6c1de85c4c1c4c4cd9a86ceda">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2013453&amp;href=/doi/10.1021%2Fjm2013453" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1189–1204</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 9, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 October 2011</li><li><span class="item_label"><b>Published</b> online</span>25 January 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2013453" title="DOI URL">https://doi.org/10.1021/jm2013453</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1189%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAntonio%2BGarofalo%252C%2BAmaury%2BFarce%252C%2BS%25C3%25A9verine%2BRavez%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D3%26contentID%3Djm2013453%26title%3DSynthesis%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2B%2528Aryloxy%2529quinazoline%2BUreas%2Bas%2BNovel%252C%2BPotent%252C%2Band%2BSelective%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1204%26publicationDate%3DFebruary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2013453"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2459</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2013453" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Garofalo&quot;},{&quot;first_name&quot;:&quot;Amaury&quot;,&quot;last_name&quot;:&quot;Farce&quot;},{&quot;first_name&quot;:&quot;Séverine&quot;,&quot;last_name&quot;:&quot;Ravez&quot;},{&quot;first_name&quot;:&quot;Amélie&quot;,&quot;last_name&quot;:&quot;Lemoine&quot;},{&quot;first_name&quot;:&quot;Perrine&quot;,&quot;last_name&quot;:&quot;Six&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Chavatte&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;Goossens&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Depreux&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1189-1204&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2013453&quot;},&quot;abstract&quot;:&quot;In our continuing search for medicinal agents to treat proliferative diseases, quinazoline derivatives were synthesized and evaluated pharmacologically as epithelial growth factor receptor and vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitors. A quantitative structure–activity relationship analysis was conducted to rationalize the structure–activity relationship and to predict how similar the inhibitor-binding profiles of two protein kinases are likely to be on the basis of the docking of lead coumpounds into the ATP-binding site. This model was used to direct the synthesis of new compounds. A series of N-(aromatic)-N′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}urea were identified as potent and selective inhibitors of the tyrosine kinase activity of VEGFR-2 (fetal liver kinase 1, kinase insert domain-containing receptor). An efficient route was developed that enabled the synthesis of a wide variety of analogues with substitution on several positions of the template. Substit&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2013453&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2013453" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2013453&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2013453" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2013453&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2013453" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2013453&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2013453&amp;href=/doi/10.1021/jm2013453" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2013453" /></input><a href="/doi/pdf/10.1021/jm2013453" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2013453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2013453%26sid%3Dliteratum%253Aachs%26pmid%3D22229669%26genre%3Darticle%26aulast%3DGarofalo%26date%3D2012%26atitle%3DSynthesis%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2B%2528Aryloxy%2529quinazoline%2BUreas%2Bas%2BNovel%252C%2BPotent%252C%2Band%2BSelective%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D3%26spage%3D1189%26epage%3D1204%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jmcmar.2012.55.issue-3/production/jmcmar.2012.55.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In our continuing search for medicinal agents to treat proliferative diseases, quinazoline derivatives were synthesized and evaluated pharmacologically as epithelial growth factor receptor and vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitors. A quantitative structure–activity relationship analysis was conducted to rationalize the structure–activity relationship and to predict how similar the inhibitor-binding profiles of two protein kinases are likely to be on the basis of the docking of lead coumpounds into the ATP-binding site. This model was used to direct the synthesis of new compounds. A series of <i>N</i>-(aromatic)-<i>N′</i>-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}urea were identified as potent and selective inhibitors of the tyrosine kinase activity of VEGFR-2 (fetal liver kinase 1, kinase insert domain-containing receptor). An efficient route was developed that enabled the synthesis of a wide variety of analogues with substitution on several positions of the template. Substitution of diarylurea, competitive with ATP, afforded several analogues with low nanomolar inhibition of enzymatic activity of VEGFR-2. In this paper, we describe the synthesis, structure–activity relationships, and pharmacological characterization of the series.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinases constitute one of the largest protein families and are implicated in many diseases by alteration in their kinase-mediated signaling pathways, such as cancer, diabetes, and inflammatory disorders.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Protein kinases play important roles in regulating most of the cellular functions (proliferation, cell cycle, cell metabolism, survival, apoptosis, DNA damage/repair, ...) by multiple pathways, which makes them attractive as drug targets.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> In recent years, angiogenesis has become an attractive therapeutic target.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Pathological angiogenesis has been associated with a variety of diseases, including diabetes retinopathy, psoriasis, rheumatoid arthritis, and cancer.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This pathology is an essential series of molecular events that occur during the formation of new blood vessels from the endothelium of preexisting vasculature and plays a vital role in tumor growth. Solid tumors cannot grow beyond a critical size until they develop new collateral blood vessels to provide oxygen and nutrients, elimination of waste materials generated from tumor metabolism, and cell dissemination leading to metastasis to other organs.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a></div><div class="NLM_p">Among the many proangiogenic factors, vascular endothelial growth factor (VEGF) has been identified as the most common regulator of tumor angiogenesis, including vascular permeability, endothelial cell activation, proliferation, and migration.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a>Crucial steps in angiogenesis are mediated through a specific VEGF receptor, the kinase insert domain-containing receptor (KDR; or vascular endothelial growth factor 2 (VEGFR-2)). This receptor tyrosine kinase (RTK) has been shown to be an important mediator of signal transduction in cells.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> These membrane molecules characteristically consist of an extracellular ligand-binding domain connected through a segment in the plasma membrane to an intracellular tyrosine kinase domain.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Binding of the ligand to the receptor results in receptor dimerization and stimulation of the receptor-associated tyrosine kinase activity, which leads to phosphorylation of tyrosine residues and initiates a signaling cascade leading to a variety of cellular responses.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a></div><div class="NLM_p">Throughout the past two decades, inhibition of VEGF activity or VEGFR-2 kinase has been shown to inhibit angiogenesis, tumor progression, and dissemination in a number of preclinical and clinical studies.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34">(27-34)</a> From examples, the use of the neutralizing monoclonal antibody against VEGF, bevacizumab,<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a>has demonstrated a prolonged survival in colorectal cancer patients. In addition, small-molecule tyrosine kinase inhibitors of KDR, such as sorafenib (a dual Raf–KDR inhibitor)<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> and sunitinib (a multitarged kinase),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> have been approved for treatment of cancers (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Up to now, there has been a lot of research focusing on the development of novel inhibitors of KDR as vandetanib (ZD6474), orally bioavailable in phase III, considered to be a dual tyrosine kinase inhibitor targeting EGFR and VEGFR-2.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of tyrosine kinase inhibitors undergoing clinical trials or marketed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Often, the fact that the biological targets belong to the same family of receptors raises the problem of selectivity. Special efforts to design multiple activating drugs can be successful using computational methods to support biochemical studies and to design selective ligands for receptor subtypes.</div><div class="NLM_p">In the present work, molecular modeling studies of these novel VEGFR-2 inhibitors were performed using a three-dimensional quantitative structure–activity relationship (3D QSAR) and docking approach. 3D QSAR methods, such as comparative molecular field analyses (CoMFA) and comparative molecular similarity index analyses (CoMSIA), were applied to these inhibitors to gain insight into how steric, electrostatic, hydrophobic, and hydrogen-bonding interactions influence their activities. In our research for selective KDR kinase inhibitors, we have recently disclosed the structure–activity relationships (SARs) of quinazoline derivatives (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as anticancer drugs.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Herein, we describe the SAR and pharmacology of a novel series of quinazoline carbamic acid esters, dual EGFR/VEGFR-2 kinase inhibitors,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and of (aryloxy)quinazoline ureas, selective VEGFR-2 kinase inhibitors.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structures of synthesized carbamic acid esters <b>1a</b> and aryloxy derivatives <b>1b</b>.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In an effort to further develop this series, a QSAR model has been derived from this activity in a two-step process. First, the docking of the most active compound of the two families of molecules has been realized to achieve a putative bioactive conformation. Second, 3D QSAR models employing the CoMFA and CoMSIA methods have been elaborated on the basis of an alignment of the compounds on the putative bioactive conformation of the two reference molecules. The excellent agreement between the docking and the QSAR fields indicates that the binding mode hypothesis is most probably fairly close to the biological binding mode, therefore offering a relevant basis for proposing improvements for the further development of the series. The second major interest of this study is the predictive power of the models, more than their insights into the structural modifications that would enhance the activity of the series, which is too homogeneous to provide an efficient basis for suggesting new scaffolds. This predictive power has been validated on external test sets and further proved on newly designed selective VEGFR-2 inhibitors. These compounds have been synthesized and evaluated in our whole cell assay by measuring the inhibition of VEGFR-2 and EGFR to provide their selectivity and antiproliferative activity toward prostate (PC3), breast (MCF-7), and colon (HT-29) cancer cells.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In our research to discover a new anticancer drug, we designed and evaluated pharmacologically 200 compounds as potent kinase inhibitors. Sixty of these compounds were used for this study. They were prepared via a generalized route outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><div class="NLM_p">The synthesis and spectroscopic data of 4-chloroquinazoline derivatives <b>7</b>–<b>10</b> have been reported (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Quinazoline Intermediates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of (aminophenyl)carbamic acid esters <b>11</b>–<b>27</b> was performed by a one-pot reduction procedure of the corresponding nitrophenyl isocyanate in the presence of various alcohols in a CH<sub>2</sub>Cl<sub>2</sub>/THF mixture.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Condensation of 1,4-phenylenediamine and the corresponding isocyanate in CHCl<sub>3</sub>afforded the desired ureas <b>28</b>–<b>32</b> in high yields and short reaction times.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Amide analogues <b>33</b> and <b>34</b> were prepared from 2-methyl-4-nitroaniline according to a two-step procedure: acetylation from chloride derivatives and reduction under a hydrogen  atmosphere using Raney nickel as the catalyst.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Target compounds <b>35</b>–<b>78</b> were obtained by nucleophilic substitution with previously synthesized anilines <b>11</b>–<b>34</b> either in 2-propanol or in DMF in the presence of sodium hydride (40–60%). The desired anilinoquinazolines <b>35</b>–<b>78</b> were isolated as hydrochloride salts (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Raney nickel, H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, ROH (80–90%); (b) Raney nickel, H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/THF (1/1), ROH (80–90%); (c) isocyanate, CHCl<sub>3</sub> (70–80%); (d) RCOCl, triethylamine, THF, 0–20 °C (70–85%); (e) Raney nickel, H<sub>2</sub>, MeOH (80–90%); (i) anilines, 2-propanol, reflux (60–80%); (j) anilines, NaH, DMF, 50 °C (25–40%).</p></p></figure><div class="NLM_p">In Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, 4-chloro-6,7-dimethoxyquinazoline (<b>7</b>) was used to prepare the aryloxy derivatives <b>79</b>–<b>93</b>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Heating at 150 °C in DMSO of quinazoline <b>7</b> with phenol derivatives gave products <b>79</b>–<b>81</b> in good yields. Amidification or condensation with aniline intermediates <b>94</b> and <b>95</b> afforded carbamic acid esters <b>82</b> and <b>83</b> and the desired ureas <b>84</b>–<b>93</b>.<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46 ref47 ref48">(42-48)</a></div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (Aryloxy)quinazoline Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Four series of new quinazolines (series A, B, C, and D), differentiated by having an ether linker at the 6- or 7-position of core and incorporating a donor/acceptor group such as an acetamide, a carbamic acid ester, or a urea substituted on an arylamino ring, have been designed using structure–activity relationships (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Suppression of the basic side chain on the quinazoline core confers an increase of cellular and enzymatic inhibitory activity. Our results show that some derivates of series A and B (6,7-dimethoxyquinazoline) have high activity on EGFR and VEGFR-2 compared to series C and D. Introduction of a urea group led to an increase in VEGFR-2 enzymatic activity but not in EGFR enzymatic activity. Also, replacement of the urea entity by a carbamic acid methyl ester group as in <b>42</b> presents a dual EGFR/VEGFR-2 activity. According to investigations, the substitution by halogens on the middle phenyl group of carbamic acid ester and urea derivatives (series A and B) appeared to be a new opportunity to develop a new dual EGFR/VEGFR-2 inhibitor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzymatic (EGFR/VEGR-2) and Cellular (PC3, Prostate Cancer Cell; HT29, Colon Cancer Cell; MCF-7, Breast Cancer Cell) Results for Quinazoline Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center">proliferative inhibition, % (or IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">no.</th><th class="colsep0 rowsep0" align="center">series</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">EGFR IC<sub>50</sub>,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> μM</th><th class="colsep0 rowsep0" align="center" char=".">VEGFR-2 IC<sub>50</sub>,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> μM</th><th class="colsep0 rowsep0" align="center">PC3</th><th class="colsep0 rowsep0" align="center">HT29</th><th class="colsep0 rowsep0" align="center">MCF-7</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">4.30</td><td class="colsep0 rowsep0" align="char" char=".">7.00</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">7%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="char" char=".">3.60</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="left">37%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">42%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>37</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-Cl-4-F</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">5.30</td><td class="colsep0 rowsep0" align="left">6.50 μM</td><td class="colsep0 rowsep0" align="left">5.70 μM</td><td class="colsep0 rowsep0" align="left">4.90 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>38</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-Br-2-F</td><td class="colsep0 rowsep0" align="char" char=".">5.70</td><td class="colsep0 rowsep0" align="char" char=".">1.65</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">31%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-(NHCOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">7.30</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCO(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>41</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCO(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">6.80</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>42</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">6.90</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">27%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.60</td><td class="colsep0 rowsep0" align="left">12%</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">6%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>44</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-(NHCOO(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">7.05</td><td class="colsep0 rowsep0" align="char" char=".">5.00</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">29%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-(NHCOO(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">6.80</td><td class="colsep0 rowsep0" align="left">20%</td><td class="colsep0 rowsep0" align="left">32%</td><td class="colsep0 rowsep0" align="left">19%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>46</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-(NHCOOCH(CH<sub>3</sub>)<sub>2</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">4.80</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">24%</td><td class="colsep0 rowsep0" align="left">36%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">6.15</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">22%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="left">9.80 μM</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOO(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">3.30</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">29%</td><td class="colsep0 rowsep0" align="left">20%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOO(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">6.40</td><td class="colsep0 rowsep0" align="char" char=".">4.90</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">41%</td><td class="colsep0 rowsep0" align="left">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>51</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">4.00</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOO(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">18%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOO(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">7.60</td><td class="colsep0 rowsep0" align="char" char=".">5.20</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">13%</td><td class="colsep0 rowsep0" align="left">33%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH(CH<sub>3</sub>)<sub>2</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">5.25</td><td class="colsep0 rowsep0" align="left">3%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">30%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-Cl-3-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">0.90</td><td class="colsep0 rowsep0" align="char" char=".">5.55</td><td class="colsep0 rowsep0" align="left">13%</td><td class="colsep0 rowsep0" align="left">4%</td><td class="colsep0 rowsep0" align="left">39%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>-3-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">7.20</td><td class="colsep0 rowsep0" align="char" char=".">7.80</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">12%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>-3-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">5.00</td><td class="colsep0 rowsep0" align="char" char=".">6.50</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">1%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">4.65</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">6%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="left">14%</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">26%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.10</td><td class="colsep0 rowsep0" align="left">35%</td><td class="colsep0 rowsep0" align="left">5.80 μM</td><td class="colsep0 rowsep0" align="left">1.50 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">6.20</td><td class="colsep0 rowsep0" align="left">43%</td><td class="colsep0 rowsep0" align="left">45%</td><td class="colsep0 rowsep0" align="left">7.15 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>63</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3-chloro-4-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">4.30</td><td class="colsep0 rowsep0" align="left">9.40 μM</td><td class="colsep0 rowsep0" align="left">6.20 μM</td><td class="colsep0 rowsep0" align="left">7.70 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>64</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-Cl-4-F</td><td class="colsep0 rowsep0" align="char" char=".">9.90</td><td class="colsep0 rowsep0" align="char" char=".">6.90</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">5.90 μM</td><td class="colsep0 rowsep0" align="left">26%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>65</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-Br-2-F</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">7.50 μM</td><td class="colsep0 rowsep0" align="left">10%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>66</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-Br-4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">9.45</td><td class="colsep0 rowsep0" align="char" char=".">6.45</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">2.55 μM</td><td class="colsep0 rowsep0" align="left">9.60 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>67</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.20</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">38%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>68</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">3.35</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">5.45 μM</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>69</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">6.95</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>70</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">3.70</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>71</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left"><i>p</i>-(NHCONHCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">6.60</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>72</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">4-Br-2-F</td><td class="colsep0 rowsep0" align="char" char=".">9.10</td><td class="colsep0 rowsep0" align="char" char=".">7.45</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">35%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>73</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">7.25</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>74</b></td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">4-Br-2-F</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.30</td><td class="colsep0 rowsep0" align="left">31%</td><td class="colsep0 rowsep0" align="left">3.60 μM</td><td class="colsep0 rowsep0" align="left">7.70 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>75</b></td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="left">11%</td><td class="colsep0 rowsep0" align="left">2.55 μM</td><td class="colsep0 rowsep0" align="left">33%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>76</b></td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">3-Cl-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">9.15</td><td class="colsep0 rowsep0" align="char" char=".">4.80</td><td class="colsep0 rowsep0" align="left">40%</td><td class="colsep0 rowsep0" align="left">2.50 μM</td><td class="colsep0 rowsep0" align="left">7.10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>77</b></td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">9.40</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">6.15 μM</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>78</b></td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>-4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.70</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">5.80 μM</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>79</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">3-Cl-4-F</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">9.80</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>80</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">4-Br-2-F</td><td class="colsep0 rowsep0" align="char" char=".">5.90</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="left">16%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>81</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">3-(NHCOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">8.90</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">5%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>82</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">4-(NHCOOCH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">1%</td><td class="colsep0 rowsep0" align="left">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>83</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">4-(NHCOOCH<sub>2</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="left">28%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>84</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-((CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="left">30%</td><td class="colsep0 rowsep0" align="left">31%</td><td class="colsep0 rowsep0" align="left">39%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>85</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-cyclohexyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="left">42%</td><td class="colsep0 rowsep0" align="left">8%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>86</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-phenyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">12%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>87</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-(4-methoxyphenyl)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="left">12%</td><td class="colsep0 rowsep0" align="left">9%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>88</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-(3-chloro-4-fluorophenyl)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="left">36%</td><td class="colsep0 rowsep0" align="left">26%</td><td class="colsep0 rowsep0" align="left">30%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>89</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-(2,4-difluorophenyl)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="left">35%</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">6.30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>90</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-(4-bromophenyl)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">13%</td><td class="colsep0 rowsep0" align="left">10%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>91</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>p</i>-(2-naphthyl)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="left">5%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">6.80 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>92</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>m</i>-phenyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">7%</td><td class="colsep0 rowsep0" align="left">0%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>93</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left"><i>m</i>-(4-methoxyphenyl)</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="left">19%</td><td class="colsep0 rowsep0" align="left">2%</td><td class="colsep0 rowsep0" align="left">0%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Compounds tested at a concentration of 10 μM. The values are the mean ± SD of at least three independent experiments (SD < 10%).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Inhibition of EGFR (purified from human carcinoma A431 cells) tyrosine kinase activity.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Inhibition of VEGFR–2 (recombinant human protein) tyrosine kinase activity.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Cell proliferation was realized by MTS assay at 10 μM from at least three independent determinations. Higher concentrations were not used to avoid precipitation of the compounds in the culture medium.</p></div></div></div><div class="NLM_p">Investigation of the SAR around the lead carbamic acid methyl ester <b>42</b> revealed a range of potent dual EGFR/VEGFR-2 inhibitors. The substitution by a halogen or methyl on the middle phenyl group of carbamic acid ester increased enzymatic activity. The effect of varying the methoxy groups on the quinazoline core by basic side chain was investigated (series C, D, and E). Our results led to a better affinity against VEGFR-2 and a loss of activity against EGFR.</div><div class="NLM_p">We have also described the discovery, SAR, and preliminary biological evaluation of a novel series of VEGFR-2-selective tyrosine kinase inhibitors characterized by the replacement of linkers at the 4-position of the quinazoline skeleton by ether (series F and G). The diarylurea of (aryloxy)quinazoline potently inhibited VEGFR-2 at submicromolar concentrations. Molecular modeling established interactions of these compounds with the binding active site. However, their potent activity against VEGFR-2 is not reflected by their antiproliferative activity on cell-based assays due to poor solubility.</div><div class="NLM_p">According to these results, the substitution by halogens or a methyl group on the middle phenyl group of urea derivatives appears to be a new opportunity to develop a new VEGFR-2-selective inhibitor. Moreover, as a diarylurea moiety is favored for optimal interaction in the active site, others compounds were realized to obtain a better affinity.</div><div class="NLM_p">These compounds were synthesized according to described procedures in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> with 4-chloro-6,7-dimethoxyquinazoline (<b>7</b>) as the starting product. Selective reaction of chloride derivative <b>7</b> with 4-amino-3-methylphenol and tetra-<i>n</i>-butylammonium bromide in a mixture of methyl ethyl ketone and sodium hydroxide provided the intermediate <b>96</b>. Condensation of <b>94</b> or <b>96</b> with the corresponding isocyanate in chloroform afforded the desired ureas <b>97</b>–<b>102</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>, 2-butanone, 20% NaOH, reflux (84%); (b) isocyanate derivatives, NEt<sub>3</sub>, CHCl<sub>3</sub>, room temperature (35–55%).</p></p></figure><div class="NLM_p">In Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the diarylurea moiety resulted in excellent kinase inhibition with a nanomolar IC<sub>50</sub> value against KDR. There was a selectivity of (aryloxy)quinazoline for this enzyme, against EGFR. Introduction of a methyl group on the phenyl ring (<b>99</b>–<b>102</b>) led to an excellent inhibitory activity against VEGFR-2, in particular for naphthalene derivative <b>102</b> (IC<sub>50</sub> = 2 nM against VEGFR-2). Substitution of the aromatic group by a bulkier group such as a halide or a naphthalene was tolerated. This enzymatic inhibition was limited by introduction of an electron donor group such as methoxy (<b>87</b> and <b>97</b>). These quinazolines were further evaluated in cell-based assays and, unfortunely, were inactive toward different cancer cell lines.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzymatic (EGFR/VEGR-2) and Cellular (PC3, Prostate Cancer Cell; HT29, Colon Cancer Cell; MCF-7, Breast Cancer Cell) Results for New Quinazoline Urea Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compounds tested at a concentration of 10 μM. The values are the mean ± SD of at least three independent experiments (SD < 10%).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Inhibition of EGFR (purified from human carcinoma A431 cells) tyrosine kinase activity.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Inhibition of VEGFR-2 (recombinant human protein) tyrosine kinase activity.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Cell proliferation was realized by MTS assay at 10 μM from at least three independent determinations. Higher concentrations were not used to avoid precipitation of the compounds in the culture medium.</p></div></div><div></div></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Molecular Modeling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All the calculations have been carried out under the Sybyl 6.9.1 molecular modeling package<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> running on Silicon Graphics Octane 2 workstations. The ligands were built from the internal fragment library of Sybyl, and their geometries were optimized by the Powell method available in the Maximin2 procedure to a gradient of 0.001 kcal/(mol·Å). The dielectric constant was set to 7.4 to implicitly represent a biological middle, the atomic charges were attributed by the Gasteiger–Hückel method, and the energy minimization was run with the Tripos force field.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">To produce a meaningful conformation for their alignment, the best compounds of the two main substitution patterns (<b>91</b> and <b>92</b>) were docked into the VEGFR-2 active site (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This was carried out by selecting a suitable reference, that is, a structure of the enzyme cocrystallized with an inhibitor structurally related to our compounds. The structure of the protein cocrystallized with a suitable furopyrimidinic inhibitor (<b>103</b>) was obtained from the Protein Data Bank (<a href="http://www.pdb.org" class="extLink">http://www.pdb.org</a>)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> under the entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn">1ywn</a>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The cocrystallized inhibitor and water molecules were removed, and hydrogens were added to the protein, taking care to be as close as possible to the biological protonation state of the residues. The binding mode of the compounds was investigated by a two-step process. They were first docked into the binding site of VEGFR-2 with GOLD 3.2,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> the binding site being defined as a 10 Å sphere around the cocrystallized inhibitor. The multiple conformations generated were then ranked by an in-house consensus scoring based on Goldscore<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and X-Score.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The consistency of the best ranked conformation was visually assessed to make sure it was the most stable binding mode prediction. The molecules were aligned on the best docking conformation of the closer reference compound to give a putative bioactive conformation. The QSAR models were achieved by randomly dividing the pool of 49 compounds into a series of training sets of 33 molecules and corresponding test sets of the 16 remaining molecules (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), following the recommendations by Oprea.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> A later batch of 16 more compounds were predicted before their testing as an external test set, therefore assessing the models from the initial 33 compounds on a very large 32-molecule test set. Each training set was employed to generate models using the CoMFA<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and CoMSIA<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> methodologies against the activity of the molecules expressed as pIC<sub>50</sub>, that is, the opposite of the logarithm of their activity, using the same set of default parameters and the same box for all the models. If they passed a <i>q</i><sup>2</sup> threshold of 0.3, their external prediction capacity was tested by predicting the values of pIC<sub>50</sub> for the corresponding test set compounds, yielding an <i>r</i><sub>pred</sub><sup>2</sup> value. Another relevant parameter is the number of components <i>N</i> of the models, showing the relative complexity of the underlying mathematical model. The resulting fields were depicted as the zones where the contributions of the fields to the activity were the largest (positive influence, >80%; negative influence, <20%).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. CoMFA- and CoMSIA-Predicted Activities</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center">set</th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">CoMSIA prediction</th><th class="colsep0 rowsep0" align="center" char=".">CoMSIA difference</th><th class="colsep0 rowsep0" align="center" char=".">CoMFA prediction</th><th class="colsep0 rowsep0" align="center" char=".">CoMFA difference</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">5.44</td><td class="colsep0 rowsep0" align="char" char=".">–0.28</td><td class="colsep0 rowsep0" align="char" char=".">5.56</td><td class="colsep0 rowsep0" align="char" char=".">–0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.12</td><td class="colsep0 rowsep0" align="char" char=".">5.66</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">5.54</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>37</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.27</td><td class="colsep0 rowsep0" align="char" char=".">5.37</td><td class="colsep0 rowsep0" align="char" char=".">–0.10</td><td class="colsep0 rowsep0" align="char" char=".">5.57</td><td class="colsep0 rowsep0" align="char" char=".">–0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>38</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">5.81</td><td class="colsep0 rowsep0" align="char" char=".">–0.02</td><td class="colsep0 rowsep0" align="char" char=".">5.73</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.14</td><td class="colsep0 rowsep0" align="char" char=".">5.22</td><td class="colsep0 rowsep0" align="char" char=".">–0.08</td><td class="colsep0 rowsep0" align="char" char=".">5.18</td><td class="colsep0 rowsep0" align="char" char=".">–0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.36</td><td class="colsep0 rowsep0" align="char" char=".">5.54</td><td class="colsep0 rowsep0" align="char" char=".">–0.18</td><td class="colsep0 rowsep0" align="char" char=".">5.65</td><td class="colsep0 rowsep0" align="char" char=".">–0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>41</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td><td class="colsep0 rowsep0" align="char" char=".">–0.14</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td><td class="colsep0 rowsep0" align="char" char=".">–0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>42</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.24</td><td class="colsep0 rowsep0" align="char" char=".">5.09</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">5.22</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.25</td><td class="colsep0 rowsep0" align="char" char=".">5.06</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">5.01</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>44</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.30</td><td class="colsep0 rowsep0" align="char" char=".">5.14</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">4.82</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">5.42</td><td class="colsep0 rowsep0" align="char" char=".">–0.25</td><td class="colsep0 rowsep0" align="char" char=".">5.58</td><td class="colsep0 rowsep0" align="char" char=".">–0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>46</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">5.13</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">5.04</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">5.25</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">5.39</td><td class="colsep0 rowsep0" align="char" char=".">–0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.48</td><td class="colsep0 rowsep0" align="char" char=".">5.21</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">5.18</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td><td class="colsep0 rowsep0" align="char" char=".">5.54</td><td class="colsep0 rowsep0" align="char" char=".">–0.23</td><td class="colsep0 rowsep0" align="char" char=".">5.75</td><td class="colsep0 rowsep0" align="char" char=".">–0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>51</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.07</td><td class="colsep0 rowsep0" align="char" char=".">5.49</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">5.73</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.28</td><td class="colsep0 rowsep0" align="char" char=".">5.37</td><td class="colsep0 rowsep0" align="char" char=".">–0.09</td><td class="colsep0 rowsep0" align="char" char=".">5.43</td><td class="colsep0 rowsep0" align="char" char=".">–0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.11</td><td class="colsep0 rowsep0" align="char" char=".">4.98</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">5.32</td><td class="colsep0 rowsep0" align="char" char=".">–0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td><td class="colsep0 rowsep0" align="char" char=".">4.82</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">5.20</td><td class="colsep0 rowsep0" align="char" char=".">–0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">5.30</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">5.39</td><td class="colsep0 rowsep0" align="char" char=".">–0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.23</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td><td class="colsep0 rowsep0" align="char" char=".">–0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">5.65</td><td class="colsep0 rowsep0" align="char" char=".">–0.36</td><td class="colsep0 rowsep0" align="char" char=".">6.17</td><td class="colsep0 rowsep0" align="char" char=".">–0.88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.21</td><td class="colsep0 rowsep0" align="char" char=".">5.44</td><td class="colsep0 rowsep0" align="char" char=".">–0.24</td><td class="colsep0 rowsep0" align="char" char=".">5.97</td><td class="colsep0 rowsep0" align="char" char=".">–0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>63</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.37</td><td class="colsep0 rowsep0" align="char" char=".">5.83</td><td class="colsep0 rowsep0" align="char" char=".">–0.46</td><td class="colsep0 rowsep0" align="char" char=".">6.09</td><td class="colsep0 rowsep0" align="char" char=".">–0.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>65</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.00</td><td class="colsep0 rowsep0" align="char" char=".">5.83</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">5.87</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>66</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td><td class="colsep0 rowsep0" align="char" char=".">5.52</td><td class="colsep0 rowsep0" align="char" char=".">–0.33</td><td class="colsep0 rowsep0" align="char" char=".">5.07</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>67</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.28</td><td class="colsep0 rowsep0" align="char" char=".">5.53</td><td class="colsep0 rowsep0" align="char" char=".">–0.25</td><td class="colsep0 rowsep0" align="char" char=".">5.41</td><td class="colsep0 rowsep0" align="char" char=".">–0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>69</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">5.43</td><td class="colsep0 rowsep0" align="char" char=".">–0.28</td><td class="colsep0 rowsep0" align="char" char=".">5.64</td><td class="colsep0 rowsep0" align="char" char=".">–0.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>71</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.18</td><td class="colsep0 rowsep0" align="char" char=".">4.97</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">5.10</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>72</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.13</td><td class="colsep0 rowsep0" align="char" char=".">5.55</td><td class="colsep0 rowsep0" align="char" char=".">–0.42</td><td class="colsep0 rowsep0" align="char" char=".">5.58</td><td class="colsep0 rowsep0" align="char" char=".">–0.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>74</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.28</td><td class="colsep0 rowsep0" align="char" char=".">5.53</td><td class="colsep0 rowsep0" align="char" char=".">–0.26</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">–0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>75</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">5.13</td><td class="colsep0 rowsep0" align="char" char=".">5.14</td><td class="colsep0 rowsep0" align="char" char=".">–0.01</td><td class="colsep0 rowsep0" align="char" char=".">4.69</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>77</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.03</td><td class="colsep0 rowsep0" align="char" char=".">5.06</td><td class="colsep0 rowsep0" align="char" char=".">–0.03</td><td class="colsep0 rowsep0" align="char" char=".">4.78</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>80</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.22</td><td class="colsep0 rowsep0" align="char" char=".">6.66</td><td class="colsep0 rowsep0" align="char" char=".">–0.44</td><td class="colsep0 rowsep0" align="char" char=".">6.65</td><td class="colsep0 rowsep0" align="char" char=".">–0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>81</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.05</td><td class="colsep0 rowsep0" align="char" char=".">4.78</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">4.96</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>82</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.17</td><td class="colsep0 rowsep0" align="char" char=".">6.40</td><td class="colsep0 rowsep0" align="char" char=".">–0.23</td><td class="colsep0 rowsep0" align="char" char=".">6.15</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>83</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.19</td><td class="colsep0 rowsep0" align="char" char=".">6.14</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">5.92</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>84</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.42</td><td class="colsep0 rowsep0" align="char" char=".">6.60</td><td class="colsep0 rowsep0" align="char" char=".">–0.18</td><td class="colsep0 rowsep0" align="char" char=".">6.33</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>85</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">6.00</td><td class="colsep0 rowsep0" align="char" char=".">6.49</td><td class="colsep0 rowsep0" align="char" char=".">–0.49</td><td class="colsep0 rowsep0" align="char" char=".">6.44</td><td class="colsep0 rowsep0" align="char" char=".">–0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>87</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">7.17</td><td class="colsep0 rowsep0" align="char" char=".">6.96</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">7.32</td><td class="colsep0 rowsep0" align="char" char=".">–0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>89</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">7.03</td><td class="colsep0 rowsep0" align="char" char=".">7.13</td><td class="colsep0 rowsep0" align="char" char=".">–0.10</td><td class="colsep0 rowsep0" align="char" char=".">7.32</td><td class="colsep0 rowsep0" align="char" char=".">–0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>92</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">6.19</td><td class="colsep0 rowsep0" align="char" char=".">4.74</td><td class="colsep0 rowsep0" align="char" char=".">1.45</td><td class="colsep0 rowsep0" align="char" char=".">5.25</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>93</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">4.86</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">5.18</td><td class="colsep0 rowsep0" align="char" char=".">–0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>97</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="char" char=".">6.81</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td><td class="colsep0 rowsep0" align="char" char=".">7.08</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>98</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">8.22</td><td class="colsep0 rowsep0" align="char" char=".">7.84</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">7.47</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>99</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="char" char=".">7.53</td><td class="colsep0 rowsep0" align="char" char=".">–0.13</td><td class="colsep0 rowsep0" align="char" char=".">7.75</td><td class="colsep0 rowsep0" align="char" char=".">–0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>100</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">8.40</td><td class="colsep0 rowsep0" align="char" char=".">8.13</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">7.87</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>101</b></td><td class="colsep0 rowsep0" align="left">training</td><td class="colsep0 rowsep0" align="char" char=".">8.22</td><td class="colsep0 rowsep0" align="char" char=".">7.98</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">7.72</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>102</b></td><td class="colsep0 rowsep0" align="left">test</td><td class="colsep0 rowsep0" align="char" char=".">8.70</td><td class="colsep0 rowsep0" align="char" char=".">7.66</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char=".">7.62</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td></tr></tbody></table></div></div><div class="NLM_p">To validate the docking, the cocrystallized ligand <b>103</b> was docked using the same procedure as that used for our compounds. The highest scoring conformation is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> with the cocrystallized conformation. Its rmsd versus the crystallographic conformation is a low 0.436 Å. Moreover, all 30 solutions are closely superimposed and form the same hydrogen bonds with Glu 883 (H on the nitrogens of the urea), with the backbone H of Asp 1044 (carbonyl of the urea), and with the backbone H of Cys 917 (N1 of the pyrimidinic cycle). The only real difference is the position of the terminal methoxy, lying in the plane of the aromatic group in the crystallographic structure and perpendicular to it in the docked conformation. We therefore concluded our docking protocol was sound and assumed the resultant conformation to be representative of the bioactive binding mode of our highest activity compounds.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking conformation of furo[2,3-<i>d</i>]pyrimidine <b>103</b> synthesized by Y. Miyazaki<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> (colored by atom types) compared with the crystallographic conformation (in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The substitution pattern of the central aromatic tensor of our molecules is either a <i>para</i> or a <i>meta</i> disubstitution. As easily understood, the <i>para</i> pattern gives a conformation closer to that of the cocrystallized compound (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a), with a good conservation of the spatial position of the molecule from the terminal aromatic group up to the central aromatic tensor. The dimethoxyquinazoline is oriented in the same direction as the central aromatic–urea chain, rather than being upright as in <b>103</b>. However, the same H bonds are found, with the distal nitrogen of the quinazoline linking with Cys 917 rather than the proximal nitrogen as in the reference compound. The second leader we have docked conserves the position of the important urea and has much the same conformation as its <i>para</i> congener. However, the aromatic tensor plane forms an angle of about 140° with <b>92</b>. Nonetheless, the distal nitrogen of the dimethoxyquinazoline is at 1.1 Å in the <b>92</b> counterpart and is therefore also implied in a H bond with Cys 917 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0016.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Docking conformation of <b>91</b>. (b) Docking of <b>92</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The remaining compounds were aligned on either <b>91</b> or <b>92</b> following their substitution pattern to yield an alignment. From it, a number of models were created as outlined previously and evaluated for their robustness (<i>N</i>, <i>r</i><sup>2</sup>) and predictive power (<i>q</i><sup>2</sup>, <i>r</i><sub>pred</sub><sup>2</sup>). The five best models are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Interestingly, all of them present a number of components <i>N</i> lower than one-fourth of the compounds included in their elaboration, thus meaning they are able to handle the activity values with a fairly simple equation. They are characterized by high <i>r</i><sup>2</sup> and <i>q</i><sup>2</sup> above the threshold value of 0.3 we have imposed in the initial selection of the models because this value means a confidence of 95% that the resulting model is not due to a chance correlation.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The major indicative factor of a predictive model is its <i>r</i><sub>pred</sub><sup>2</sup> value. With the exception of the CoMSIA model generated from training set 5, all are above 0.7, heralding the capacity of the models to predict the activity of a previously unknown compound with a fairly high accuracy of more than 70%. Although it has the highest <i>r</i><sub>pred</sub><sup>2</sup> for both CoMFA and CoMSIA, model 1 is somewhat hampered by its rather low <i>q</i><sup>2</sup>, indicating it has a poorer internal prediction capacity than the other models. Moreover, it also has a rather high number of components <i>N</i> for its CoMSIA part, indicating that the underlying mathematical model is more complex. Model 2 has the same number of components, but displays improved <i>q</i><sup>2</sup> and only a very slight decrease in <i>r</i><sub>pred</sub><sup>2</sup> for the CoMFA method. This is correlated to a possible instability in the predictions of the activity of the training set, as the leave-one-out cross-validated <i>r</i><sup>2</sup> represents the internal predictive power. In essence, at least one of the molecules in the training set could not be predicted from the model derived from the others, resulting in a large prediction error. While fairly attractive, we have not chosen it as our final model due to its relatively large <i>N</i>. The next model fared little better. It is quite correct in terms of predictive power but in our opinion lacks high enough <i>q</i><sup>2</sup> values, being the second worst model. Moreover, its practical use may be overburdened by the high number of components of the CoMFA part. The two remaining models share some features of interest. First, they display a balanced profile of stability (<i>r</i><sup>2</sup>) and predictivity (<i>q</i><sup>2</sup> and <i>r</i><sub>pred</sub><sup>2</sup>) that can be seen as a proof of their inherent robustness. Second, they have a low number of components, model 4 being better than model 5 in this aspect. Third, their external predictivity does not appear to be too strongly overestimated. It should be kept in mind that the higher the <i>r</i><sub>pred</sub><sup>2</sup>, the more confident one should be regarding the predictive power of a model. However, evaluation of the predictive capacity is tricky and can very easily lead to a false overconfidence over the reality of the prediction. We were rather suspicious of the <i>r</i><sub>pred</sub><sup>2</sup> nearing 0.90. In the meantime, the goal of the models is to provide biological activities of the compounds prior to their testing as accurately as possible, that is, with the highest <i>r</i><sub>pred</sub><sup>2</sup> possible. We therefore set model 4 as our predictive tool for the last batch of 16 molecules. Interestingly, all the models had a quite close repartition of fields. For the CoMFA models, the steric field is slightly less important than the electrostatic field, in a proportion of about 40/60. For the CoMSIA models, the global trend in field repartition is also well conserved among the models, although the individual percentages between the fields are more varied. Roughly, the steric contribution is about 5%, while the electrostatic fields contribute about 20%. Acceptor fields are fairly unimportant, with a 10% contribution, while hydrophobic and hydrogen bond donor fields are respectively 30% and 35%. This may be relatively well explained when noting that the loss of donor hydrogen bonds around the urea has a larger impact on the binding than the acceptor capacity or size of the molecule, as long as it is able to fit in the pocket. In our study, the large effect of the hydrophobicity is somewhat of a curse, as a high hydrophobicity could have a negative impact on the solubility of the compounds and therefore their cellular effect, while contributing favorably to the binding at a molecular level.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Statistical Results for the Top Five Models<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">CoMSIA</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">CoMFA</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">model no.</th><th class="colsep0 rowsep0" align="center" char="."><i>N</i></th><th class="colsep0 rowsep0" align="center" char="."><i>r</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>q</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>r</i><sub>pred</sub><sup>2</sup></th><th class="colsep0 rowsep0" align="center">fields</th><th class="colsep0 rowsep0" align="center" char="."><i>N</i></th><th class="colsep0 rowsep0" align="center" char="."><i>r</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>q</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>r</i><sub>pred</sub><sup>2</sup></th><th class="colsep0 rowsep0" align="center">fields</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="left">S, E</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="left">S, E, H, D, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="left">S, E</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="left">S, E, H, D, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="left">S, E</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="left">S, E, H, D, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="left">S, E</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="left">S, E, H, D, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="left">S, E</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="left">S, E, H, D, A</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Fields used in the models: S (steric), E (electrostatic), H (hydrophobic), D (hydrogen bond donor), A (hydrogen bond acceptor).</p></div></div></div><div class="NLM_p">The repartition of the compounds in the training and test sets is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. All three broad classes of activity (good, from 1 to 2.4; average from 2.5 to 3.4; low above 3.5) are well represented in both sets, with maybe a slight overrepresentation of the good activity compounds in the test set (four of the six compounds of this class). This does not show up prominetly inthe predictions of either the CoMSIA (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) or the CoMFA (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) model, as there are only two compounds predicted with about 1 log of error by both methods. One of them is compound <b>102</b>, which is the most active molecule. Due to the randomness of the repartition in the training and test sets, it fell in the test set and could not be predicted accurately from the compounds in the corresponding training set. By comparison, the second best compound, <b>91</b>, was attributed to the training set and is well predicted, therefore showing that the extrapolation from a model should be taken with caution. The second mispredicted compound is <b>92</b>, which was again classed in the test set. It fared rather poorly in the CoMSIA model, but slightly better in the CoMFA model. In the meantime, high-activity compounds, such as <b>98</b>, <b>100</b>, and <b>101</b>, were predicted much more accurately, with only compound <b>98</b> being missed by more than 0.5 log, and only by the CoMFA method. All of them were used for the training of the model, therefore stressing the possible effect of the underrepresentation of the highest activity class in the training set, rendering the model less able to extrapolate to the best pIC<sub>50</sub> values. It should also be noted that compound <b>69</b> was not included in the model due to the undetermined nature of its IC<sub>50</sub>. A series of 16 already synthetized compounds were tested later. We used them to further test the predictive ability of our model by estimating their activity before their testing as an external validation set. The results are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0017.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Repartition of the activities of the compounds in the training (blue tilted squares) and test (orange triangles) sets of model 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0018.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Predictions of CoMSIA model 4 for the training (blue tilted squares) and test (orange triangles) sets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0019.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Predictions of CoMFA model 4 for the training (blue tilted squares) and test (orange triangles) sets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Prediction for the 16 Compounds of the External Validation Set</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">CoMSIA prediction</th><th class="colsep0 rowsep0" align="center" char=".">CoMSIA difference</th><th class="colsep0 rowsep0" align="center" char=".">CoMFA prediction</th><th class="colsep0 rowsep0" align="center" char=".">CoMFA difference</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">6.28</td><td class="colsep0 rowsep0" align="char" char=".">5.145</td><td class="colsep0 rowsep0" align="char" char=".">1.135</td><td class="colsep0 rowsep0" align="char" char=".">5.314</td><td class="colsep0 rowsep0" align="char" char=".">0.966</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">6.19</td><td class="colsep0 rowsep0" align="char" char=".">5.212</td><td class="colsep0 rowsep0" align="char" char=".">0.978</td><td class="colsep0 rowsep0" align="char" char=".">5.522</td><td class="colsep0 rowsep0" align="char" char=".">0.668</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">6.07</td><td class="colsep0 rowsep0" align="char" char=".">5.115</td><td class="colsep0 rowsep0" align="char" char=".">0.955</td><td class="colsep0 rowsep0" align="char" char=".">5.54</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">5.28</td><td class="colsep0 rowsep0" align="char" char=".">5.281</td><td class="colsep0 rowsep0" align="char" char=".">–0.001</td><td class="colsep0 rowsep0" align="char" char=".">5.164</td><td class="colsep0 rowsep0" align="char" char=".">0.116</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>64</b></td><td class="colsep0 rowsep0" align="char" char=".">5.16</td><td class="colsep0 rowsep0" align="char" char=".">5.478</td><td class="colsep0 rowsep0" align="char" char=".">–0.318</td><td class="colsep0 rowsep0" align="char" char=".">5.476</td><td class="colsep0 rowsep0" align="char" char=".">–0.316</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>79</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6.538</td><td class="colsep0 rowsep0" align="char" char=".">–1.538</td><td class="colsep0 rowsep0" align="char" char=".">6.475</td><td class="colsep0 rowsep0" align="char" char=".">–1.475</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>80</b></td><td class="colsep0 rowsep0" align="char" char=".">6.22</td><td class="colsep0 rowsep0" align="char" char=".">6.362</td><td class="colsep0 rowsep0" align="char" char=".">–0.142</td><td class="colsep0 rowsep0" align="char" char=".">6.209</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>86</b></td><td class="colsep0 rowsep0" align="char" char=".">7.22</td><td class="colsep0 rowsep0" align="char" char=".">6.903</td><td class="colsep0 rowsep0" align="char" char=".">0.317</td><td class="colsep0 rowsep0" align="char" char=".">7.36</td><td class="colsep0 rowsep0" align="char" char=".">–0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>88</b></td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">6.446</td><td class="colsep0 rowsep0" align="char" char=".">0.954</td><td class="colsep0 rowsep0" align="char" char=".">6.639</td><td class="colsep0 rowsep0" align="char" char=".">0.761</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>90</b></td><td class="colsep0 rowsep0" align="char" char=".">7.22</td><td class="colsep0 rowsep0" align="char" char=".">7.099</td><td class="colsep0 rowsep0" align="char" char=".">0.121</td><td class="colsep0 rowsep0" align="char" char=".">7.389</td><td class="colsep0 rowsep0" align="char" char=".">–0.169</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>91</b></td><td class="colsep0 rowsep0" align="char" char=".">7.52</td><td class="colsep0 rowsep0" align="char" char=".">7.145</td><td class="colsep0 rowsep0" align="char" char=".">0.375</td><td class="colsep0 rowsep0" align="char" char=".">7.434</td><td class="colsep0 rowsep0" align="char" char=".">0.086</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">5.14</td><td class="colsep0 rowsep0" align="char" char=".">5.087</td><td class="colsep0 rowsep0" align="char" char=".">0.053</td><td class="colsep0 rowsep0" align="char" char=".">5.275</td><td class="colsep0 rowsep0" align="char" char=".">–0.135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>76</b></td><td class="colsep0 rowsep0" align="char" char=".">5.32</td><td class="colsep0 rowsep0" align="char" char=".">5.001</td><td class="colsep0 rowsep0" align="char" char=".">0.319</td><td class="colsep0 rowsep0" align="char" char=".">5.141</td><td class="colsep0 rowsep0" align="char" char=".">0.179</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>78</b></td><td class="colsep0 rowsep0" align="char" char=".">5.25</td><td class="colsep0 rowsep0" align="char" char=".">4.996</td><td class="colsep0 rowsep0" align="char" char=".">0.254</td><td class="colsep0 rowsep0" align="char" char=".">5.011</td><td class="colsep0 rowsep0" align="char" char=".">0.239</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>68</b></td><td class="colsep0 rowsep0" align="char" char=".">5.47</td><td class="colsep0 rowsep0" align="char" char=".">4.922</td><td class="colsep0 rowsep0" align="char" char=".">0.548</td><td class="colsep0 rowsep0" align="char" char=".">4.834</td><td class="colsep0 rowsep0" align="char" char=".">0.636</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>70</b></td><td class="colsep0 rowsep0" align="char" char=".">5.43</td><td class="colsep0 rowsep0" align="char" char=".">5.489</td><td class="colsep0 rowsep0" align="char" char=".">–0.059</td><td class="colsep0 rowsep0" align="char" char=".">5.121</td><td class="colsep0 rowsep0" align="char" char=".">0.309</td></tr></tbody></table></div></div><div class="NLM_p">Interestingly, the predictions were close enough to the actual values, with 14 compounds out of 16 predicted within 1 log of the experimental values and 11 within 0.5 log. Compound <b>48</b> was within 1.2 log, and only compound <b>79</b> was really mispredicted, with about 1.5 log of difference for both the CoMFA and CoMSIA models. This could be due to its somewhat shorter length compared to those of most of the other molecules included in the model, as it is a key synthesis intermediary, lacking the urea moiety. With respect to the reduced initial training set, these results implied the model fared fairly well. As a posttesting validation, we tried to create a model trained on all 49 compounds available in the first stage to more accurately predict the remaining 16. The CoMFA and CoMSIA models behaved quite well (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). They are comparable to model 4, with an improved CoMFA <i>r</i><sup>2</sup>, but a poorer CoMFA <i>q</i><sup>2</sup>. However, they were not better in the prediction of the second series of compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). In particular, compound <b>79</b> is still mispredicted by about 1.5 log. We therefore have not evaluated any further the development of this model and have reverted to model 4.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Statistical Results for Model 6</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center" char=".">CoMSIA</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">CoMFA</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."><i>N</i></th><th class="colsep0 rowsep0" align="center" char="."><i>r</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>q</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>N</i></th><th class="colsep0 rowsep0" align="center" char="."><i>r</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>q</i><sup>2</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.894</td><td class="colsep0 rowsep0" align="char" char=".">0.753</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.659</td><td class="colsep0 rowsep0" align="char" char=".">0.870</td></tr></tbody></table></div></div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0020.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Residuals of the second series of compounds by models 4 and 6 for the CoMFA (orange triangles) and CoMSIA (blue tilted squares) methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The two methods we have employed have the major advantage of providing a visual 3D depiction of the molecular fields around the compounds. We have compared them with the docking of the two lead compounds of our series. The CoMFA fields (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) give indications of the steric and electrostatic zones of interactions. There are two favorable contours for the steric field. A large contour is next to the aromatic group of the central tensor, where the pocket is widely open. A smaller one is at the other end of the urea, showing the interest of a substitution of an appropriate length on this moiety. The pocket is relatively tightly packed, so the naphthalene of <b>91</b> barely fits in this zone, just as the methoxyphenyl of <b>93</b>. A totally flexible end group such as the butane of <b>84</b> is also of the appropriate length. However, as none of our compounds have a longer chain, we can only guess they should not fit as well in the binding site. The sterically restricted zones complement this first view with a cluster of medium-sized contours around the aromatic tensor, on the side of the benzyl that is opposite that of the favorable zone. This is again in agreement with the binding site geometry, as they correspond to Val 846 and 914, closing this part of the pocket. Interestingly, a large hindrance zone and several smaller zones are placed at the entry of the pocket, indicating that too long groups on the quinazoline side are not useful for the activity and indeed are even unfavorable. This may be linked to the larger moieties replacing the two methoxy groups of the reference molecules, indicating either a loss of activity due to a lowered solubility or just an unfavorable entropic effect of fixing these long chains in a restrictive conformational environment. The electrostatic field is somewhat less informative, with respectively a small and a large favorable zone in the middle of the terminal and central aromatic groups of the reference compounds, offering the idea that these aromatic groups must bear a slightly decreased electronic load. The unfavorable contours and the favorable zone at the methoxy level are nearly useless as they are not related to the protein.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0021.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Steric (green, favorable; yellow, unfavorable) and electrostatic (blue, positive charge favorable; red, negative charge favorable) CoMFA fields.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The CoMSIA steric fields (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>a) are larger and more easily interpretable than their CoMFA counterparts, but point to the same trend. Two large favorable contours surround the terminal and central aromatics, clearly hinting to the importance of occupying the right end side of the pocket by a substitution on the urea. The central zone only includes the <i>meta</i>-substituted tensor. This may be an artifact related to the larger number of 1,4-substituted molecules having less impact on the variations of the fields. On the contrary, the two unfavorable zones near the methoxy point again to the worsened activity of compounds with longer chains on the oxygens. As previously described, the favorable electrostatic contours (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>a) show the importance of the electronic load of the central aromatic group. However, the urea is surrounded by two zones of major interest. A favorable one is placed next to the carboxy and an unfavorable one next to the distal nitrogen. They may be related to the hydrogen bonding occurring at these positions. The same is true for the favorable zone lying just under the distal nitrogen of the quinazoline. However, the interest of the larger contours around the methoxy is low, due to the aforementioned unfavorable steric effect of long chains in this position and the near to none correlation with residues of the protein. A large hydrophilic contour nearly completely surrounds the aromatic tensor (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>b). This could herald the lowered activity of molecules bearing a substitution of this element other than the straightforward 1,3- or 1,4-disubstitution. However, the smaller hydrophobic region that includes most of the urea is less easy to understand. It might come from the shorter compounds completely missing the urea, for which a hydrophobic substitution is the most common in our study. These compounds are in fact synthesis intermediaries that were tested to assess the effect of the urea. The hydrogen bond donor fields (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>c) display a large favorable contour in front of the nitrogen of the urea. As they are involved in a critical interaction with Glu 883, this contour is in very close agreement with the docking and the previous knowledge of the subject. A medium-sized unfavorable contour appears next to the oxygen of the tensor. Our compounds are built around either a phenoxyquinazoline or an anilinoquinazoline. Therefore, we can conclude easily that the hydrogen capacity of the anilinoquinazoline is not favorable to the activity of the molecules, bringing a fresh insight into the further development of the series. The acceptor fields are also in very good agreement with the docking. A small favorable contour appears around the Cys 917 backbone hydrogen involved in an interaction with the quinazoline. An unfavorable contour is displayed above the carbonyl of the urea. This group is engaged in a hydrogen bond with the backbone of Asp 1044, so this result more closely attracted our attention. Upon a closer investigation, this zone prohibits the placement of the carbonyl in an upward position that would hinder its interaction with Asp 1044 rather than clueing toward an unfavorable effect of this interaction. A few compounds of very feeble activity are pointing their carbonyl in this region, with a corresponding loss of the third hydrogen bond of the urea. Lastly, a large favorable contour is drawn around the oxygen of the tensor. It shows that a nitrogen in this position is not the best choice, and reinforces the unfavorable hydrogen donor contour. Taken together, the hydrogen bond fields offer an interesting view of the best scaffold in the series, which should be able to accept a hydrogen from Cys 917 and Asp 1044, give one or two hydrogens to Glu 883, and bear a tensor devoid of a hydrogen donor. All these conclusions are in excellent agreement with the docking, further corroborating the hypothesis of the binding mode we made at the first step of our study.</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0022.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. CoMSIA fields of <b>91</b> and <b>92</b>: (a) steric (green, favorable; yellow, unfavorable) and electrostatic (blue, positive charge favorable; red, negative charge favorable), (b) hydrophobic (yellow, hydrophobic favorable; white, hydrophilic favorable), (c) hydrogen bond donor (cyan, favorable; purple, unfavorable) and acceptor (magenta, favorable; red, unfavorable).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As they have proved to be quite predictive, these models were employed to imagine new structures and help rank them to prioritize the synthesis of the most promising. We have chosen molecules related to the previous series to keep the synthetic route close to those already described and to preserve the cohesion of the whole series. A number of new structures were proposed, following these guidelines and the interest of the substitution of the aromatic linker with a hydrophobic moiety, among which the bioisostery of methyl to halogen. Four compounds were chosen for biological evaluation as they were predicted to be the most promising (<b>106</b>–<b>109</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). These compounds were synthesized according to procedures described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> with the 4-chloro-6,7-dimethoxyquinazoline (<b>7</b>) as the starting product. Selective reaction of chloride derivative <b>7</b> with 4-amino-3-chlorophenol or 4-amino-2-chlorophenol and tetra-<i>n</i>-butylammonium bromide in a mixture of methyl ethyl ketone and sodium hydroxide provided the intermediates <b>104</b> and <b>105</b>. Condensation of <b>104</b> or <b>105</b> with the corresponding isocyanate in chloroform afforded the desired ureas <b>106–108</b> and <b>109</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Prediction for the Four Newly Synthetized Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0002.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0003.gif" alt="" id="fx5" /></img><div></div></div><figure id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0001.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>, 2-butanone, 20% NaOH, reflux (40–70%); (b) isocyanate derivatives, NEt<sub>3</sub>, CHCl<sub>3</sub>, room temperature (10–38%).</p></p></figure><div class="NLM_p last">Most interestingly, none of the compounds were predicted with an error as high as 0.3 log by the CoMSIA model, while the CoMFA model fared somewhat worse, with two underestimated molecules at more than 0.5 log from their experimental value. Moreover, it appeared that the overall ranking of the compounds prior to their synthesis presented no match between the CoMFA ranking and the experimental pIC<sub>50</sub>. On the other hand, the best and worst compounds of this new series were correctly guessed by the CoMSIA model. In more detail, compound <b>108</b>, the chlorinated congener of compound <b>102</b>, was predicted to be close to the latter by the CoMSIA model, while it was predicted to be noticeably worse by the CoMFA model, which proved to be very precise. This could be due to a less accurate account of the charge repartition on the aromatic center bearing the chlorine by the CoMSIA model. On the basis of methylated compounds <b>100</b>–<b>102</b>, we have tried the chlorinated aromatic tensor analogues <b>106</b>–<b>109</b>. Relocating the chlorine on this benzene from position 3 to position 2 had the effect of improving the CoMSIA-predicted values, as we expected in part due to the fact that compound <b>109</b> is the sole molecule with this substitution pattern. However, it had the reverse effect for CoMFA, most probably due to an overevaluation of the electrostatic effect of the halogen on the charge repartition of the central aromatic group. Experimentally, compound <b>109</b> was slightly overpredicted by the CoMSIA model, while compound <b>106</b> was largely underestimated by the CoMFA model. Comparing these compounds with their methylated congener, compound <b>100</b>, the CoMSIA model accurately predicted the new molecules to be somewhat less good, but rather close to compound <b>101</b>, of only slightly lower activity. The effect of this different pattern on the CoMFA prediction is intriguing. Although this model consistently gave not so good predictions for the best compounds of the series, such a high underestimation for compound <b>106</b> appears to be related again to the higher electrostatic field contribution in this model. Compound <b>107</b>, the chlorinated analogue of compound <b>101</b>, suffered from the same drawback, with a serious underestimation from the CoMFA model, while it has been reasonably well predicted by the CoMSIA model. In hindsight, these compounds showed the validity of the models in interpolating to more fully complete the chemical cover of the series but also illustrated the greater robustness of the CoMSIA predictions and the rather low interest of the CoMFA model in predicting better than average activity compounds, maybe due to an overemphasis on the electrostatic field around the central aromatic group.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of 60 new VEGFR-2 inhibitors have been synthesized and tested on the enzyme. Their activity was evaluated in vitro. In an effort to further develop this series, a QSAR model has been derived from this activity in a two-step process. First, the docking of the most active compound of the two families of molecules has been realized to achieve a putative bioactive conformation. Second, 3D QSAR models employing the CoMFA and CoMSIA methods have been elaborated on the basis of an alignment of the compounds on the putative bioactive conformation of the two reference molecules. The excellent agreement between the docking and the QSAR fields indicates that the binding mode hypothesis is most probably fairly close to the biological binding mode, therefore offering a relevant basis for proposing improvements for the further development of the series. The second major interest of this study is the predictive power of the models, more than their insights into the structural modifications that would enhance the activity of the series, which is too homogeneous to provide an efficient basis for suggesting new scaffolds. This predictive power has been validated on external test sets and further proved on newly synthesized compounds before their biological evaluation. It was employed to propose some new compounds, the most promising of which have been synthesized and tested, with fairly promising results. We plan to further investigate the effect of the modification of the tail of the compounds, lying in a large favorable steric contour, up to the largest group still able to fit in the binding site, with a combined docking–QSAR–in vitro assay methodology.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p">Melting points were determined with a Büchi 535 capillary melting point apparatus and are uncorrected. Kieselgel 60 F-254 commercial plates were used for analytical TLC as well as UV light and/or with iodine to follow the course of the reaction. Flash chromatography (FC) was performed with silica gel Kieselgel Si 60, 0.063–0.200 mm (Merck). The structure of each compound was confirmed by IR (Bruker VECTOR 22 instrument) and <sup>1</sup>H NMR (300 MHz, Bruker AC300P spectrometer). Chemicals shifts (δ) are reported in parts per million downfield from TMS, <i>J</i> values are in hertz, and the splitting patterns are abbreviated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet. The purity of the compounds was tested by HPLC separation followed by APCI<sup>+</sup> (atmospheric pressure chemical ionization) mass spectral detection on an LC–MS system, Thermo Electon Surveyor MSQ, and was >95%.</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 4-Chloro-6,7-dimethoxyquinazoline (<b>7</b>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></h4><div class="NLM_p last">To a solution of methyl-2-amino-4,5-dimethoxybenzoate (4.0 g, 19.0 mmol) in DMF (40 mL) and methanol (10 mL) were added formamide (76.0 mmol) and sodium methoxide (54.0 mmol). The resulting mixture was refluxed for 16 h. After quenching by water (100 mL), the mixture was neutralized by 1 M HCl solution. The precipitate was collected by filtration, washed with H<sub>2</sub>O (30 mL) and Et<sub>2</sub>O (30 mL), and dried in vacuo to give quinazolinone <b>2</b> as a white solid (82%) which was used directly in the next step. A mixture of <b>2</b> (3.0 g, 15.0 mmol) and phosphorus oxychloride (30 mL) was refluxed for 2 h. After removal of the solvent, the residue was dissolved in ice–water (50 mL), and the mixture was neutralized by ammonium hydroxide. The precipate was collected by filtration and dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The organic layer was washed with a 1 M solution of K<sub>2</sub>CO<sub>3</sub> (3 × 40 mL) and brine (1 × 40 mL) and dried over CaCl<sub>2</sub>, and the solvent was removed under reduced pressure. The spectroscopic data for compound <b>3</b> are in agreement with those reported in the literature.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (<b>94</b>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></h4><div class="NLM_p last">A solution of <b>7</b> (2.00 g, 8.90 mmol), 4-aminophenol (1.17 g, 10.70 mmol), and tetra-<i>n</i>-butylammonium bromide (1.43 g, 4.45 mmol) in methyl ethyl ketone (20 mL) and a 20% solution of NaOH (10 mL) was refluxed for 30 min. After dilution by CHCl<sub>3</sub> (100 mL) and H<sub>2</sub>O (20 mL), the organic layer was washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure, and then the precipitated solid was collected by filtration and washed with MeOH (15 mL) to give <b>94</b> as a white solid (89%). The spectroscopic data for compound <b>94</b> are in agreement with those reported in the literature.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 3-[(6,7-Dimethoxy-4-quinazolinyl)oxy]aniline (<b>95</b>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></h4><div class="NLM_p last">A solution of <b>7</b> (2.00 g, 8.90 mmol), 3-aminophenol (1.17 g, 10.70 mmol), and tetra-<i>n</i>-butylammonium bromide (1.43 g, 4.45 mmol) in methyl ethyl ketone (20 mL) and a 20% solution of NaOH (10 mL) was refluxed for 30 min. After dilution by CHCl<sub>3</sub> (100 mL) and H<sub>2</sub>O (20 mL), the organic layer was washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure, and then the precipitated solid was collected by filtration and washed with MeOH (15 mL) to give <b>95</b> as a white solid (93%). The spectroscopic data for compound <b>95</b> are in agreement with those reported in the literature.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-3-methylaniline (<b>96</b>)</h4><div class="NLM_p last">A solution of <b>7</b> (2.00 g, 8.90 mmol), 4-amino-3-methylphenol (1.12 g, 10.70 mmol), and tetra-<i>n</i>-butylammonium bromide (1.43 g, 4.45 mmol) in methyl ethyl ketone (20 mL) and a 20% solution of NaOH (10 mL) was refluxed for 30 min. After dilution by CHCl<sub>3</sub> (100 mL) and H<sub>2</sub>O (20 mL), the organic layer was washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure, and then the precipitated solid was collected by filtration and washed with MeOH (15 mL) to give <b>96</b> as a white solid (84%). Mp: 221–223 °C. IR (cm<sup>–1</sup>): 3384 (NH<sub>2</sub>), 1205 (C═C—O), 1075 (C–O–C methoxy). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.51 (s, 1H, ArH), 7.52 (s, 1H, ArH), 7.33 (s, 1H, ArH), 6.57 (d, 1H, <i>J</i> = 2.10 Hz, ArH), 6.43 (dd, 1H, <i>J</i> = 2.10 and 8.00 Hz, ArH), 6.36 (d, 1H, <i>J</i> = 8.01 Hz, ArH), 5.22 (s, 2H, NH<sub>2</sub>), 4.02 (s, 3H, OCH<sub>3</sub>), 3.98 (s, 3H, OCH<sub>3</sub>), 2.15 (s, 3H, CH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> 312 [(M + H)<sup>+</sup>].</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure for Urea Derivatives <b>97</b> and <b>98</b></h4><div class="NLM_p">To a stirred solution of <b>94</b> (0.20 g, 0.67 mmol) and NEt<sub>3</sub> (0.17 g, 1.68 mmol) in 10 mL of CHCl<sub>3</sub> were added phenyl isocyanate derivatives (0.80 mmol). After 16 h, the residue was filtered off, washed by chloroform (5 mL) and petrolum ether (10 mL), and recrystallized.</div><div id="sec3_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> <i>N</i>-{4-[(6,7-Dimethoxyquinazolin-4-yl)oxy]phenyl}-<i>N</i>′-(3-methoxyphenyl)urea (<b>97</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>97</b> as a white solid (81%). Mp: 237–239 °C. IR (cm<sup>–1</sup>): 3214 (NH), 1695 (C═O), 1208 (C═C—O), 1079 (C–O–C methoxy). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.80 (s, 1H, NH), 8.70 (s, 1H, NH), 8.52 (s, 1H, ArH), 7.50–7.60 (m, 3H, ArH), 7.36 (s, 1H, ArH), 7.15–7.25 (m, 4H, ArH), 6.94 (d, <i>J</i> = 6.80 Hz, 1H, ArH), 6.55 (d, <i>J</i> = 6.80 Hz, 1H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 3.72 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub> 447 [(M + H)<sup>+</sup>].</div></div><div id="sec3_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>N</i>-(3-Bromophenyl)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}urea (<b>98</b>)</h5><div class="NLM_p last">Crystallization from acetonitrile gave pure <b>98</b> as a white solid (69%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3214 (NH), 1697 (C═O), 1206 (C═C—O), 1080 (C–O–C methoxy), 1056 (C–Br). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.75 (s, 1H, NH), 8.70 (s, 1H, NH), 8.51 (s, 1H, ArH), 7.50–7.70 (m, 3H, ArH), 7.34 (s, 1H, ArH), 7.15–7.25 (m, 4H, ArH), 6.98 (d, <i>J</i> = 7.40 Hz, 1H, ArH), 6.70 (d, <i>J</i> = 7.40 Hz, 1H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>19</sub>BrN<sub>4</sub>O<sub>4</sub> 495 [(M + H)<sup>+</sup> for <sup>79</sup>Br] and 497 [(M + H)<sup>+</sup> for <sup>81</sup>Br].</div></div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure for Urea Derivatives <b>99</b>–<b>102</b></h4><div class="NLM_p">To a stirred solution of <b>96</b> (0.20 g, 0.64 mmol) and NEt<sub>3</sub> (0.19 g, 1.60 mmol) in 10 mL of CHCl<sub>3</sub> were added phenyl isocyanate derivatives (0.83 mmol). After 16 h, the residue was filtered off, washed by chloroform (5 mL) and petrolum ether (10 mL), and recrystallized.</div><div id="sec3_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> <i>N</i>-(4-Bromophenyl)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]-3-methylphenyl}urea (<b>99</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>99</b> as a white solid (65%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3213 (NH), 1695 (C═O), 1206 (C═C—O), 1079 (C–O–C methoxy), 1057 (C–Br). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.02 (s, 1H, NH), 8.52 (s, 1H, NH), 8.01 (s, 1H, ArH), 7.90 (d, <i>J</i> = 9.10 Hz, 1H, ArH), 7.57 (s, 1H, ArH), 7.51 (d, <i>J</i> = 8.70 Hz, 2H, ArH), 7.39 (s, 1H, ArH), 7.28 (m, 2H, ArH), 7.05–7.15 (m, 3H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>), 2.28 (s, 3H, CH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>21</sub>BrN<sub>4</sub>O<sub>4</sub> 509 [(M + H)<sup>+</sup> for <sup>79</sup>Br] and 511 [(M + H)<sup>+</sup> for <sup>81</sup>Br].</div></div><div id="sec3_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> <i>N</i>-(3-Bromophenyl)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]-3-methylphenyl}urea (<b>100</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>100</b> as a white solid (60%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3214 (NH), 1695 (C═O), 1206 (C═C—O), 1079 (C–O–C methoxy), 1052 (C–Br). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.85 (s, 1H, NH), 8.75 (s, 1H, NH), 8.10 (s, 1H, ArH), 7.50–7.65 (m, 3H, ArH), 7.35 (s, 1H, ArH), 7.15–7.25 (m, 4H, ArH), 6.95 (m, 1H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>), 2.27 (s, 3H, CH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>21</sub>BrN<sub>4</sub>O<sub>4</sub> 509 [(M + H)<sup>+</sup> for <sup>79</sup>Br] and 511 [(M + H)<sup>+</sup> for <sup>81</sup>Br].</div></div><div id="sec3_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> <i>N</i>-(3-Chloro-4–fluoroanilino)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]-3-methylphenyl}urea (<b>101</b>)</h5><div class="NLM_p last">Crystallization from acetonitrile gave pure <b>101</b> as a white solid (75%). Mp: >250 °C. IR (cm<sup>–1</sup>) 3213 (NH), 1695 (C═O), 1206 (C═C—O), 1079 (C–O–C methoxy), 1057 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.21 (s, 1H, NH), 8.52 (s, 1H, NH), 8.08 (s, 1H, ArH), 7.80–7.90 (m, 2H, ArH), 7.52 (s, 1H, ArH), 7.30–7.40 (m, 2H, ArH), 7.11 (s, 1H, ArH), 7.08 (d, <i>J</i> = 2.30 Hz, 1H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>), 2.28 (s, 3H, CH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>20</sub>ClFN<sub>4</sub>O<sub>4</sub> 483 [(M + H)<sup>+</sup> for <sup>35</sup>Cl] and 485 [(M + H)<sup>+</sup> for <sup>37</sup>Cl].</div></div><div id="sec3_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>N</i>-{4-[(6,7-Dimethoxyquinazolin-4-yl)oxy]-3-methylphenyl}-<i>N</i>′-(2-naphthyl)urea (<b>102</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>102</b> as a white solid (55%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3213 (NH), 1697 (C═O), 1206 (C═C—O), 1079 (C–O–C methoxy). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.17 (s, 1H, NH), 8.81 (s, 1H, NH), 8.52 (s, 1H, ArH), 8.15–8.25 (m, 2H, ArH), 7.60–7.80 (m, 2H, ArH), 7.30–7.50 (m, 5H, ArH), 7.13 (s, 1H, ArH), 7.07 (d, <i>J</i> = 2.10 Hz, 1H, ArH), 6.95 (d, <i>J</i> = 2.40 Hz, 1H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>), 2.28 (s, 3H, CH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> 481 [(M + H)<sup>+</sup>].</div></div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-3-chloroaniline (<b>104</b>)</h4><div class="NLM_p last">A solution of <b>7</b> (2.00 g, 8.90 mmol), 4-amino-3-chlorophenol hydrochloride (1.93 g, 10.70 mmol), and tetra-<i>n</i>-butylammonium bromide (1.43 g, 4.45 mmol) in methyl ethyl ketone (20 mL) and a 20% solution of NaOH (10 mL) was refluxed for 30 min. After dilution by CHCl<sub>3</sub> (100 mL) and H<sub>2</sub>O (20 mL), the organic layer was washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure, and then the precipitated solid was collected by filtration and washed with MeOH (15 mL) to give <b>104</b> as a brown solid (70%). Mp: 208–210 °C. IR (cm<sup>–1</sup>): 3385 (NH<sub>2</sub>), 1201 (C═C—O), 1070 (C–O–C methoxy), 1048 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.53 (s, 1H, ArH), 7.51 (s, 1H, ArH), 7.36 (s, 1H, ArH), 7.22 (d, 1H, <i>J</i> = 2.67 Hz, ArH), 6.98 (dd, 1H, <i>J</i> = 2.79 and 8.73 Hz, ArH), 6.84 (d, 1H, <i>J</i> = 8.76 Hz, ArH), 5.34 (s, 2H, NH<sub>2</sub>), 3.97 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>3</sub> 331 [(M + H)<sup>+</sup> for <sup>35</sup>Cl] and 333 [(M + H)<sup>+</sup> for <sup>37</sup>Cl].</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-2-chloroaniline (<b>105</b>)</h4><div class="NLM_p last">A solution of <b>7</b> (2.00 g, 8.90 mmol), 4-amino-2-chlorophenol (1.54 g, 10.70 mmol), and tetra-<i>n</i>-butylammonium bromide (1.43 g, 4.45 mmol) in methyl ethyl ketone (20 mL) and a 20% solution of NaOH (10 mL) was refluxed for 30 min. After dilution by CHCl<sub>3</sub> (100 mL) and H<sub>2</sub>O (20 mL), the organic layer was washed with water and brine and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure, and then the precipitated solid was collected by filtration and washed with MeOH (15 mL) to give <b>108</b> as a brown solid (40%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3385 (NH<sub>2</sub>), 1203 (C═C—O), 1068 (C–O–C methoxy), 1051 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 8.50 (s, 1H, ArH), 7.52 (s, 1H, ArH), 7.38 (s, 1H, ArH), 7.05 (d, 1H, <i>J</i> = 8.81 Hz, ArH), 6.70 (d, 1H, <i>J</i> = 2.62 Hz, ArH), 6.60 (dd, 1H, <i>J</i> = 2.32 and 8.80 Hz, ArH), 5.35 (s, 2H, NH<sub>2</sub>), 4.00 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>3</sub> 331 [(M + H)<sup>+</sup> for <sup>35</sup>Cl] and 333 [(M + H)<sup>+</sup> for <sup>37</sup>Cl].</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for Urea Derivatives (<b>106</b>–<b>108</b>)</h4><div class="NLM_p">To a stirred solution of <b>104</b> (0.20 g, 0.60 mmol) and NEt<sub>3</sub> (0.15 g, 1.50 mmol) in 10 mL of CHCl<sub>3</sub> were added phenyl isocyanate derivatives (0.72 mmol). After 16 h at room temperature, the solvent was removed under reduced pressure. The residue was dissolved in AcOEt, washed with a solution of HCl (1 N, 3 × 15 mL), a 10% solution of K<sub>2</sub>CO<sub>3</sub>(3 × 15 mL), and brine, and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure. The residue was purified by FC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95/5).</div><div id="sec3_1_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>N</i>-(3-Bromophenyl)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]-3-chlorophenyl}urea (<b>106</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>106</b> as a white solid (10%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3210 (NH), 1694 (C═O), 1219 (C–F), 1205 (C═C—O), 1081 (C–O–C methoxy), 1055 (C–Br), 1050 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.61 (s, 1H, NH), 8.57 (s, 1H, ArH), 8.45 (s, 1H, NH), 8.15 (d, 1H, <i>J</i> = 9.60 Hz, ArH), 7.89 (s, 1H, ArH), 7.55–7.58 (m, 2H, ArH), 7.39 (s, 1H, ArH), 7.23–7.32 (m, 3H, ArH), 7.16 (m, 1H, ArH), 3.99 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>18</sub>BrClN<sub>4</sub>O<sub>4</sub> 529 [(M + H)<sup>+</sup> for <sup>79</sup>Br/<sup>35</sup>Cl], 531 [(M + H)<sup>+</sup> for <sup>79</sup>Br/<sup>37</sup>Cl], 531 [(M + H)<sup>+</sup> for <sup>81</sup>Br/<sup>35</sup>Cl], and 533 [(M + H)<sup>+</sup> for <sup>81</sup>Br/<sup>37</sup>Cl].</div></div><div id="sec3_1_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i>-(3-Chloro-4-fluoroanilino)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]-3-methylphenyl}urea (<b>107</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>107</b> as a white solid (10%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3211 (NH), 1699 (C═O), 1205 (C═C—O), 1079 (C–O–C methoxy), 1057 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.89 (s, 1H, NH), 8.68 (s, 1H, ArH), 8.54 (s, 1H, NH), 8.16 (d, 1H, <i>J</i> = 9.06 Hz, ArH), 7.83 (dd, <i>J</i> = 7.01 and 4.47 Hz, 1H, ArH), 7.59 (s, 1H, ArH), 7.56 (d, 1H, <i>J</i> = 2.16 Hz, ArH), 7.42 (s, 1H, ArH), 7.30–7.39 (m, 3H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.98 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>17</sub>Cl<sub>2</sub>FN<sub>4</sub>O<sub>4</sub> 503 [(M + H)<sup>+</sup> for <sup>35</sup>Cl /<sup>35</sup>Cl], 505 [(M + H)<sup>+</sup> for <sup>37</sup>Cl /<sup>35</sup>Cl], and 507 [(M + H)<sup>+</sup> for <sup>37</sup>Cl /<sup>37</sup>Cl].</div></div><div id="sec3_1_9_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>N</i>-{4-[(6,7-Dimethoxyquinazolin-4-yl)oxy]-3-chlorophenyl}-<i>N</i>′-(2-naphthyl)urea (<b>108</b>)</h5><div class="NLM_p last">Crystallization from EtOH/H<sub>2</sub>0 (95/5) gave pure <b>108</b> as a white solid (10%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3213 (NH), 1697 (C═O), 1206 (C═C—O), 1079 (C–O–C methoxy), 1057 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.62 (s, 1H, NH), 9.33 (s, 1H, ArH), 8.53 (s, 1H, NH), 8.09 (m, 2H, ArH), 7.76–7.84 (m, 4H, ArH), 7.50 (m, 1H, ArH), 7.32–7.48 (m, 3H, ArH), 7.21 (s, 1H, ArH), 6.74 (d, <i>J</i> = 8.13 Hz, 1H, ArH), 4.01 (s, 3H, OCH<sub>3</sub>), 3.97 (s, 3H, OCH<sub>3</sub>), 2.28 (s, 3H, CH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>4</sub> 501 [(M + H)<sup>+</sup> for <sup>35</sup>Cl /<sup>35</sup>Cl], 503 [(M + H)<sup>+</sup> for <sup>37</sup>Cl /<sup>35</sup>Cl], and 505 [(M + H)<sup>+</sup> for <sup>37</sup>Cl /<sup>37</sup>Cl].</div></div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(3-Bromophenyl)-<i>N</i>′-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]-2-chlorophenyl}urea (<b>109</b>)</h4><div class="NLM_p last">To a stirred solution of <b>105</b> (0.20 g, 0.60 mmol) and NEt<sub>3</sub> (0.15 g, 1.50 mmol) in 10 mL of CHCl<sub>3</sub> was added 3-bromophenyl isocyanate (0.14 g, 0.72 mmol). After 48 h at room temperature, the solvent was removed under reduced pressure. The residue was dissolved in AcOEt, washed with a solution of HCl (1 N, 3 × 15 mL), a 10% solution of K<sub>2</sub>CO<sub>3</sub> (3 × 15 mL), and brine, and dried over MgSO<sub>4</sub>. The solvent was removed under reduced pressure. The residue was washed by EtOH. Crystallization from EtOH/H<sub>2</sub>O (95/5) gave pure <b>109</b> as a white solid (38%). Mp: >250 °C. IR (cm<sup>–1</sup>): 3200 (NH), 1618 (C═O), 1236 (C–F), 1208 (C═C—O), 1137 (C–O–C methoxy), 1048 (C–Br), 1031 (C–Cl). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ (ppm) 9.05 (s, 1H, NH), 9.01 (s, 1H, NH), 8.54 (s, 1H, ArH), 7.58 (d, 2H, ArH), 7.57 (s, 1H, ArH), 7.40 (m, 3H, ArH), 7.16–7.35 (m, 4H, ArH), 3.99 (s, 3H, OCH<sub>3</sub>), 3.98 (s, 3H, OCH<sub>3</sub>). LC–MS (APCI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>18</sub>BrClN<sub>4</sub>O<sub>4</sub> 529 [(M + H)<sup>+</sup> for <sup>79</sup>Br/<sup>35</sup>Cl], 531 [(M + H)<sup>+</sup> for <sup>79</sup>Br/<sup>37</sup>Cl], 531 [(M + H)<sup>+</sup> for <sup>81</sup>Br/<sup>35</sup>Cl], and 533 [(M + H)<sup>+</sup> for <sup>81</sup>Br/<sup>37</sup>Cl].</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Cell Culture and Cell Proliferation Assay</h3><div class="NLM_p">Human prostate cancer cells (PC3) and breast cancer cell line MCF7 were grown at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub> in RPMI-1640 medium (Sigma), minimum essential medium (MEM; Sigma), and Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% fetal bovine serum, glutamine (2 mM), penicillin (100 IU/mL), and streptomycin (100 μg/mL). Colon cancer cells (HT29) were grown at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub> in DMEM + Glutamax-I (Gibco) supplemented with 10% fetal bovine serum, penicillin (100 IU/mL), and streptomycin (100 μg/mL).</div><div class="NLM_p last">In the cell proliferation assay, cells were plated in triplicate on 96-well plates (3000 cells/well) and incubated for 24 h. The cells were then incubated in culture medium that contained various concentrations of tested compounds, each dissolved in less than 0.1% DMSO. After 72 h, cell growth was estimated by the colorimetric MTS test.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> In Vitro Kinase Assays</h3><div class="NLM_p">Kinase assays were performed in 96-well plates (Multiscreen Durapore, Millipore) using [γ-<sup>32</sup>P]ATP (Amersham Biosciences) and the synthetic polymer poly(Glu4/Tyr) (Sigma Chemicals) as a phosphoacceptor substrate. Tested compounds were dissolved in DMSO. The final concentration of DMSO in the assay solutions was 0.1%, which was shown to have no effect on the kinase activity.</div><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> EGFR Tyrosine Kinase Activity</h4><div class="NLM_p last">A 20 ng sample of EGFR (purified from human carcinoma A431 cells, Sigma Chemicals) was incubated for 1 h at 28 °C using various concentrations of tested compounds in kinase buffer (HEPES, 50 mM, pH 7.5, BSA, 0.1 mg/mL, MnCl<sub>2</sub>, 10 mM, MgCl<sub>2</sub>, 5 mM, Na<sub>3</sub>VO<sub>4</sub>, 100 μM, DTT, 0.5 mM, poly(Glu4/Tyr), 250 μg/mL, ATP, 5 μM, [γ-<sup>32</sup>P]ATP, 0.5 μCi).</div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> VEGFR–2 Tyrosine kinase Activity</h4><div class="NLM_p">A 10 ng sample of VEGFR-2 (recombinant human protein, Invitrogen) was incubated for 1 h at 28 °C using various concentrations of tested compounds in kinase buffer (Tris, 50 mM, pH 7.5, BSA, 25 μg/mL, MnCl<sub>2</sub>, 1.5 mM, MgCl<sub>2</sub>, 10 mM, DTT, 2.5 mM, Na<sub>3</sub>VO<sub>4</sub>, 100 μM, β-glycerophosphate, 5 mM, poly(Glu4/Tyr), 250 μg/mL, ATP, 5 μM, [γ-<sup>32</sup>P]ATP, 0.5 μCi).</div><div class="NLM_p last">The reaction was stopped by adding 20 μL of trichloroacetic acid, 100%. The wells were screened and washed 10 times with trichloroacetic acid, 10%. The plates were counted in a Top Count for 1 min/well.</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amaury Farce</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4e2f232f3b3c3760282f3c2d2b637c0e3b20273863222722222b7c60283c"><span class="__cf_email__" data-cfemail="22434f4357505b0c44435041470f1062574c4b540f4e4b4e4e47100c4450">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Garofalo</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Séverine Ravez</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amélie Lemoine</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Perrine Six</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Chavatte</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence Goossens</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Depreux</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord de France, F-59000 Lille, France</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm2013453" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack" id="ACK-d7e5358-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Kinase assays were realized on the Binding-Platform of ICPAL, Université Lille 2, supported by PRIM (Pôle de Recherche Interdisciplinaire pour le Médicament). We thank the LaRMNS, RMN Laboratory, Faculty of Pharmacy.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> Abbreviations Used</h2><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">FC</td><td class="NLM_def"><p class="first last">flash chromatography</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Barton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeling, A.</span><span> </span><span class="NLM_article-title">Growth factor and their receptors: new targets for prostate cancer therapy</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=114-122&author=J.+Bartonauthor=G.+Blackledgeauthor=A.+Wakeling&title=Growth+factor+and+their+receptors%3A+new+targets+for+prostate+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DJ.%26aulast%3DBlackledge%26aufirst%3DG.%26aulast%3DWakeling%26aufirst%3DA.%26atitle%3DGrowth%2520factor%2520and%2520their%2520receptors%253A%2520new%2520targets%2520for%2520prostate%2520cancer%2520therapy%26jtitle%3DUrology%26date%3D2001%26volume%3D58%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The role of protein phosphorylation in human health and disease</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">5001</span><span class="NLM_x">–</span> <span class="NLM_lpage">5010</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1046%2Fj.0014-2956.2001.02473.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=11589691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1els70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=5001-5010&author=P.+Cohen&title=The+role+of+protein+phosphorylation+in+human+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The role of protein phosphorylation in human health and disease</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5001-5010</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The reversible phosphorylation of proteins regulates almost all aspects of cell life, while abnormal phosphorylation is a cause or consequence of many diseases.  Mutations in particular protein kinases and phosphatases gives rise to a no. of disorders and many naturally occurring toxins and pathogens exert their effects by altering the phosphorylation states of intracellular proteins.  In this lecture, I present an overview of the progress that is being made in developing specific inhibitors of protein kinases for the treatment of cancer and chronic inflammatory diseases and describe how recent advances in our understanding of the specificity and regulation of one particular protein kinase (GSK3) may facilitate the development of drugs to treat diabetes that would not have the potential to be oncogenic.  I also discuss the exploitation of specific protein kinase inhibitors for the study of cell signalling and make recommendations for their effective use in cell-based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjsuAXr4EpLVg90H21EOLACvtfcHk0liYPRCPNYYBJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1els70%253D&md5=a7b1a0673af6e3d13711c5f972109000</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1046%2Fj.0014-2956.2001.02473.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0014-2956.2001.02473.x%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520role%2520of%2520protein%2520phosphorylation%2520in%2520human%2520health%2520and%2520disease%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D5001%26epage%3D5010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Protein kinase inhibitors as a therapeutic modality</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar0201207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=462-469&author=A.+Levitzki&title=Protein+kinase+inhibitors+as+a+therapeutic+modality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Far0201207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far0201207%26sid%3Dliteratum%253Aachs%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DProtein%2520kinase%2520inhibitors%2520as%2520a%2520therapeutic%2520modality%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2003%26volume%3D36%26spage%3D462%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases—the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%E2%80%94the+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%25E2%2580%2594the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Zwick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bange, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">Receptor tyrosine kinase as targets for anticancer drugs</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=17-22&author=E.+Zwickauthor=J.+Bangeauthor=A.+Ullrich&title=Receptor+tyrosine+kinase+as+targets+for+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwick%26aufirst%3DE.%26aulast%3DBange%26aufirst%3DJ.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DReceptor%2520tyrosine%2520kinase%2520as%2520targets%2520for%2520anticancer%2520drugs%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: from rational design to clinical trials</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fmed.1022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=11607931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=499-512&author=P.+Traxlerauthor=G.+Boldauthor=E.+Buchdungerauthor=G.+Caravattiauthor=P.+Furetauthor=P.+Manleyauthor=T.+O%E2%80%99Reillyauthor=J.+Woodauthor=J.+Zimmermann&title=Tyrosine+kinase+inhibitors%3A+from+rational+design+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase inhibitors: From rational design to clinical trials</span></div><div class="casAuthors">Traxler, Peter; Bold, Guido; Buchdunger, Elisabeth; Caravatti, Giorgio; Furet, Pascal; Manley, Paul; O'Reilly, Terence; Wood, Jeanette; Zimmermann, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499-512</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms.  The inhibition of growth related kinases, esp. Tyr kinases, might provide new therapies for diseases such as cancer.  The progress made in the crystn. of protein kinases has confirmed that the ATP-binding domain of Tyr kinases is an attractive target for drug design.  Three successful examples of drug design at Novartis using a Tyr kinase as a mol. target are described.  PK1166, a pyrrolo[2,3,-d]pyrimidine deriv., is a dual inhibitor of both the EGFR and the ErbB2 kinases.  The compd. entered clin. trials in 1999, based on its favorable pre-clin. profile: potent inhibition of EGF-mediated signalling in cells, in vivo antitumor activity in several EGFR over-expressing xenograft tumor models in nude mice, long-lasting inhibition of EGF-stimulated EGFR auto-phosphorylation in tumor tissue, good oral bioavailability in animals, and no prohibitive in vitro and in vivo toxicity findings.  The anilino-phthalazine deriv. PTK787/ZK222584 (Phase I, co-developed by Schering AG, Berlin) is a potent and selective inhibitor of both the KDR and Flt-1 kinases with interesting anti-angiogenic and pharmacokinetic properties (orally bioavailable).  STI 571 (Glivec, Gleevec), a phenylamino-pyrimidine deriv., is a potent inhibitor of the Abl Tyr kinase, which is present in 95% of patients with chronic myelogenous leukemia (CML).  The compd. specifically inhibits proliferation of v-Abl and Bcr-Abl expressing cells (including cells from CML patients) and shows anti-tumor activity as a single agent in animal models at well-tolerated doses.  Pharmacol. relevant concns. are achieved in the plasma of animals (oral administration).  Promising data from phase I and II clin. trials in CML patients (98% hematol. response rate in Phase I) support the fact that the STI571 represents a new treatment modality for CML.  In addn., potent inhibition of the PDGFR and c-Kit Tyr kinases also indicates its possible clin. use in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4W1Gy1U-gvLVg90H21EOLACvtfcHk0lgK4s6eRzGZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D&md5=bc5ca99f96e51da0736842df4fea841e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fmed.1022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1022%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DManley%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520from%2520rational%2520design%2520to%2520clinical%2520trials%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D499%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Traxler, P.</span><span> </span><span class="NLM_article-title">Tyrosine kinases as targets in cancer therapy—successes and failures</span> <span class="citation_source-journal">Exp. Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=499-512&author=P.+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapy%E2%80%94successes+and+failures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase inhibitors: From rational design to clinical trials</span></div><div class="casAuthors">Traxler, Peter; Bold, Guido; Buchdunger, Elisabeth; Caravatti, Giorgio; Furet, Pascal; Manley, Paul; O'Reilly, Terence; Wood, Jeanette; Zimmermann, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499-512</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms.  The inhibition of growth related kinases, esp. Tyr kinases, might provide new therapies for diseases such as cancer.  The progress made in the crystn. of protein kinases has confirmed that the ATP-binding domain of Tyr kinases is an attractive target for drug design.  Three successful examples of drug design at Novartis using a Tyr kinase as a mol. target are described.  PK1166, a pyrrolo[2,3,-d]pyrimidine deriv., is a dual inhibitor of both the EGFR and the ErbB2 kinases.  The compd. entered clin. trials in 1999, based on its favorable pre-clin. profile: potent inhibition of EGF-mediated signalling in cells, in vivo antitumor activity in several EGFR over-expressing xenograft tumor models in nude mice, long-lasting inhibition of EGF-stimulated EGFR auto-phosphorylation in tumor tissue, good oral bioavailability in animals, and no prohibitive in vitro and in vivo toxicity findings.  The anilino-phthalazine deriv. PTK787/ZK222584 (Phase I, co-developed by Schering AG, Berlin) is a potent and selective inhibitor of both the KDR and Flt-1 kinases with interesting anti-angiogenic and pharmacokinetic properties (orally bioavailable).  STI 571 (Glivec, Gleevec), a phenylamino-pyrimidine deriv., is a potent inhibitor of the Abl Tyr kinase, which is present in 95% of patients with chronic myelogenous leukemia (CML).  The compd. specifically inhibits proliferation of v-Abl and Bcr-Abl expressing cells (including cells from CML patients) and shows anti-tumor activity as a single agent in animal models at well-tolerated doses.  Pharmacol. relevant concns. are achieved in the plasma of animals (oral administration).  Promising data from phase I and II clin. trials in CML patients (98% hematol. response rate in Phase I) support the fact that the STI571 represents a new treatment modality for CML.  In addn., potent inhibition of the PDGFR and c-Kit Tyr kinases also indicates its possible clin. use in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4W1Gy1U-gvLVg90H21EOLACvtfcHk0lgK4s6eRzGZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D&md5=bc5ca99f96e51da0736842df4fea841e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapy%25E2%2580%2594successes%2520and%2520failures%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Targets%26date%3D2001%26volume%3D21%26spage%3D499%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Angiogenesis in health and disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1038%2Fnm0603-653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=12778163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=653-660&author=P.+Carmeliet&title=Angiogenesis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in health and disease</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels constitute the first organ in the embryo and form the largest network in our body but, sadly, are also often deadly.  When dysregulated, the formation of new blood vessels contributes to numerous malignant, ischemic, inflammatory, infectious and immune disorders.  Mol. insights into these processes are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVe6HXO3QPLbVg90H21EOLACvtfcHk0lgK4s6eRzGZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D&md5=501ed35c48dbcc7c9d18b804c996284a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-653%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D653%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Otrock, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarem, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamseddine, A. I.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor family of ligands and receptors: reviews</span> <span class="citation_source-journal">Blood Cells, Mol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.bcmd.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=17344076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=258-268&author=Z.+K.+Otrockauthor=J.+A.+Makaremauthor=A.+I.+Shamseddine&title=Vascular+endothelial+growth+factor+family+of+ligands+and+receptors%3A+reviews"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor family of ligands and receptors: Review</span></div><div class="casAuthors">Otrock, Zaher K.; Makarem, Jawad A.; Shamseddine, Ali I.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Cells, Molecules, & Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-268</span>CODEN:
                <span class="NLM_cas:coden">BCMDFX</span>;
        ISSN:<span class="NLM_cas:issn">1079-9796</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  VEGF signaling often represents a crit. rate-limiting step in physiol. angiogenesis.  The VEGF family comprises seven secreted glycoproteins that are designated VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, placental growth factor (PlGF) and VEGF-F.  The VEGF family members bind their cognate receptors.  The receptors identified so far are designated VEGFR-1, VEGFR-2, VEGFR-3 and the neuropilins (NP-1 and NP-2).  We review in this article the biol. of the VEGF ligands and the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEwGCsSDNpgLVg90H21EOLACvtfcHk0linUNzgHG39wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFegs7s%253D&md5=1533d087c198c9b3298171dae6d59927</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bcmd.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcmd.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DOtrock%26aufirst%3DZ.%2BK.%26aulast%3DMakarem%26aufirst%3DJ.%2BA.%26aulast%3DShamseddine%26aufirst%3DA.%2BI.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520family%2520of%2520ligands%2520and%2520receptors%253A%2520reviews%26jtitle%3DBlood%2520Cells%252C%2520Mol.%2520Dis.%26date%3D2007%26volume%3D38%26spage%3D258%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bishop-Bailey, D.</span><span> </span><span class="NLM_article-title">Tumour vascularisation: a druggable target</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.coph.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19056315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFaht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=96-101&author=D.+Bishop-Bailey&title=Tumour+vascularisation%3A+a+druggable+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour vascularisation: a druggable target</span></div><div class="casAuthors">Bishop-Bailey, David</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">96-101</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tumor growth, spreading and metastasis require the development of a local vasculature.  There have been great advances in the understanding of how this new vasculature arises, particularly in our increased knowledge of the process of angiogenesis, although, a vast no. of pro-angiogenic and anti-angiogenic mediators have been identified, one of the key signaling processes in the development of the tumor vasculature is the hypoxia-induced stimulation of vascular endothelial cell growth factors (VEGFs) prodn.  Anti-VEGF therapy therefore not only provides a new paradigm for limiting tumor growth via targeting angiogenesis, but also provides prototypic agents to test the hypothesis that by controlling the development of the tumor vasculature we are able to limit, and potentially stop, tumor growth and spreading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqccdJORGSeBrVg90H21EOLACvtfcHk0linUNzgHG39wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFaht7s%253D&md5=f7dde53a0196024b99ab009270fd6fe9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DBishop-Bailey%26aufirst%3DD.%26atitle%3DTumour%2520vascularisation%253A%2520a%2520druggable%2520target%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2009%26volume%3D9%26spage%3D96%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindoh, M.</span><span> </span><span class="NLM_article-title">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1111%2Fj.1349-7006.2007.00704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=18167133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=459-466&author=K.+Hidaauthor=Y.+Hidaauthor=M.+Shindoh&title=Understanding+tumor+endothelial+cell+abnormalities+to+develop+ideal+anti-angiogenic+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span></div><div class="casAuthors">Hida, Kyoko; Hida, Yasuhiro; Shindoh, Masanobu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor angiogenesis is necessary for solid tumor progression and metastasis.  Tumor blood vessels were shown to differ from their normal counterparts, for example, by changes in morphol.  An important concept in tumor angiogenesis is that tumor endothelial cells are assumed to be genetically normal, even though these endothelial cells are structurally and functionally abnormal.  To date, many anti-angiogenic drugs were developed, but, their therapeutic efficacy is not dramatic and they were also reported to cause toxic side effects.  To develop ideal antiangiogenic therapies, understanding tumor endothelial cell abnormalities is important.  The authors have isolated tumor endothelial cells from mouse tumor xenografts and have shown that tumor-assocd. endothelial cells are abnormal.  Tumor-assocd. endothelial cells upregulate many genes, such as epidermal growth factor receptor (EGFR).  Tumor-assocd. endothelial cells are also more sensitive to EGF.  They also have relatively large, heterogeneous nuclei.  Unexpectedly, tumor endothelial cells are cytogenetically abnormal.  Fluorescence in situ hybridization (FISH) anal. showed that freshly isolated uncultured tumor endothelial cells were aneuploid and had abnormal multiple centrosomes.  The degree of aneuploidy was exacerbated by passage in culture.  In marked contrast, freshly isolated normal skin and adipose endothelial cells were diploid.  They had normal centrosomes and remained cytogenetically stable in culture even up to 20 passages.  The authors conclude that tumor endothelial cells can acquire cytogenetic abnormalities while in the tumor microenvironment.  Questions as to whether or not tumor endothelial cells become resistant to antiangiogenic drugs are thus raised.  The authors' preliminary data show that tumor endothelial cells are more resistant to certain chemotherapeutic drugs.  Studies to evaluate the mechanism for cytogenetic abnormalities in tumor endothelial cells are underway.  It is becoming quite clear that the tumor vasculature is much more complex and unpredictable than initially perceived.  Here, the authors provide an overview of the current studies on tumor endothelial cell abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6NvCQ0OhH7Vg90H21EOLACvtfcHk0linUNzgHG39wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D&md5=eca837a1371c1d0ff455fd3c3d523403</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00704.x%26sid%3Dliteratum%253Aachs%26aulast%3DHida%26aufirst%3DK.%26aulast%3DHida%26aufirst%3DY.%26aulast%3DShindoh%26aufirst%3DM.%26atitle%3DUnderstanding%2520tumor%2520endothelial%2520cell%2520abnormalities%2520to%2520develop%2520ideal%2520anti-angiogenic%2520therapies%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Otrock, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahfouz, R. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarem, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamseddine, A. I.</span><span> </span><span class="NLM_article-title">Understanding the biology of angiogenesis: review of the most important molecular mechanisms</span> <span class="citation_source-journal">Blood Cells, Mol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.bcmd.2007.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=17553709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFKisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=212-220&author=Z.+K.+Otrockauthor=R.+A.+R.+Mahfouzauthor=J.+A.+Makaremauthor=A.+I.+Shamseddine&title=Understanding+the+biology+of+angiogenesis%3A+review+of+the+most+important+molecular+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the biology of angiogenesis: Review of the most important molecular mechanisms</span></div><div class="casAuthors">Otrock, Zaher K.; Mahfouz, Rami A. R.; Makarem, Jawad A.; Shamseddine, Ali I.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Cells, Molecules, & Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-220</span>CODEN:
                <span class="NLM_cas:coden">BCMDFX</span>;
        ISSN:<span class="NLM_cas:issn">1079-9796</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is an important process for forming new blood vessels.  It is fundamental in many biol. processes including development, reprodn. and wound repair.  Under these conditions, angiogenesis is a highly regulated process.  Numerous inducers of angiogenesis have been identified, including the members of the vascular endothelial growth factor family, angiopoietins, transforming growth factors, platelet-derived growth factor, tumor necrosis factor-α, interleukins and members of the fibroblast growth factor family.  Vascular endothelial growth factor-A is the most potent pro-angiogenic protein described to date.  It induces proliferation, sprouting and tube formation of endothelial cells.  Angiogenesis is therefore a putative target for therapy.  The potential application of different angiogenesis inhibitors is currently under intense clin. investigation.  A better understanding of the biol. of angiogenesis may reveal new targets for treating many diseases that are assocd. with this complex process.  In this review, we summarize the most important mol. mechanisms mediating angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri3qfVcA9RsbVg90H21EOLACvtfcHk0lg4sQRVBjUCmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFKisrg%253D&md5=abe32c8a9a792ddf45cf8e78a634998e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bcmd.2007.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcmd.2007.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DOtrock%26aufirst%3DZ.%2BK.%26aulast%3DMahfouz%26aufirst%3DR.%2BA.%2BR.%26aulast%3DMakarem%26aufirst%3DJ.%2BA.%26aulast%3DShamseddine%26aufirst%3DA.%2BI.%26atitle%3DUnderstanding%2520the%2520biology%2520of%2520angiogenesis%253A%2520review%2520of%2520the%2520most%2520important%2520molecular%2520mechanisms%26jtitle%3DBlood%2520Cells%252C%2520Mol.%2520Dis.%26date%3D2007%26volume%3D39%26spage%3D212%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Senger, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Water, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berse, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, H. F.</span><span> </span><span class="NLM_article-title">Vascular permeability factor (VPF, VEGF) in tumor biology</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1007%2FBF00665960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=8281615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2cXnsVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=303-324&author=D.+R.+Sengerauthor=L.+Van+de+Waterauthor=L.+F.+Brownauthor=J.+A.+Nagyauthor=K.+T.+Yeoauthor=T.+K.+Yeoauthor=B.+Berseauthor=R.+W.+Jackmanauthor=A.+M.+Dvorakauthor=H.+F.+Dvorak&title=Vascular+permeability+factor+%28VPF%2C+VEGF%29+in+tumor+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular permeability factor (VPF,VEGF) in tumor biology</span></div><div class="casAuthors">Senger, Donald R.; Van De Water, Livingston; Brown, Lawrence F.; Nagy, Janice A.; Yeo, Kiang Teck; Yeo, Tet Kin; Berse, Brygida; Jackman, Robert W.; Dvorak, Ann M.; Dvorak, Harold F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">303-24</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    </div><div class="casAbstract">A review with 89 refs.  Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a multifunctional cytokine expressed and secreted at high levels by many tumor cells of animal and human origin.  As secreted by tumor cells, VPF/VEGF is a 34-42 kDa heparin-binding, dimeric, disulfide-bonded glycoprotein that acts directly on endothelial cells (EC) by way of specific receptors to activate phospholipase C and induce [Ca2+]i transients.  Two high affinity VPF/VEGF receptors, both tyrosine kinases, have thus far been described.  VPF/VEGF is likely to have a no. of important roles in tumor biol. related, but not limited to, the process of tumor angiogenesis.  As a potent permeability factor, VPF/VEGF promotes extravasation of plasma fibrinogen, leading to fibrin deposition which alters the tumor extracellular matrix.  This matrix promotes the ingrowth of macrophages, fibroblasts, and endothelial cells.  Moreover, VPF/VEGF is a selective endothelial cell (EC) growth factor in vitro, and it presumably stimulates EC proliferation in vivo.  Furthermore, VPF/VEGF has been found in animal and human tumor effusions by immunoassay and by functional assays and very likely accounts for the induction of malignant ascites.  In addn. to its role in tumors, VPF/VEGF has recently been found to have a role in wound healing and its expression by activated macrophages suggest that it probably also participates in certain types of chronic inflammation.  VPF/VEGF is expressed in normal development and in certain normal adult organs, notably kidney, heart, adrenal gland and lung.  Its functions in normal adult tissues are under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoypXw29msdV7Vg90H21EOLACvtfcHk0lg4sQRVBjUCmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnsVejug%253D%253D&md5=bf7d474ad681de62f1cc73029a90e376</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2FBF00665960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00665960%26sid%3Dliteratum%253Aachs%26aulast%3DSenger%26aufirst%3DD.%2BR.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DL.%2BF.%26aulast%3DNagy%26aufirst%3DJ.%2BA.%26aulast%3DYeo%26aufirst%3DK.%2BT.%26aulast%3DYeo%26aufirst%3DT.%2BK.%26aulast%3DBerse%26aufirst%3DB.%26aulast%3DJackman%26aufirst%3DR.%2BW.%26aulast%3DDvorak%26aufirst%3DA.%2BM.%26aulast%3DDvorak%26aufirst%3DH.%2BF.%26atitle%3DVascular%2520permeability%2520factor%2520%2528VPF%252C%2520VEGF%2529%2520in%2520tumor%2520biology%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D1993%26volume%3D12%26spage%3D303%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Roy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ylä-Herttuala, S.</span><span> </span><span class="NLM_article-title">Biology of vascular endothelial growth factors</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">2879</span><span class="NLM_x">–</span> <span class="NLM_lpage">2887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=2879-2887&author=H.+Royauthor=S.+Bhardwajauthor=S.+Yl%C3%A4-Herttuala&title=Biology+of+vascular+endothelial+growth+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DH.%26aulast%3DBhardwaj%26aufirst%3DS.%26aulast%3DYl%25C3%25A4-Herttuala%26aufirst%3DS.%26atitle%3DBiology%2520of%2520vascular%2520endothelial%2520growth%2520factors%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D2879%26epage%3D2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, S. D.</span><span> </span><span class="NLM_article-title">Roles of main pro- and anti-angiogenic factors in tumor angiogenesis</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.3748%2Fwjg.v10.i4.463" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=463-470&author=Z.+Huangauthor=S.+D.+Bao&title=Roles+of+main+pro-+and+anti-angiogenic+factors+in+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v10.i4.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v10.i4.463%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBao%26aufirst%3DS.%2BD.%26atitle%3DRoles%2520of%2520main%2520pro-%2520and%2520anti-angiogenic%2520factors%2520in%2520tumor%2520angiogenesis%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2004%26volume%3D4%26spage%3D463%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gleadle, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratcliffe, P. J.</span><span> </span><span class="NLM_article-title">Hypoxia and the regulation of gene expression</span> <span class="citation_source-journal">Mol. Med. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2FS1357-4310%2897%2901198-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=9575495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK1cXisVOqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=122-129&author=J.+M.+Gleadleauthor=P.+J.+Ratcliffe&title=Hypoxia+and+the+regulation+of+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia and the regulation of gene expression</span></div><div class="casAuthors">Gleadle, Jonathan M.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">122-129</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 45 refs.  The optimal delivery of oxygen to tissues is essential both to ensure adequate energy provision and to avoid the toxic effects of higher oxygen concns.  For this to occur, organisms must be able to sense oxygen and respond to changes in oxygen tension by altering gene expression.  The anal. of the regulation of erythropoiesis has provided important insights into the mechanisms of oxygen-regulated gene expression.  These mechanisms have a role in the regulation of many genes, in many cell types and appear to be of relevance to many common pathologies in which disturbances of oxygen supply are central.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXyEtSoI4bQrVg90H21EOLACvtfcHk0lg4sQRVBjUCmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVOqu7c%253D&md5=31840c786a6c7214fcfc95c08ea4b16d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2897%2901198-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252897%252901198-2%26sid%3Dliteratum%253Aachs%26aulast%3DGleadle%26aufirst%3DJ.%2BM.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DHypoxia%2520and%2520the%2520regulation%2520of%2520gene%2520expression%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1998%26volume%3D4%26spage%3D122%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Smyth, T.</span><span> </span><span class="NLM_article-title">The biology of vascular endothelial growth factor</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1210%2Fer.18.1.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=9034784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=4-25&author=N.+Ferraraauthor=T.+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of vascular endothelial growth factor</span></div><div class="casAuthors">Ferrara, Napoleone; Davis-Smyth, Terri</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-25</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 250 refs., on: biol. activities of vascular endothelial growth factor (VEGF); organization of the VEGF gene; properties of the VEGF isoforms; regulation of VEGF gene expression; the VEGF receptors; VEGF-related mols.; role of VEGF and its receptors in physiol. angiogenesis; role of VEGF in pathol. angiogenesis; and therapeutic applications of VEGF-induced angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5imhPXJtxxrVg90H21EOLACvtfcHk0ljMvsd-mj5wbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D&md5=22796890fbe49a721d330447396aea8b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1210%2Fer.18.1.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.18.1.4%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DDavis-Smyth%26aufirst%3DT.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocr.%2520Rev.%26date%3D1997%26volume%3D18%26spage%3D4%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Roskoski, R.,  Jr.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor (VEGF) signaling in tumor progression</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.critrevonc.2007.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=17324579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ns1OgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=179-213&author=R.+Roskoski&title=Vascular+endothelial+growth+factor+%28VEGF%29+signaling+in+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor (VEGF) signaling in tumor progression</span></div><div class="casAuthors">Roskoski Robert Jr</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-213</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Vascular endothelial cells are ordinarily quiescent in adult humans and divide less than once per decade.  When tumors reach a size of about 0.2-2.0mm in diameter, they become hypoxic and limited in size in the absence of angiogenesis.  There are about 30 endogenous pro-angiogenic factors and about 30 endogenous anti-angiogenic factors.  In order to increase in size, tumors undergo an angiogenic switch where the action of pro-angiogenic factors predominates, resulting in angiogenesis and tumor progression.  One mechanism for driving angiogenesis results from the increased production of vascular endothelial growth factor (VEGF) following up-regulation of the hypoxia-inducible transcription factor.  The human VEGF family consists of VEGF (VEGF-A), VEGF-B, VEGF-C, VEGF-D, and placental growth factor (PlGF).  The VEGF family of receptors consists of three protein-tyrosine kinases and two non-protein kinase receptors (neuropilin-1 and -2).  Owing to the importance of angiogenesis in tumor progression, inhibition of VEGF signaling represents an attractive cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHS2jvhIW2-BBrI9DTGjC0fW6udTcc2eaKFKq-fLN0urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ns1OgtA%253D%253D&md5=cf49919265b5bdef75791ea02b4bb99e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2007.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2007.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520signaling%2520in%2520tumor%2520progression%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2007%26volume%3D62%26spage%3D179%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Roskoski, R,  Jr.</span><span> </span><span class="NLM_article-title">VEGF receptor protein-tyrosine kinases: structure and regulation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=287-291&author=R+Roskoski&title=VEGF+receptor+protein-tyrosine+kinases%3A+structure+and+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR%26atitle%3DVEGF%2520receptor%2520protein-tyrosine%2520kinases%253A%2520structure%2520and%2520regulation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D375%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Shibuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson-Welsh, L.</span><span> </span><span class="NLM_article-title">Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.yexcr.2005.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16336962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=549-560&author=M.+Shibuyaauthor=L.+Claesson-Welsh&title=Signal+transduction+by+VEGF+receptors+in+regulation+of+angiogenesis+and+lymphangiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis</span></div><div class="casAuthors">Shibuya, Masabumi; Claesson-Welsh, Lena</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The VEGF/VPF (vascular endothelial growth factor/vascular permeability factor) ligands and receptors are crucial regulators of vasculogenesis, angiogenesis, lymphangiogenesis and vascular permeability in vertebrates.  VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).  VEGFR1, which occurs in transmembrane and sol. forms, neg. regulates vasculogenesis and angiogenesis during early embryogenesis, but it also acts as a pos. regulator of angiogenesis and inflammatory responses, playing a role in several human diseases such as rheumatoid arthritis and cancer.  The sol. VEGFR1 is overexpressed in placenta in preeclampsia patients.  VEGFR2 has crit. functions in physiol. and pathol. angiogenesis through distinct signal transduction pathways regulating proliferation and migration of endothelial cells.  VEGFR3, a receptor for the lymphatic growth factors VEGF-C and VEGF-D, but not for VEGF-A, regulates vascular and lymphatic endothelial cell function during embryogenesis.  Loss-of-function variants of VEGFR3 have been identified in lymphedema.  Formation of tumor lymphatics may be stimulated by tumor-produced VEGF-C, allowing increased spread of tumor metastases through the lymphatics.  Mapping the signaling system of these important receptors may provide the knowledge necessary to suppress specific signaling pathways in major human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TrItSz12JLVg90H21EOLACvtfcHk0ljMvsd-mj5wbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWltbo%253D&md5=7e59aaa57fe5a35b1b44e7f4d7bb552b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2005.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2005.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DShibuya%26aufirst%3DM.%26aulast%3DClaesson-Welsh%26aufirst%3DL.%26atitle%3DSignal%2520transduction%2520by%2520VEGF%2520receptors%2520in%2520regulation%2520of%2520angiogenesis%2520and%2520lymphangiogenesis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2006%26volume%3D312%26spage%3D549%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rahimi, N.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.exer.2006.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16713597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1005-1016&author=N.+Rahimi&title=Vascular+endothelial+growth+factor+receptors%3A+molecular+mechanisms+of+activation+and+therapeutic+potentials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor receptors: Molecular mechanisms of activation and therapeutic potentials</span></div><div class="casAuthors">Rahimi, Nader</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis-assocd. eye diseases are among the most common cause of blindness in the United States and worldwide.  Recent advances in the development of angiogenesis-based therapies for treatment of angiogenesis-assocd. diseases have provided new hope in a wide variety of human diseases ranging from eye diseases to cancer.  One group of growth factor receptors critically implicated in angiogenesis is vascular endothelial growth factor receptors (VEGFR), a subfamily of receptor tyrosine kinases (RTKs).  VEGFR-1 and VEGFR-2 are closely related receptor tyrosine kinases and have both common and specific ligands.  VEGFR-1 is a kinase-impaired RTK and its kinase activity is suppressed by a single amino acid substitution in its kinase domain and by its carboxyl terminus.  VEGFR-2 is highly active kinase, stimulates a variety of signaling pathways and broad biol. responses in endothelial cells.  The mechanisms that govern VEGFR-2 activation, its ability to recruit signaling proteins and to undergo downregulation are highly regulated by phosphorylation activation loop tyrosines and its carboxyl terminus.  Despite their differential potentials to undergo tyrosine phosphorylation and kinase activation, both VEGFR-1 and VEGFR-2 are required for normal embryonic development and pathol. angiogenesis.  VEGFR-1 regulates angiogenesis by mechanisms that involve ligand trapping, receptor homodimerization and heterodimerization.  This review highlights recent insights into the mechanism of activation of VEGFR-1 and VEGFR-2, and focuses on the signaling pathways employed by VEGFR-1 and VEGFR-2 that regulate angiogenesis and their therapeutic potentials in angiogenesis-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Df0usV5jvLVg90H21EOLACvtfcHk0ljMvsd-mj5wbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGnsrg%253D&md5=cdcb6127f3a97f5665e4992f54a88476</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DRahimi%26aufirst%3DN.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520receptors%253A%2520molecular%2520mechanisms%2520of%2520activation%2520and%2520therapeutic%2520potentials%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2006%26volume%3D83%26spage%3D1005%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Cell signaling by receptor tyrosine kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2FS0092-8674%2800%2900114-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=11057895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=211-225&author=J.+Schlessinger&title=Cell+signaling+by+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cell signaling by receptor tyrosine kinases</span></div><div class="casAuthors">Schlessinger, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-225</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 109 refs.  The purpose of this review is to describe general concepts underlying the mechanism of action of RTKs and the signaling pathways that they regulate, while attempting to shed light on the question of how specificity is defined by the action of RTKs, and how a specific biol. response can be generated by the diverse array of signaling pathways activated by all RTKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0AvjN2PpaVbVg90H21EOLACvtfcHk0ljWE0sMybRqIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrs%253D&md5=7b4cacd2513290f3b3e6120b58647654</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900114-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900114-8%26sid%3Dliteratum%253Aachs%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DCell%2520signaling%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCell%26date%3D2000%26volume%3D103%26spage%3D211%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Tyrosine phosphorylation: thirty years and counting</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.ceb.2009.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19269802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=140-146&author=T.+Hunter&title=Tyrosine+phosphorylation%3A+thirty+years+and+counting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine phosphorylation: thirty years and counting</span></div><div class="casAuthors">Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-146</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging.  Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a no. of which were approved for clin. use.  The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozf_yslNwApbVg90H21EOLACvtfcHk0ljWE0sMybRqIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D&md5=ef5dbec53a41f9691317cc5b1b47b3cb</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DTyrosine%2520phosphorylation%253A%2520thirty%2520years%2520and%2520counting%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gibson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodburn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarlett, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. S.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor tyrosine kinase: structure-activity relationships and antitumour activity of novel quinazolines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2723</span><span class="NLM_x">–</span> <span class="NLM_lpage">2728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2723-2728&author=K.+H.+Gibsonauthor=W.+Grundyauthor=A.+Godfreyauthor=J.+R.+Woodburnauthor=S.+E.+Ashtonauthor=B.+J.+Curryauthor=L.+Scarlettauthor=A.+J.+Barkerauthor=D.+S.+Brown&title=Epidermal+growth+factor+receptor+tyrosine+kinase%3A+structure-activity+relationships+and+antitumour+activity+of+novel+quinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DK.%2BH.%26aulast%3DGrundy%26aufirst%3DW.%26aulast%3DGodfrey%26aufirst%3DA.%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DCurry%26aufirst%3DB.%2BJ.%26aulast%3DScarlett%26aufirst%3DL.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DD.%2BS.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%253A%2520structure-activity%2520relationships%2520and%2520antitumour%2520activity%2520of%2520novel%2520quinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2723%26epage%3D2728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouyssegur, J.</span><span> </span><span class="NLM_article-title">Targeting the Erk signalling pathway in cancer therapy</span> <span class="citation_source-journal">Ann. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1080%2F07853890600551037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16720434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVyms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=200-211&author=M.+Kohnoauthor=J.+Pouyssegur&title=Targeting+the+Erk+signalling+pathway+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the ERK signaling pathway in cancer therapy</span></div><div class="casAuthors">Kohno, Michiaki; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Medicine (Basingstoke, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">200-211</span>CODEN:
                <span class="NLM_cas:coden">ANMDEU</span>;
        ISSN:<span class="NLM_cas:issn">0785-3890</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  The extracellular signal-regulated kinase (ERK) signaling pathway is a major determinant in the control of diverse cellular processes such as proliferation, survival, differentiation and motility.  This pathway is often up-regulated in human tumors and as such represents an attractive target for the development of anticancer drugs.  Because of its multiple roles in the acquisition of a complex malignant phenotype, specific blockade of the ERK pathway is expected to result in not only an anti-proliferative effect but also in anti-metastatic and anti-angiogenic effects in tumor cells.  Recently potent small-mol. inhibitors targeting the components of the ERK pathway have been developed.  Among them, BAY 43-9006 (Raf inhibitor), and PD184352, PD0325901 and ARRY-142886 (MEK1/2 inhibitors) have reached the clin. trial stage.  We briefly discuss the possibility that combination of ERK pathway inhibitors (cytostatic agents) and conventional anticancer drugs (cytotoxic agents) provides an excellent basis for the development of new chemotherapeutic strategies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC9mDu6Gn4nrVg90H21EOLACvtfcHk0liH89jm4BQR9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVyms7c%253D&md5=64efca43e25a60c2396842beef7559aa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F07853890600551037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07853890600551037%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520Erk%2520signalling%2520pathway%2520in%2520cancer%2520therapy%26jtitle%3DAnn.%2520Med.%26date%3D2006%26volume%3D38%26spage%3D200%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Djordjevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, P. C.</span><span> </span><span class="NLM_article-title">Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=426-432&author=S.+Djordjevicauthor=P.+C.+Driscoll&title=Structural+insight+into+substrate+specificity+and+regulatory+mechanisms+of+phosphoinositide+3-kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDjordjevic%26aufirst%3DS.%26aulast%3DDriscoll%26aufirst%3DP.%2BC.%26atitle%3DStructural%2520insight%2520into%2520substrate%2520specificity%2520and%2520regulatory%2520mechanisms%2520of%2520phosphoinositide%25203-kinases%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2002%26volume%3D27%26spage%3D426%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gourley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, J. S.</span><span> </span><span class="NLM_article-title">Angiogenesis: new targets for the development of anticancer chemotherapies</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.2174%2F1381612003400867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=10788590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjt1Cltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=417-439&author=M.+Gourleyauthor=J.+S.+Williamson&title=Angiogenesis%3A+new+targets+for+the+development+of+anticancer+chemotherapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis: new targets for the development of anticancer chemotherapies</span></div><div class="casAuthors">Gourley, Maralea; Williamson, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">417-439</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 120 refs.  Angiogenesis is the process by which new blood vessels are formed from preexisting microvasculature.  To ensure an adequate blood supply, tumor cells release angiogenic factors that are capable of promoting nearby blood vessels to extend vascular branches to the tumor.  In addn., larger tumors have been shown to release angiogenic inhibitory factors that prevent blood vessels from sending branches to smaller, more distant tumors that compete for oxygen and nutrients.  Angiogenesis is a complex multistep biochem. process, and offers several potential mol. targets for non-cytotoxic anticancer therapies.  Strategies for exploiting tumor angiogenesis for novel cancer drug discovery include: (i) inhibition of proteolytic enzymes that breakdown the extracellular matrix surrounding existing capillaries; (ii) inhibition of endothelial cell migration; (iii) inhibition of endothelial cell proliferation; (iv) enhancement of tumor endothelial cell apoptosis.  There is also a host of misc. agents that inhibit angiogenesis for which the specific mechanisms are not clear.  Several methods have been developed for measuring antiangiogenic activity both in vitro and in vivo.  Although there has been intensive research efforts focused at the phenomena of angiogenesis, as well as the search for antiangiogenic agents for more than two decades, many questions remain unanswered with regard to the overall biochem. mechanisms of the angiogenesis process and the potential therapeutic utility of angiogenic inhibitors.  Nevertheless potent angiogenic inhibitors capable of blocking tumor growth have been discovered, and appear to have potential for development into novel anticancer therapeutics.  However there are still hurdles to be overcome before these inhibitors become mainstream therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozUc0mX-Ip9rVg90H21EOLACvtfcHk0liH89jm4BQR9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjt1Cltb0%253D&md5=9eba84a10096c9a95e513187c745de37</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1381612003400867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612003400867%26sid%3Dliteratum%253Aachs%26aulast%3DGourley%26aufirst%3DM.%26aulast%3DWilliamson%26aufirst%3DJ.%2BS.%26atitle%3DAngiogenesis%253A%2520new%2520targets%2520for%2520the%2520development%2520of%2520anticancer%2520chemotherapies%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2000%26volume%3D6%26spage%3D417%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Brunella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanza, E.</span><span> </span><span class="NLM_article-title">Possible novel targets for therapeutic angiogenesis</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.coph.2008.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19071062" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=102-108&author=C.+Brunellaauthor=E.+Costanza&title=Possible+novel+targets+for+therapeutic+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrunella%26aufirst%3DC.%26aulast%3DCostanza%26aufirst%3DE.%26atitle%3DPossible%2520novel%2520targets%2520for%2520therapeutic%2520angiogenesis%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2009%26volume%3D9%26spage%3D102%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Raffetto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalil, R. A.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=346-359&author=J.+D.+Raffettoauthor=R.+A.+Khalil&title=Matrix+metalloproteinases+and+their+inhibitors+in+vascular+remodeling+and+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaffetto%26aufirst%3DJ.%2BD.%26aulast%3DKhalil%26aufirst%3DR.%2BA.%26atitle%3DMatrix%2520metalloproteinases%2520and%2520their%2520inhibitors%2520in%2520vascular%2520remodeling%2520and%2520vascular%2520disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D346%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindoh, M.</span><span> </span><span class="NLM_article-title">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1111%2Fj.1349-7006.2007.00704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=18167133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=459-466&author=K.+Hidaauthor=Y.+Hidaauthor=M.+Shindoh&title=Understanding+tumor+endothelial+cell+abnormalities+to+develop+ideal+anti-angiogenic+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span></div><div class="casAuthors">Hida, Kyoko; Hida, Yasuhiro; Shindoh, Masanobu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor angiogenesis is necessary for solid tumor progression and metastasis.  Tumor blood vessels were shown to differ from their normal counterparts, for example, by changes in morphol.  An important concept in tumor angiogenesis is that tumor endothelial cells are assumed to be genetically normal, even though these endothelial cells are structurally and functionally abnormal.  To date, many anti-angiogenic drugs were developed, but, their therapeutic efficacy is not dramatic and they were also reported to cause toxic side effects.  To develop ideal antiangiogenic therapies, understanding tumor endothelial cell abnormalities is important.  The authors have isolated tumor endothelial cells from mouse tumor xenografts and have shown that tumor-assocd. endothelial cells are abnormal.  Tumor-assocd. endothelial cells upregulate many genes, such as epidermal growth factor receptor (EGFR).  Tumor-assocd. endothelial cells are also more sensitive to EGF.  They also have relatively large, heterogeneous nuclei.  Unexpectedly, tumor endothelial cells are cytogenetically abnormal.  Fluorescence in situ hybridization (FISH) anal. showed that freshly isolated uncultured tumor endothelial cells were aneuploid and had abnormal multiple centrosomes.  The degree of aneuploidy was exacerbated by passage in culture.  In marked contrast, freshly isolated normal skin and adipose endothelial cells were diploid.  They had normal centrosomes and remained cytogenetically stable in culture even up to 20 passages.  The authors conclude that tumor endothelial cells can acquire cytogenetic abnormalities while in the tumor microenvironment.  Questions as to whether or not tumor endothelial cells become resistant to antiangiogenic drugs are thus raised.  The authors' preliminary data show that tumor endothelial cells are more resistant to certain chemotherapeutic drugs.  Studies to evaluate the mechanism for cytogenetic abnormalities in tumor endothelial cells are underway.  It is becoming quite clear that the tumor vasculature is much more complex and unpredictable than initially perceived.  Here, the authors provide an overview of the current studies on tumor endothelial cell abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6NvCQ0OhH7Vg90H21EOLACvtfcHk0liH89jm4BQR9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D&md5=eca837a1371c1d0ff455fd3c3d523403</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00704.x%26sid%3Dliteratum%253Aachs%26aulast%3DHida%26aufirst%3DK.%26aulast%3DHida%26aufirst%3DY.%26aulast%3DShindoh%26aufirst%3DM.%26atitle%3DUnderstanding%2520tumor%2520endothelial%2520cell%2520abnormalities%2520to%2520develop%2520ideal%2520anti-angiogenic%2520therapies%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Masood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P. S.</span><span> </span><span class="NLM_article-title">Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fijc.10996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=12594815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVehtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2003&pages=603-610&author=R.+Masoodauthor=A.+Kundraauthor=S.+Zhuauthor=G.+Xiaauthor=P.+Scaliaauthor=D.+L.+Smithauthor=P.+S.+Gill&title=Malignant+mesothelioma+growth+inhibition+by+agents+that+target+the+VEGF+and+VEGF-C+autocrine+loops"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops</span></div><div class="casAuthors">Masood, Rizwan; Kundra, Ajay; Zhu, SuTao; Xia, Guangbin; Scalia, Pierluigi; Smith, D. Lynne; Gill, Parkash S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">603-610</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Malignant mesothelioma (MM) is a locally aggressive tumor that originates from the mesothelial cells of the pleural and sometimes peritoneal surface.  Conventional treatments for MM, consisting of chemotherapy or surgery give little survival benefit to patients, who generally die within 1 yr of diagnosis.  Hence, there is an urgent need for the development of alternative therapies.  Vascular endothelial growth factor (VEGF) is an autocrine growth factor for MM.  The closely related mol., VEGF-C, is also implicated in malignant mesothelioma growth.  VEGF-C and its cognate receptor VEGFR-3 are co-expressed in mesothelioma cell lines.  A functional VEGF-C autocrine growth loop was demonstrated in mesothelioma cells by targeting VEGF-C expression and binding to VEGFR-3.  The ability of novel agents that reduce the levels of VEGF and VEGF-C to inhibit mesothelioma cell growth in vitro was assessed.  Antisense oligonucleotide (ODN) complementary to VEGF that inhibited VEGF and VEGF-C expression simultaneously specifically inhibited mesothelioma cell growth.  Similarly, antibodies to VEGF receptor (VEGFR-2) and VEGF-C receptor (VEGFR-3) were synergistic in inhibiting mesothelioma cell growth.  In addn., a diphtheria toxin-VEGF fusion protein (DT-VEGF), which is toxic to cells that express VEGF receptors was very effective in inhibiting mesothelioma cell growth in vitro.  These results indicate that targeting VEGF and VEGF-C simultaneously may be an effective therapeutic approach for malignant mesothelioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplulg_0LcHdrVg90H21EOLACvtfcHk0ljGAXuiJbCtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVehtLw%253D&md5=edeb814f312d7b37c16ce1ab68d2a53a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fijc.10996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10996%26sid%3Dliteratum%253Aachs%26aulast%3DMasood%26aufirst%3DR.%26aulast%3DKundra%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DScalia%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DGill%26aufirst%3DP.%2BS.%26atitle%3DMalignant%2520mesothelioma%2520growth%2520inhibition%2520by%2520agents%2520that%2520target%2520the%2520VEGF%2520and%2520VEGF-C%2520autocrine%2520loops%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2003%26volume%3D104%26spage%3D603%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Booy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirzada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahib, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehrke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadkhoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, M.</span><span> </span><span class="NLM_article-title">Monoclonal and bispecific antibodies as novel therapeutics</span> <span class="citation_source-journal">Arch. Immunol. Ther. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1007%2Fs00005-006-0011-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16648969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvF2kt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=85-101&author=E.+P.+Booyauthor=D.+Joharauthor=S.+Maddikaauthor=H.+Pirzadaauthor=M.+M.+Sahibauthor=I.+Gehrkeauthor=S.+Loewenauthor=S.+F.+Louisauthor=K.+Kadkhodaauthor=M.+Mowatauthor=M.+Los&title=Monoclonal+and+bispecific+antibodies+as+novel+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal and bispecific antibodies as novel therapeutics</span></div><div class="casAuthors">Booy, Evan P.; Johar, Dina; Maddika, Srilekha; Pirzada, Hasan; Sahib, Mickey M.; Gehrke, Iris; Loewen, Shauna; Louis, Sherif F.; Kadkhoda, Kamran; Mowat, Michael; Los, Marek</div><div class="citationInfo"><span class="NLM_cas:title">Archivum Immunologiae et Therapiae Experimentalis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-101</span>CODEN:
                <span class="NLM_cas:coden">AITEAT</span>;
        ISSN:<span class="NLM_cas:issn">0004-069X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Gene amplification, over-expression, and mutation of growth factors, or the receptors themselves, causes increased signaling through receptor kinases, which has been implicated in many human cancers and is assocd. with poor prognosis.  Tumor growth has been shown to be decreased by interrupting this process of extensive growth factor-mediated signaling by directly targeting either the surface receptor or the ligand and thereby preventing cell survival and promoting apoptosis.  Monoclonal antibodies have long been eyed as a potential new class of therapeutics targeting cancer and other diseases.  Antibody-based therapy initially entered clin. practice when trastuzumab/Herceptin became the first clin. approved drug against an oncogene product as a well-established blocking reagent for tumors with hyperactivity of epidermal growth factor signaling pathways.  In the first part of this review we explain basic terms related to the development of antibody-based drugs, give a brief historic perspective of the field, and also touch on topics such as the "humanization of antibodies" or creation of hybrid antibodies.  The second part of the review gives an overview of the clin. usage of bispecific antibodies and antibodies "armed" with cytotoxic agents or enzymes.  Further within this section, cancer-specific, site-specific, or signaling pathway-specific therapies are discussed in detail.  Among other antibody-based therapeutic products, we discuss: Avastin (bevacizumab), CG76030, Theragyn (pemtumomab), daclizumab (Zenapax), TriAb, MDX-210, Herceptin (trastuzumab), panitumumab (ABX-EGF), mastuzimab (EMD-72000), Erbitux (certuximab, IMC225), Panorex (edrecolomab), STI571, CeaVac, Campath (alemtuizumab), Mylotarg (gemtuzumab, ozogamicin), and many others.  The end of the review deliberates upon potential problems assocd. with cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI2od5G6SCK7Vg90H21EOLACvtfcHk0ljGAXuiJbCtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvF2kt7s%253D&md5=614a7b672981ad6db344aabcbcfbee7f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00005-006-0011-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00005-006-0011-5%26sid%3Dliteratum%253Aachs%26aulast%3DBooy%26aufirst%3DE.%2BP.%26aulast%3DJohar%26aufirst%3DD.%26aulast%3DMaddika%26aufirst%3DS.%26aulast%3DPirzada%26aufirst%3DH.%26aulast%3DSahib%26aufirst%3DM.%2BM.%26aulast%3DGehrke%26aufirst%3DI.%26aulast%3DLoewen%26aufirst%3DS.%26aulast%3DLouis%26aufirst%3DS.%2BF.%26aulast%3DKadkhoda%26aufirst%3DK.%26aulast%3DMowat%26aufirst%3DM.%26aulast%3DLos%26aufirst%3DM.%26atitle%3DMonoclonal%2520and%2520bispecific%2520antibodies%2520as%2520novel%2520therapeutics%26jtitle%3DArch.%2520Immunol.%2520Ther.%2520Exp.%26date%3D2006%26volume%3D54%26spage%3D85%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2005&pages=328-335&author=N.+Ferraraauthor=K.+J.+Hillanauthor=W.+Novotny&title=Bevacizumab+%28Avastin%29%2C+a+humanized+anti-VEGF+monoclonal+antibody+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DBevacizumab%2520%2528Avastin%2529%252C%2520a%2520humanized%2520anti-VEGF%2520monoclonal%2520antibody%2520for%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D333%26spage%3D328%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Scanga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowdley, K.</span><span> </span><span class="NLM_article-title">Sorafenib: a glimmer of hope for unresectable hepatocellular carcinoma?</span> <span class="citation_source-journal">Hepathology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fhep.22756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19115217" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=332-334&author=A.+Scangaauthor=K.+Kowdley&title=Sorafenib%3A+a+glimmer+of+hope+for+unresectable+hepatocellular+carcinoma%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fhep.22756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22756%26sid%3Dliteratum%253Aachs%26aulast%3DScanga%26aufirst%3DA.%26aulast%3DKowdley%26aufirst%3DK.%26atitle%3DSorafenib%253A%2520a%2520glimmer%2520of%2520hope%2520for%2520unresectable%2520hepatocellular%2520carcinoma%253F%26jtitle%3DHepathology%26date%3D2009%26volume%3D49%26spage%3D332%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Escudier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczylik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negrier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevreau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demkow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowski, R. M.</span><span> </span><span class="NLM_article-title">Sorafenib in advanced clear-cell renal-cell carcinoma</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=332-334&author=B.+Escudierauthor=T.+Eisenauthor=W.+M.+Stadlerauthor=C.+Szczylikauthor=S.+Oudardauthor=M.+Siebelsauthor=S.+Negrierauthor=C.+Chevreauauthor=E.+Solskaauthor=A.+A.+Desaiauthor=F.+Rollandauthor=T.+Demkowauthor=T.+E.+Hutsonauthor=M.+Goreauthor=S.+Freemanauthor=B.+Schwartzauthor=M.+Shanauthor=R.+Simantovauthor=R.+M.+Bukowski&title=Sorafenib+in+advanced+clear-cell+renal-cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEscudier%26aufirst%3DB.%26aulast%3DEisen%26aufirst%3DT.%26aulast%3DStadler%26aufirst%3DW.%2BM.%26aulast%3DSzczylik%26aufirst%3DC.%26aulast%3DOudard%26aufirst%3DS.%26aulast%3DSiebels%26aufirst%3DM.%26aulast%3DNegrier%26aufirst%3DS.%26aulast%3DChevreau%26aufirst%3DC.%26aulast%3DSolska%26aufirst%3DE.%26aulast%3DDesai%26aufirst%3DA.%2BA.%26aulast%3DRolland%26aufirst%3DF.%26aulast%3DDemkow%26aufirst%3DT.%26aulast%3DHutson%26aufirst%3DT.%2BE.%26aulast%3DGore%26aufirst%3DM.%26aulast%3DFreeman%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DShan%26aufirst%3DM.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DBukowski%26aufirst%3DR.%2BM.%26atitle%3DSorafenib%2520in%2520advanced%2520clear-cell%2520renal-cell%2520carcinoma%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2009%26volume%3D49%26spage%3D332%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Motzer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redman, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudes, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figlin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePrimo, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bello, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theuer, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1200%2FJCO.2005.02.2574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16330672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1ChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=16-24&author=R.+J.+Motzerauthor=M.+D.+Michaelsonauthor=B.+G.+Redmanauthor=G.+R.+Hudesauthor=G.+Wildingauthor=R.+A.+Figlinauthor=M.+S.+Ginsbergauthor=S.+T.+Kimauthor=C.+M.+Baumauthor=S.+E.+DePrimoauthor=J.+Z.+Liauthor=C.+L.+Belloauthor=C.+P.+Theuerauthor=D.+J.+Georgeauthor=B.+I.+Rini&title=Activity+of+SU11248%2C+a+multitargeted+inhibitor+of+vascular+endothelial+growth+factor+receptor+and+platelet-derived+growth+factor+receptor%2C+in+patients+with+metastatic+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Motzer, Robert J.; Michaelson, M. Dror; Redman, Bruce G.; Hudes, Gary R.; Wilding, George; Figlin, Robert A.; Ginsberg, Michelle S.; Kim, Sindy T.; Baum, Charles M.; DePrimo, Samuel E.; Li, Jim Z.; Bello, Carlo L.; Theuer, Charles P.; George, Daniel J.; Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-24</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor suppressor gene activity, resulting in high expression of pro-angiogenic growth factors: vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).  SU11248 (sunitinib malate), a small mol. inhibitor with high binding affinity for VEGF and PDGF receptors, was tested for clin. activity in patients with metastatic RCC.  Patients and Methods: Patients with metastatic RCC and progression on first-line cytokine therapy were enrolled onto a multicenter phase II trial.  SU11248 monotherapy was administered in repeated 6-wk cycles of daily oral therapy for 4 wk, followed by 2 wk off.  Overall response rate was the primary end point, and time to progression and safety were secondary end points.  Results: Twenty-five (40%) of 63 patients treated with SU11248 achieved partial responses; 17 addnl. patients (27%) demonstrated stable disease lasting ≥ 3 mo.  Median time to progression in the 63 patients was 8.7 mo.  Dosing was generally tolerated with manageable toxicities.  Conclusion: SU11248, a multitargeted receptor tyrosine kinase inhibitor of VEGF and PDGF receptors, demonstrates antitumor activity in metastatic RCC as second-line therapy, a setting where no effective systemic therapy is presently recognized.  The genetics of RCC and these promising clin. results support the hypothesis that VEGF and PDGF receptor-mediated signaling is an effective therapeutic target in RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCep3NZbaojLVg90H21EOLACvtfcHk0lgGHsiYVaprsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1ChtA%253D%253D&md5=f3304eba449f0ff4ac20ac0cf8a878c5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.02.2574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.02.2574%26sid%3Dliteratum%253Aachs%26aulast%3DMotzer%26aufirst%3DR.%2BJ.%26aulast%3DMichaelson%26aufirst%3DM.%2BD.%26aulast%3DRedman%26aufirst%3DB.%2BG.%26aulast%3DHudes%26aufirst%3DG.%2BR.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DFiglin%26aufirst%3DR.%2BA.%26aulast%3DGinsberg%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BT.%26aulast%3DBaum%26aufirst%3DC.%2BM.%26aulast%3DDePrimo%26aufirst%3DS.%2BE.%26aulast%3DLi%26aufirst%3DJ.%2BZ.%26aulast%3DBello%26aufirst%3DC.%2BL.%26aulast%3DTheuer%26aufirst%3DC.%2BP.%26aulast%3DGeorge%26aufirst%3DD.%2BJ.%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DActivity%2520of%2520SU11248%252C%2520a%2520multitargeted%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%252C%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span> </span><span class="NLM_article-title">ZD6474—a novel inhibitor of VEGFR and EGFR tyrosine kinase</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">S6</span><span class="NLM_x">–</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=S6-S13&author=A.+J.+Ryanauthor=S.+R.+Wedge&title=ZD6474%E2%80%94a+novel+inhibitor+of+VEGFR+and+EGFR+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DZD6474%25E2%2580%2594a%2520novel%2520inhibitor%2520of%2520VEGFR%2520and%2520EGFR%2520tyrosine%2520kinase%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3DS6%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vita, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Placido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1158%2F1078-0432.CCR-1100-03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=14760102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=784-793&author=F.+Ciardielloauthor=R.+Biancoauthor=R.+Caputoauthor=R.+Caputoauthor=V.+Damianoauthor=T.+Troianiauthor=D.+Melisiauthor=F.+De+Vitaauthor=S.+De+Placidoauthor=A.+R.+Biancoauthor=G.+Tortora&title=Antitumor+activity+of+ZD6474%2C+a+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+in+human+cancer+cells+with+acquired+resistance+to+antiepidermal+growth+factor+receptor+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy</span></div><div class="casAuthors">Ciardiello, Fortunato; Bianco, Roberto; Caputo, Roberta; Caputo, Rosa; Damiano, Vincenzo; Troiani, Teresa; Melisi, Davide; De Vita, Ferdinando; De Placido, Sabino; Bianco, A. Raffaele; Tortora, Giampaolo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">784-793</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) autocrine signaling pathway is involved in cancer development and progression.  EGFR inhibitors such as C225 (cetuximab), a chimeric human-mouse anti-EGFR monoclonal antibody, and ZD1839 (gefitinib), a small mol. EGFR-selective tyrosine kinase inhibitor, are in advanced clin. development.  The potential emergence of cancer cell resistance in EGFR-expressing cancers treated with EGFR inhibitors could det. lack of activity of these drugs in some cancer patients.  Vascular endothelial growth factor (VEGF) is secreted by cancer cells and plays a key role in the regulation of tumor-induced endothelial cell proliferation and permeability.  ZD6474 is a small mol. VEGF flk-1/KDR (VEGFR-2) tyrosine kinase inhibitor that also demonstrates inhibitory activity against EGFR tyrosine kinase.  The antitumor activity of ZD1839, C225, and ZD6474 was tested in athymic mice bearing human GEO colon cancer xenografts.  GEO cell lines resistant to EGFR inhibitors were established from GEO xenografts growing in mice treated chronically with ZD1839 or C225.  Expression of EGFR was evaluated by flow cytometry.  Expression of various proteins involved in intracellular cell signaling was assessed by Western blotting.  Tumor growth data were evaluated for statistical significance using the Student's t test.  All Ps were two-sided.  Although chronic administration of optimal doses of C225 or ZD1839 efficiently blocked GEO tumor growth in the majority of mice, tumors slowly started to grow within 80-90 days, despite continuous treatment.  In contrast, continuous treatment of mice bearing established GEO xenografts with ZD6474 resulted in efficient tumor growth inhibition for the entire duration of dosing (up to 150 days).  ZD6474 activity was also detd. in mice pretreated with ZD1839 or C225.  When GEO growth was apparent after 4 wk of treatment with EGFR inhibitors, mice were either re-treated with EGFR inhibitors or treated with ZD6474.  GEO tumor growth was blocked only in mice treated with ZD6474, whereas tumor progression was obsd. in mice re-treated with C225 or ZD1839.  GEO tumors growing during treatment with C225 or with ZD1839 were established as cell lines (GEO-C225-RES and GEO-ZD1839-RES, resp.).  Cell membrane-assocd. EGFR expression was only slightly reduced in these cell lines compared with parental GEO cells.  Western blotting revealed no major change in the expression of the EGFR ligand transforming growth factor α of bcl-2, bcl-xL, p53, p27, MDM-2, akt, activated phospho-akt, or mitogen-activated protein kinase.  However, both GEO-C225-RES and GEO-ZD1839-RES cells exhibited a 5-10-fold increase in activated phospho-mitogen-activated protein kinase and in the expression of cyclooxygenase-2 and of VEGF compared with GEO cells.  GEO-C225-RES and GEO-ZD1839-RES growth as xenografts in nude mice was not significantly affected by treatment with either C225 or ZD1839 but was efficiently inhibited by ZD6474.  Long-term treatment of GEO xenografts with selective EGFR inhibitors results in the development of EGFR inhibitor-resistant cancer cells.  Growth of EGFR inhibitor-resistant tumors can be inhibited by ZD6474.  These data indicate that inhibition of VEGF signaling has potential as an anticancer strategy, even in tumors that are resistant to EGF inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXQ5DOhiBGb7Vg90H21EOLACvtfcHk0lgoleMB2vbzSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKitw%253D%253D&md5=cabb04fc66ce376a26ed101f9717e376</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-1100-03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-1100-03%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DBianco%26aufirst%3DR.%26aulast%3DCaputo%26aufirst%3DR.%26aulast%3DCaputo%26aufirst%3DR.%26aulast%3DDamiano%26aufirst%3DV.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DMelisi%26aufirst%3DD.%26aulast%3DDe%2BVita%26aufirst%3DF.%26aulast%3DDe%2BPlacido%26aufirst%3DS.%26aulast%3DBianco%26aufirst%3DA.%2BR.%26aulast%3DTortora%26aufirst%3DG.%26atitle%3DAntitumor%2520activity%2520of%2520ZD6474%252C%2520a%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520human%2520cancer%2520cells%2520with%2520acquired%2520resistance%2520to%2520antiepidermal%2520growth%2520factor%2520receptor%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D784%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Morabito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccirillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falasconi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Feo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normanno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, F.</span><span> </span><span class="NLM_article-title">Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=378-390&author=A.+Morabitoauthor=M.+C.+Piccirilloauthor=F.+Falasconiauthor=G.+De+Feoauthor=A.+Del+Giudiceauthor=J.+Bryceauthor=M.+Di+Maioauthor=E.+De+Maioauthor=N.+Normannoauthor=F.+Perrone&title=Vandetanib+%28ZD6474%29%2C+a+dual+inhibitor+of+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+and+epidermal+growth+factor+receptor+%28EGFR%29+tyrosine+kinases%3A+current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorabito%26aufirst%3DA.%26aulast%3DPiccirillo%26aufirst%3DM.%2BC.%26aulast%3DFalasconi%26aufirst%3DF.%26aulast%3DDe%2BFeo%26aufirst%3DG.%26aulast%3DDel%2BGiudice%26aufirst%3DA.%26aulast%3DBryce%26aufirst%3DJ.%26aulast%3DDi%2BMaio%26aufirst%3DM.%26aulast%3DDe%2BMaio%26aufirst%3DE.%26aulast%3DNormanno%26aufirst%3DN.%26aulast%3DPerrone%26aufirst%3DF.%26atitle%3DVandetanib%2520%2528ZD6474%2529%252C%2520a%2520dual%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520and%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520tyrosine%2520kinases%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlot, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.3109%2F14756360903169485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=20222760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVygtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=158-171&author=A.+Garofaloauthor=L.+Goossensauthor=A.+Lemoineauthor=A.+Farceauthor=Y.+Arlotauthor=P.+Depreux&title=Quinazoline-urea%2C+new+protein+kinase+inhibitors+in+treatment+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer</span></div><div class="casAuthors">Garofalo, Antonio; Goossens, Laurence; Lemoine, Amelie; Farce, Amaury; Arlot, Yannick; Depreux, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">158-171</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor-2 (VEGFR-2), two protein tyrosine kinases, are involved in pathol. disorders and the progression of different types of carcinomas.  Concomitant inhibition of both tyrosine kinase activities appears to be an attractive target for cancer chemotherapy.  A series of new quinazolines I (R1, R2 = MeO, Et2NCH2CH2O; R3 = Me, MeO, EtO, EtNH, PhNH, 2,4-F2C6H3NH, etc.) substituted by amide, urea, or carbamate groups has been synthesized.  The biol. activities of these new compds. have been evaluated for their enzyme inhibition and antiproliferative activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPsXFXwjxLrVg90H21EOLACvtfcHk0ljDmpEOx6pg7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVygtbc%253D&md5=5eba33689803516f1f1ba8c3bda6b5b6</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.3109%2F14756360903169485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756360903169485%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DArlot%26aufirst%3DY.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DQuinazoline-urea%252C%2520new%2520protein%2520kinase%2520inhibitors%2520in%2520treatment%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2010%26volume%3D25%26spage%3D158%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkots, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroogy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambing, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchaleelaha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbach, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span> </span><span class="NLM_article-title">Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3772</span><span class="NLM_x">–</span> <span class="NLM_lpage">3793</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020143r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3772-3793&author=A.+Pandeyauthor=D.+L.+Volkotsauthor=J.+M.+Seroogyauthor=J.+W.+Roseauthor=J.+C.+Yuauthor=J.+L.+Lambingauthor=A.+Hutchaleelahaauthor=S.+J.+Hollenbachauthor=K.+Abeauthor=N.+A.+Gieseauthor=R.+M.+Scarborough&title=Identification+of+orally+active%2C+potent%2C+and+selective+4-piperazinylquinazolines+as+antagonists+of+the+platelet-derived+growth+factor+receptor+tyrosine+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fjm020143r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020143r%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DVolkots%26aufirst%3DD.%2BL.%26aulast%3DSeroogy%26aufirst%3DJ.%2BM.%26aulast%3DRose%26aufirst%3DJ.%2BW.%26aulast%3DYu%26aufirst%3DJ.%2BC.%26aulast%3DLambing%26aufirst%3DJ.%2BL.%26aulast%3DHutchaleelaha%26aufirst%3DA.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26atitle%3DIdentification%2520of%2520orally%2520active%252C%2520potent%252C%2520and%2520selective%25204-piperazinylquinazolines%2520as%2520antagonists%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3772%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Six, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howsam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">(4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl) carbamic acid ester: a novel series of dual EGFR/VEGFR-2 receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=65-72&author=A.+Garofaloauthor=L.+Goossensauthor=A.+Lemoineauthor=P.+Ravezauthor=P.+Sixauthor=M.+Howsamauthor=A.+Farceauthor=P.+Depreux&title=%284-%286%2C7-Disubstituted+quinazolin-4-ylamino%29phenyl%29+carbamic+acid+ester%3A+a+novel+series+of+dual+EGFR%2FVEGFR-2+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DRavez%26aufirst%3DP.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DHowsam%26aufirst%3DM.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3D%25284-%25286%252C7-Disubstituted%2520quinazolin-4-ylamino%2529phenyl%2529%2520carbamic%2520acid%2520ester%253A%2520a%2520novel%2520series%2520of%2520dual%2520EGFR%252FVEGFR-2%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Six, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2106</span><span class="NLM_x">–</span> <span class="NLM_lpage">2112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2106-2112&author=A.+Garofaloauthor=L.+Goossensauthor=A.+Farceauthor=A.+Lemoineauthor=P.+Ravezauthor=P.+Sixauthor=P.+Depreux&title=Impact+of+aryloxy-linked+quinazolines%3A+a+novel+series+of+selective+VEGFR-2+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DRavez%26aufirst%3DP.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DImpact%2520of%2520aryloxy-linked%2520quinazolines%253A%2520a%2520novel%2520series%2520of%2520selective%2520VEGFR-2%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2106%26epage%3D2112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Furuta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, A.</span><span> </span><span class="NLM_article-title">Identification of potent and selective inhibitors of PDGF Receptor autophosphorylation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2186</span><span class="NLM_x">–</span> <span class="NLM_lpage">2192</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0506423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2186-2192&author=T.+Furutaauthor=T.+Sakaiauthor=T.+Sengaauthor=T.+Osawaauthor=K.+Kuboauthor=T.+Shimizuauthor=R.+Suzukiauthor=T.+Yoshinoauthor=M.+Endoauthor=A.+Miwa&title=Identification+of+potent+and+selective+inhibitors+of+PDGF+Receptor+autophosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0506423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0506423%26sid%3Dliteratum%253Aachs%26aulast%3DFuruta%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DSenga%26aufirst%3DT.%26aulast%3DOsawa%26aufirst%3DT.%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DMiwa%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520PDGF%2520Receptor%2520autophosphorylation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2186%26epage%3D2192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Desroses, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconde, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hénichart, J. P.</span><span> </span><span class="NLM_article-title">Synthesis of unsymmetrical dialkoxy quinazolines</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1080%2F00304940409356628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=445-452&author=M.+Desrosesauthor=G.+Lacondeauthor=P.+Depreuxauthor=J.+P.+H%C3%A9nichart&title=Synthesis+of+unsymmetrical+dialkoxy+quinazolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of unsymmetrical dialkoxy quinazolines</span></div><div class="casAuthors">Desroses, Matthieu; Laconde, Guillaume; Depreux, Patrick; Henichart, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-452</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">The prepn. of title compds. is described.  Thus, alkylation of Me 3,4-dihydroxybenzoate with 1-iodobutane gave Me 4-butoxy-3-hydroxybenzoate which on alkylation with 2-(diethylamino)ethyl chloride hydrochloride gave Me 4-butoxy-3-(2-diethylaminoethoxy)benzoate hydrochloride.  Nitration of the later followed by redn. and cyclization with HCO2NH4/HCONH2 gave title 7-butoxy-6-(2-diethylaminoethoxy)-3H-quinazolin-4-one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKN6iNOhB0rVg90H21EOLACvtfcHk0ljf-kwJyar4Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOmtb4%253D&md5=cf115709ad66a7a7e54d6356876d0934</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1080%2F00304940409356628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304940409356628%26sid%3Dliteratum%253Aachs%26aulast%3DDesroses%26aufirst%3DM.%26aulast%3DLaconde%26aufirst%3DG.%26aulast%3DDepreux%26aufirst%3DP.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.%2BP.%26atitle%3DSynthesis%2520of%2520unsymmetrical%2520dialkoxy%2520quinazolines%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2004%26volume%3D36%26spage%3D445%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Telliez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desroses, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommery, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconde, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hénichart, J. P.</span><span> </span><span class="NLM_article-title">Derivatives of Iressa, a specific epidermal growth factor receptor inhibitor, are powerful apoptosis inducers in PC3 prostatic cancer cells</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=318-332&author=A.+Telliezauthor=M.+Desrosesauthor=N.+Pommeryauthor=O.+Briandauthor=A.+Farceauthor=G.+Lacondeauthor=A.+Lemoineauthor=P.+Depreuxauthor=J.+P.+H%C3%A9nichart&title=Derivatives+of+Iressa%2C+a+specific+epidermal+growth+factor+receptor+inhibitor%2C+are+powerful+apoptosis+inducers+in+PC3+prostatic+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTelliez%26aufirst%3DA.%26aulast%3DDesroses%26aufirst%3DM.%26aulast%3DPommery%26aufirst%3DN.%26aulast%3DBriand%26aufirst%3DO.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DLaconde%26aufirst%3DG.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DDepreux%26aufirst%3DP.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.%2BP.%26atitle%3DDerivatives%2520of%2520Iressa%252C%2520a%2520specific%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%252C%2520are%2520powerful%2520apoptosis%2520inducers%2520in%2520PC3%2520prostatic%2520cancer%2520cells%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D318%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebegue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">A novel and efficient one-pot synthesis of (aminophenyl)carbamic acid ester</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1080%2F00397911.2010.494818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVChtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=2007-2016&author=A.+Garofaloauthor=L.+Goossensauthor=N.+Lebegueauthor=P.+Depreux&title=A+novel+and+efficient+one-pot+synthesis+of+%28aminophenyl%29carbamic+acid+ester"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and efficient one-pot synthesis of (aminophenyl)carbamic acid esters</span></div><div class="casAuthors">Garofalo, Antonio; Goossens, Laurence; Six, Perrine; Lebegue, Nicolas; Depreux, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2007-2016</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A novel and efficient protocol was developed for the synthesis of various (aminophenyl)carbamic acid esters from the redn. and condensation of nitrophenyl isocyanate derivs.  The reaction takes place in various hydroxy derivs. such as alcs. or phenols under a hydrogen atm. using Raney nickel as catalyst.  Products are obtained by a convenient one-pot synthesis with excellent yields and short reaction times.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAAz1E5Y0vTrVg90H21EOLACvtfcHk0ljf-kwJyar4Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVChtrY%253D&md5=82317ba16da12969fec07fd0329dc47a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1080%2F00397911.2010.494818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2010.494818%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DLebegue%26aufirst%3DN.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DA%2520novel%2520and%2520efficient%2520one-pot%2520synthesis%2520of%2520%2528aminophenyl%2529carbamic%2520acid%2520ester%26jtitle%3DSynth.%2520Commun.%26date%3D2011%26volume%3D41%26spage%3D2007%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Elliott, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaddix, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">Nitrosoureido nucleosides as potential inhibitors of nucleotide biosynthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=250-254&author=R.+D.+Elliottauthor=H.+J.+Thomasauthor=S.+C.+Shaddixauthor=D.+J.+Adamsonauthor=R.+W.+Brockmanauthor=J.+M.+Riordanauthor=J.+A.+Montgomery&title=Nitrosoureido+nucleosides+as+potential+inhibitors+of+nucleotide+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a039%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DR.%2BD.%26aulast%3DThomas%26aufirst%3DH.%2BJ.%26aulast%3DShaddix%26aufirst%3DS.%2BC.%26aulast%3DAdamson%26aufirst%3DD.%2BJ.%26aulast%3DBrockman%26aufirst%3DR.%2BW.%26aulast%3DRiordan%26aufirst%3DJ.%2BM.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DNitrosoureido%2520nucleosides%2520as%2520potential%2520inhibitors%2520of%2520nucleotide%2520biosynthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D250%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldyrou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Six, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Cordonnier, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonte, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, J. F.</span><span> </span><span class="NLM_article-title">Design, synthesis and DNA-binding of N-alkyl(anilino)quinazoline derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8089</span><span class="NLM_x">–</span> <span class="NLM_lpage">8103</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1009605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8089-8103&author=A.+Garofaloauthor=L.+Goossensauthor=B.+Baldyrouauthor=A.+Lemoineauthor=S.+Ravezauthor=P.+Sixauthor=M.+H.+David-Cordonnierauthor=J.+P.+Bonteauthor=P.+Depreuxauthor=A.+Lansiauxauthor=J.+F.+Goossens&title=Design%2C+synthesis+and+DNA-binding+of+N-alkyl%28anilino%29quinazoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm1009605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009605%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DBaldyrou%26aufirst%3DB.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DRavez%26aufirst%3DS.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DDavid-Cordonnier%26aufirst%3DM.%2BH.%26aulast%3DBonte%26aufirst%3DJ.%2BP.%26aulast%3DDepreux%26aufirst%3DP.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DJ.%2BF.%26atitle%3DDesign%252C%2520synthesis%2520and%2520DNA-binding%2520of%2520N-alkyl%2528anilino%2529quinazoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8089%26epage%3D8103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span> <span class="citation_source-book">SYBYL 6.9.1</span>; <span class="NLM_publisher-name">Tripos Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL+6.9.1%3B+Tripos+Inc.%3A+St.+Louis%2C+MO%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSYBYL%25206.9.1%26pub%3DTripos%2520Inc%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Clark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, R. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Opdenbosch, N.</span><span> </span><span class="NLM_article-title">Validation of the general purpose Tripos 5.2 force field</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fjcc.540100804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK3cXhtlygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1989&pages=982-1012&author=M.+Clarkauthor=R.+D.+Cramerauthor=N.+van+Opdenbosch&title=Validation+of+the+general+purpose+Tripos+5.2+force+field"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the general purpose Tripos 5.2 force field</span></div><div class="casAuthors">Clark, Matthew; Cramer, Richard D., III; Van Opdenbosch, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">982-1012</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    </div><div class="casAbstract">A mol. mechanics force field implemented in the Sybyl program is described along with a statistical evaluation of its efficiency on a variety of compds. by anal. of internal coordinates and thermodn. barriers.  The goal of the force field is to provide good quality geometries and relative energies for a large variety of org. mols. by energy minimization.  Performance in protein modeling was tested by minimizations starting from crystallog. coordinates for three cyclic hexapeptides in the crystal lattice.  Accuracy in calcg. thermodn. barriers was tested for 17 energy differences between conformers, 12 stereoisomers, and 15 torsional barriers.  Performance in general purpose applications was assessed by minimizing 76 diverse complex org. crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk84YWRXYBF7Vg90H21EOLACvtfcHk0lh_PG91RrZAkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtlygsbk%253D&md5=b855270284acf42c6f03c495326aeda8</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjcc.540100804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.540100804%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%26aulast%3DCramer%26aufirst%3DR.%2BD.%26aulast%3Dvan%2BOpdenbosch%26aufirst%3DN.%26atitle%3DValidation%2520of%2520the%2520general%2520purpose%2520Tripos%25205.2%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1989%26volume%3D10%26spage%3D982%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Garyauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lh_PG91RrZAkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGary%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, R. T.</span><span> </span><span class="NLM_article-title">Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2203-2207&author=Y.+Miyazakiauthor=S.+Matsunagaauthor=J.+Tangauthor=Y.+Maedaauthor=M.+Nakanoauthor=R.+J.+Philippeauthor=M.+Shibaharaauthor=W.+Liuauthor=H.+Satoauthor=L.+Wangauthor=R.+T.+Nolte&title=Novel+4-amino-furo%5B2%2C3-d%5Dpyrimidines+as+Tie-2+and+VEGFR2+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DPhilippe%26aufirst%3DR.%2BJ.%26aulast%3DShibahara%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26atitle%3DNovel%25204-amino-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tie-2%2520and%2520VEGFR2%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2203%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljWR_ATyZAxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. J.</span><span> </span><span class="NLM_article-title">Further development and validation of empirical scoring functions for structure-based binding affinity prediction</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1023%2FA%3A1016357811882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=12197663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlSqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=11-26&author=R.+Wangauthor=L.+Laiauthor=S.+J.+Wang&title=Further+development+and+validation+of+empirical+scoring+functions+for+structure-based+binding+affinity+prediction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Further development and validation of empirical scoring functions for structure-based binding affinity prediction</span></div><div class="casAuthors">Wang, Renxiao; Lai, Luhua; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">New empirical scoring functions have been developed to est. the binding affinity of a given protein-ligand complex with known three-dimensional structure.  These scoring functions include terms accounting for van der Waals interaction, hydrogen bonding, deformation penalty, and hydrophobic effect.  A special feature is that three different algorithms have been implemented to calc. the hydrophobic effect term, which results in three parallel scoring functions.  All three scoring functions are calibrated through multivariate regression anal. of a set of 200 protein-ligand complexes and they reproduce the binding free energies of the entire training set with std. deviations of 2.2 kcal/mol, 2.1 kcal/mol, and 2.0 kcal/mol, resp.  These three scoring functions are further combined into a consensus scoring function, X-CSCORE.  When tested on an independent set of 30 protein-ligand complexes, X-CSCORE is able to predict their binding free energies with a std. deviation of 2.2 kcal/mol.  The potential application of X-CSCORE to mol. docking is also investigated.  Our results show that this consensus scoring function improves the docking accuracy considerably when compared to the conventional force field computation used for mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqULje6PqR73rVg90H21EOLACvtfcHk0ljWR_ATyZAxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlSqs7k%253D&md5=f77fd72d168df67d7fb66a88bc3b6cd9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1023%2FA%3A1016357811882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1016357811882%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%2BJ.%26atitle%3DFurther%2520development%2520and%2520validation%2520of%2520empirical%2520scoring%2520functions%2520for%2520structure-based%2520binding%2520affinity%2520prediction%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2002%26volume%3D16%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2215</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00040a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2206-2215&author=T.+I.+Opreaauthor=C.+L.+Wallerauthor=G.+R.+Marshall&title=Three-dimensional+quantitative+structure-activity+relationship+of+human+immunodeficiency+virus+%28I%29+protease+inhibitors.+2.+Predictive+power+using+limited+exploration+of+alternate+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm00040a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00040a013%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DWaller%26aufirst%3DC.%2BL.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DThree-dimensional%2520quantitative%2520structure-activity%2520relationship%2520of%2520human%2520immunodeficiency%2520virus%2520%2528I%2529%2520protease%2520inhibitors.%25202.%2520Predictive%2520power%2520using%2520limited%2520exploration%2520of%2520alternate%2520binding%2520modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2206%26epage%3D2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Cramer, R. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunce, J. D.</span><span> </span><span class="NLM_article-title">Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">5959</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00226a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5959-5967&author=R.+D.+Cramerauthor=D.+E.+Pattersonauthor=J.+D.+Bunce&title=Comparative+molecular+field+analysis+%28CoMFA%29.+1.+Effect+of+shape+on+binding+of+steroids+to+carrier+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative molecular field analysis (CoMFA).  1.  Effect of shape on binding of steroids to carrier proteins</span></div><div class="casAuthors">Cramer, Richard D., III; Patterson, David E.; Bunce, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5959-67</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Comparative mol. field anal. (CoMFA) which represents ligand mols. by their steric and electrostatic fields was used to analyze the affinity of 21 steroids to corticosteroid- and testosterone-binding globulins and then to predict the binding consts. of 10 more, structurally diverse, steroids.  QSAR obtained with CoMFA parameters had greater predictive, and also correlative, power then QSAR obtained by other parameters combinations.  The predicted affinities of the addnl. 10 steroids were highly correlated with the actual binding data with the poorest predictions being for steroids that were most dissimilar from the original 21 steroids analyzed.  The CoMFA methodol is characterized by inherent generality, ease of use, superior anal. power, and predictive utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkkJZS5v2zRrVg90H21EOLACvtfcHk0ljWR_ATyZAxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D&md5=8829e9efd71a65faa7c9397c9eb13cc7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja00226a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00226a005%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DR.%2BD.%26aulast%3DPatterson%26aufirst%3DD.%2BE.%26aulast%3DBunce%26aufirst%3DJ.%2BD.%26atitle%3DComparative%2520molecular%2520field%2520analysis%2520%2528CoMFA%2529.%25201.%2520Effect%2520of%2520shape%2520on%2520binding%2520of%2520steroids%2520to%2520carrier%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D5959%26epage%3D5967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mietzner, T.</span><span> </span><span class="NLM_article-title">Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4130</span><span class="NLM_x">–</span> <span class="NLM_lpage">4146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00050a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=4130-4146&author=G.+Klebeauthor=U.+Abrahamauthor=T.+Mietzner&title=Molecular+similarity+indices+in+a+comparative+analysis+%28CoMSIA%29+of+drug+molecules+to+correlate+and+predict+their+biological+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity</span></div><div class="casAuthors">Klebe, Gerhard; Abraham, Ute; Mietzner, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4130-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">An alternative approach is reported to compute property fields based on similarity indexes of drug mols. that have been brought into a common alignment.  The fields of different physicochem. properties use a Gaussian-type distance dependence, and no singularities occur at the at. positions.  Accordingly, no arbitrary definitions of cutoff limits and deficiencies due to different slopes of the fields are encountered.  The fields are evaluated by a PLS anal. similar to the CoMFA formalism.  Two data sets of steroids binding to the corticosteroid-binding-globulin and thermolysin inhibitors were analyzed in terms of the conventional CoMFA method (Lennard-Jones and Coulomb potential fields) and the new comparative mol. similarity indexes anal. (CoMSIA).  Models of comparative statistical significance were obtained.  Field contribution maps were produced for the different models.  Due to cutoff settings in the CoMFA fields and the steepness of the potentials close to the mol. surface, the CoMFA maps are often rather fragmentary and not contiguously connected.  This makes their interpretation difficult.  The maps obtained by the new CoMSIA approach are superior and easier to interpret.  Whereas the CoMFA maps denote regions apart from the mols. where interactions with a putative environment are to be expected, the CoMSIA maps highlight those regions within the area occupied by the ligand skeletons that require a particular physicochem. property important for activity.  This is a more significant guide to trace the features that really matter esp. with respect to the design of novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprb-_Wx0SAN7Vg90H21EOLACvtfcHk0ljWR_ATyZAxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWhu7Y%253D&md5=f0b5d27f6556fc93d4a1007c245a4d6a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm00050a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00050a010%26sid%3Dliteratum%253Aachs%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DAbraham%26aufirst%3DU.%26aulast%3DMietzner%26aufirst%3DT.%26atitle%3DMolecular%2520similarity%2520indices%2520in%2520a%2520comparative%2520analysis%2520%2528CoMSIA%2529%2520of%2520drug%2520molecules%2520to%2520correlate%2520and%2520predict%2520their%2520biological%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D4130%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Clark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, R. D.,  III.</span><span> </span><span class="NLM_article-title">The probability of chance correlation using partial least squares (PLS)</span> <span class="citation_source-journal">Quant. Struct.-Act. Relat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fqsar.19930120205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=137-145&author=M.+Clarkauthor=R.+D.+Cramer&title=The+probability+of+chance+correlation+using+partial+least+squares+%28PLS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The probability of chance correlation using partial least squares (PLS)</span></div><div class="casAuthors">Clark, Matthew; Cramer, Richard D. III</div><div class="citationInfo"><span class="NLM_cas:title">Quantitative Structure-Activity Relationships</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-45</span>CODEN:
                <span class="NLM_cas:coden">QSARDI</span>;
        ISSN:<span class="NLM_cas:issn">0931-8771</span>.
    </div><div class="casAbstract">The frequency of chance correlation using partial least squares (PLS) has been measured exptl. for variously dimensioned data, comprising either completely random nos., random nos. contg. a perfect correlation within, and comparative mol. field anal. (CoMFA) field descriptors, esp. for QSAR of drugs.  This frequency, much lower than that for stepwise multiple regression, is maximal for datasets in which the no. of descriptors equals the no. of compds., and surprisingly decreases indefinitely as the no. of descriptors becomes much greater than the no. of compds.  However, perfect correlations involving descriptor subsets are not detected by PLS if the no. of irrelevant descriptors is excessive.  In CoMFA applications, the probability of chance correlation is usually negligible.  For example with 21 compds. a cross-validated r2 value greater than 0.25 will occur by chance in less than 5% of trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre8G_RM6wwULVg90H21EOLACvtfcHk0liziGYIlGhSpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFaqurY%253D&md5=9f296f29b7e328db12bcba97f26b9a81</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fqsar.19930120205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqsar.19930120205%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%26aulast%3DCramer%26aufirst%3DR.%2BD.%26atitle%3DThe%2520probability%2520of%2520chance%2520correlation%2520using%2520partial%2520least%2520squares%2520%2528PLS%2529%26jtitle%3DQuant.%2520Struct.-Act.%2520Relat.%26date%3D1993%26volume%3D12%26spage%3D137%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yongtao Li, Xiaohe Luo, Qingxiang Guo, Yongwei Nie, Tianqi Wang, Chao Zhang, Zhi Huang, Xin Wang, Yanhua Liu, Yanan Chen, Jianyu Zheng, Shengyong Yang, Yan Fan, <span class="NLM_string-name hlFld-ContribAuthor">Rong Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 3166-3192. <a href="https://doi.org/10.1021/acs.jmedchem.8b00209" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00209%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN1-%2525284-%252528%2525287-Cyclopentyl-6-%252528dimethylcarbamoyl%252529-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-2-yl%252529amino%252529phenyl%252529-N8-hydroxyoctanediamide%252Bas%252Ba%252BNovel%252BInhibitor%252BTargeting%252BCyclin-dependent%252BKinase%252B4%25252F9%252B%252528CDK4%25252F9%252529%252Band%252BHistone%252BDeacetlyase1%252B%252528HDAC1%252529%252Bagainst%252BMalignant%252BCancer%26aulast%3DLi%26aufirst%3DYongtao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07022018%26date%3D23032018%26date%3D08032018%26volume%3D61%26issue%3D7%26spage%3D3166%26epage%3D3192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoming  Wang</span>, <span class="hlFld-ContribAuthor ">Andreas  Lerchen</span>, and <span class="hlFld-ContribAuthor ">Frank  Glorius</span>  . </span><span class="cited-content_cbyCitation_article-title">A Comparative Investigation: Group 9 Cp*M(III)-Catalyzed Formal [4 + 2] Cycloaddition as an Atom-Economic Approach to Quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (9)
                                     , 2090-2093. <a href="https://doi.org/10.1021/acs.orglett.6b00716" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b00716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b00716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b00716%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BComparative%252BInvestigation%25253A%252BGroup%252B9%252BCp%252AM%252528III%252529-Catalyzed%252BFormal%252B%25255B4%2525C2%2525A0%25252B%252B2%25255D%252BCycloaddition%252Bas%252Ban%252BAtom-Economic%252BApproach%252Bto%252BQuinazolines%26aulast%3DWang%26aufirst%3DXiaoming%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11032016%26date%3D25042016%26date%3D06052016%26volume%3D18%26issue%3D9%26spage%3D2090%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Shuang  Ma</span>, <span class="hlFld-ContribAuthor ">Chan  Zou</span>, <span class="hlFld-ContribAuthor ">Shu  Zhou</span>, <span class="hlFld-ContribAuthor ">Qi-Zheng  Sun</span>, <span class="hlFld-ContribAuthor ">Chuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Li-Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Shan  Feng</span>, <span class="hlFld-ContribAuthor ">Lin-Li  Li</span>, and <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (4)
                                     , 1641-1655. <a href="https://doi.org/10.1021/jm301537p" title="DOI URL">https://doi.org/10.1021/jm301537p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301537p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301537p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252BPyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252BLeading%252Bto%252Bthe%252BDiscovery%252Bof%252Ba%252BNovel%252BMultikinase%252BInhibitor%252BThat%252BPotently%252BInhibits%252BFLT3%252Band%252BVEGFR2%252Band%252BEvaluation%252Bof%252BIts%252BActivity%252Bagainst%252BAcute%252BMyeloid%252BLeukemia%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DYang%26aufirst%3DLing-Ling%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D20102012%26date%3D19022013%26date%3D28022013%26date%3D30012013%26volume%3D56%26issue%3D4%26spage%3D1641%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10797-10822. <a href="https://doi.org/10.1021/jm301085w" title="DOI URL">https://doi.org/10.1021/jm301085w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301085w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252B%252528VEGF%252529%252BReceptors%25253A%252BDrugs%252Band%252BNew%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25072012%26date%3D06112012%26date%3D27122012%26date%3D25102012%26volume%3D55%26issue%3D24%26spage%3D10797%26epage%3D10822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Na  Xue</span>, <span class="hlFld-ContribAuthor ">Xingang  Liu</span>, <span class="hlFld-ContribAuthor ">Qiaoyun  Wang</span>, <span class="hlFld-ContribAuthor ">Hongyi  Yan</span>, <span class="hlFld-ContribAuthor ">Yifan  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Shi</span>, <span class="hlFld-ContribAuthor ">Deying  Cao</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.647591" title="DOI URL">https://doi.org/10.3389/fphar.2021.647591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.647591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.647591%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DDiscovery%252Bof%252BPotent%252BEGFR%252BInhibitors%252BWith%252B6-Arylureido-4-anilinoquinazoline%252BDerivatives%26aulast%3DLi%26aufirst%3DMeng%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranju  Bansal</span>, <span class="hlFld-ContribAuthor ">Anjleena  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic progression of quinazolines as targeted chemotherapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113016. <a href="https://doi.org/10.1016/j.ejmech.2020.113016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bprogression%252Bof%252Bquinazolines%252Bas%252Btargeted%252Bchemotherapeutic%252Bagents%26aulast%3DBansal%26aufirst%3DRanju%26date%3D2021%26volume%3D211%26spage%3D113016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaled  El-Adl</span>, <span class="hlFld-ContribAuthor ">Abdel-Ghany A.  El-Helby</span>, <span class="hlFld-ContribAuthor ">Rezk R.  Ayyad</span>, <span class="hlFld-ContribAuthor ">Hazem A.  Mahdy</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Khalifa</span>, <span class="hlFld-ContribAuthor ">Hamdy A.  Elnagar</span>, <span class="hlFld-ContribAuthor ">Ahmed B.M.  Mehany</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Metwaly</span>, <span class="hlFld-ContribAuthor ">Mostafa A.  Elhendawy</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Radwan</span>, <span class="hlFld-ContribAuthor ">Mahmoud A.  ElSohly</span>, <span class="hlFld-ContribAuthor ">Ibrahim H.  Eissa</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115872. <a href="https://doi.org/10.1016/j.bmc.2020.115872" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115872%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Banti-proliferative%252Bevaluation%252Bof%252Bnew%252Bquinazolin-4%2525283H%252529-ones%252Bas%252Bpotential%252BVEGFR-2%252Binhibitors%26aulast%3DEl-Adl%26aufirst%3DKhaled%26date%3D2021%26volume%3D29%26spage%3D115872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim H.  Eissa</span>, <span class="hlFld-ContribAuthor ">Abdel-Ghany A.  El-Helby</span>, <span class="hlFld-ContribAuthor ">Hazem A.  Mahdy</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Khalifa</span>, <span class="hlFld-ContribAuthor ">Hamdy A.  Elnagar</span>, <span class="hlFld-ContribAuthor ">Ahmed B.M.  Mehany</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Metwaly</span>, <span class="hlFld-ContribAuthor ">Mostafa A.  Elhendawy</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Radwan</span>, <span class="hlFld-ContribAuthor ">Mahmoud A.  ElSohly</span>, <span class="hlFld-ContribAuthor ">Khaled  El-Adl</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104380. <a href="https://doi.org/10.1016/j.bioorg.2020.104380" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104380%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bquinazolin-4%2525283H%252529-ones%252Bas%252BVEGFR-2%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Banti-proliferative%252Bevaluation%26aulast%3DEissa%26aufirst%3DIbrahim%2BH.%26date%3D2020%26volume%3D105%26spage%3D104380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Nian  Chen</span>, <span class="hlFld-ContribAuthor ">Ting  Li</span>, <span class="hlFld-ContribAuthor ">Li  Cheng</span>, <span class="hlFld-ContribAuthor ">Tai-Sheng  Qin</span>, <span class="hlFld-ContribAuthor ">Ye-Xiang  Sun</span>, <span class="hlFld-ContribAuthor ">Chu-Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Yue-Zhen  He</span>, <span class="hlFld-ContribAuthor ">Guang  Liu</span>, <span class="hlFld-ContribAuthor ">Di  Yao</span>, <span class="hlFld-ContribAuthor ">Ying  Wei</span>, <span class="hlFld-ContribAuthor ">Qiu-Yin  Li</span>, <span class="hlFld-ContribAuthor ">Guang-Ji  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112661. <a href="https://doi.org/10.1016/j.ejmech.2020.112661" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112661%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Banti-bladder%252Bcancer%252Bactivity%252Bevaluation%252Bof%252Bquinazolinyl-arylurea%252Bderivatives%26aulast%3DChen%26aufirst%3DJia-Nian%26date%3D2020%26volume%3D205%26spage%3D112661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Bei  Xu</span>, <span class="hlFld-ContribAuthor ">Yan-Ying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jia-Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Xin-Yue  Chai</span>, <span class="hlFld-ContribAuthor ">Lin  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Rh
              III
              -Catalyzed one-pot cascade synthesis of quinazolines with
              N
              -alkoxyamide as an amidating reagent. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (10)
                                     , 1230-1234. <a href="https://doi.org/10.1039/D0QO00084A" title="DOI URL">https://doi.org/10.1039/D0QO00084A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00084A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00084A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRh%252BIII%252B-Catalyzed%252Bone-pot%252Bcascade%252Bsynthesis%252Bof%252Bquinazolines%252Bwith%252BN%252B-alkoxyamide%252Bas%252Ban%252Bamidating%252Breagent%26aulast%3DXu%26aufirst%3DHui-Bei%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D10%26spage%3D1230%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liew</span>, <span class="hlFld-ContribAuthor ">Malagobadan</span>, <span class="hlFld-ContribAuthor ">Arshad</span>, <span class="hlFld-ContribAuthor ">Nagoor</span>. </span><span class="cited-content_cbyCitation_article-title">A Review of the Structure–Activity Relationship of Natural and Synthetic Antimetastatic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 138. <a href="https://doi.org/10.3390/biom10010138" title="DOI URL">https://doi.org/10.3390/biom10010138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10010138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10010138%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DA%252BReview%252Bof%252Bthe%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BNatural%252Band%252BSynthetic%252BAntimetastatic%252BCompounds%26aulast%3DLiew%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton V.  Kolotaev</span>, <span class="hlFld-ContribAuthor ">Karine R.  Matevosyan</span>, <span class="hlFld-ContribAuthor ">Vasiliy N.  Osipov</span>, <span class="hlFld-ContribAuthor ">Derenik S.  Khachatryan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new quinazoline-containing hydroxamic acids as potential HDAC/VEGFR inhibitors. Unusual rearrangements with pyrrolidone ring opening and dehydration of 3-N-hydroxyquinazoline fragment containing tetracycles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (51)
                                     , 151315. <a href="https://doi.org/10.1016/j.tetlet.2019.151315" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151315%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bnew%252Bquinazoline-containing%252Bhydroxamic%252Bacids%252Bas%252Bpotential%252BHDAC%25252FVEGFR%252Binhibitors.%252BUnusual%252Brearrangements%252Bwith%252Bpyrrolidone%252Bring%252Bopening%252Band%252Bdehydration%252Bof%252B3-N-hydroxyquinazoline%252Bfragment%252Bcontaining%252Btetracycles%26aulast%3DKolotaev%26aufirst%3DAnton%2BV.%26date%3D2019%26volume%3D60%26issue%3D51%26spage%3D151315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saw  Simeon</span>, <span class="hlFld-ContribAuthor ">Nathjanan  Jongkon</span>, <span class="hlFld-ContribAuthor ">Warot  Chotpatiwetchkul</span>, <span class="hlFld-ContribAuthor ">M. Paul  Gleeson</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2019,</strong> <em>33 </em>
                                    (8)
                                     , 745-757. <a href="https://doi.org/10.1007/s10822-019-00221-z" title="DOI URL">https://doi.org/10.1007/s10822-019-00221-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-019-00221-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-019-00221-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DInsights%252Binto%252Bthe%252BEGFR%252BSAR%252Bof%252BN-phenylquinazolin-4-amine-derivatives%252Busing%252Bquantum%252Bmechanical%252Bpairwise-interaction%252Benergies%26aulast%3DSimeon%26aufirst%3DSaw%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D8%26spage%3D745%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanzheng  Huang</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaming  Li</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Mengqi  Hu</span>, <span class="hlFld-ContribAuthor ">Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Sufan  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2019,</strong> <em>30 </em>
                                    (5)
                                     , 508-516. <a href="https://doi.org/10.1097/CAD.0000000000000718" title="DOI URL">https://doi.org/10.1097/CAD.0000000000000718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000000718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000000718%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Btetrahydroisoquinoline-based%252Bdiaryl%252Burea%252Bderivatives%252Bfor%252Bsuppressing%252BVEGFR-2%252Bsignaling%26aulast%3DHuang%26aufirst%3DYuanzheng%26date%3D2019%26volume%3D30%26issue%3D5%26spage%3D508%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balakrishna  Moku</span>, <span class="hlFld-ContribAuthor ">Lekkala  Ravindar</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">The significance of N-methylpicolinamides in the development of anticancer therapeutics: Synthesis and structure-activity relationship (SAR) studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 513-537. <a href="https://doi.org/10.1016/j.bioorg.2019.02.030" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bsignificance%252Bof%252BN-methylpicolinamides%252Bin%252Bthe%252Bdevelopment%252Bof%252Banticancer%252Btherapeutics%25253A%252BSynthesis%252Band%252Bstructure-activity%252Brelationship%252B%252528SAR%252529%252Bstudies%26aulast%3DMoku%26aufirst%3DBalakrishna%26date%3D2019%26volume%3D86%26spage%3D513%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>, <span class="hlFld-ContribAuthor ">Jian  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>170 </em>, 55-72. <a href="https://doi.org/10.1016/j.ejmech.2019.03.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvancements%252Bof%252B4-aminoquinazoline%252Bderivatives%252Bas%252Bkinase%252Binhibitors%252Band%252Btheir%252Bapplications%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2019%26volume%3D170%26spage%3D55%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meinrad  Drexel</span>, <span class="hlFld-ContribAuthor ">Johannes  Kirchmair</span>, <span class="hlFld-ContribAuthor ">Sandra  Santos-Sierra</span>. </span><span class="cited-content_cbyCitation_article-title">INH14, a Small-Molecule Urea Derivative, Inhibits the IKKα/β-Dependent TLR Inflammatory Response. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2019,</strong> <em>20 </em>
                                    (5)
                                     , 710-717. <a href="https://doi.org/10.1002/cbic.201800647" title="DOI URL">https://doi.org/10.1002/cbic.201800647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201800647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201800647%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DINH14%25252C%252Ba%252BSmall-Molecule%252BUrea%252BDerivative%25252C%252BInhibits%252Bthe%252BIKK%2525CE%2525B1%25252F%2525CE%2525B2-Dependent%252BTLR%252BInflammatory%252BResponse%26aulast%3DDrexel%26aufirst%3DMeinrad%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D5%26spage%3D710%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nevine M.Y.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Rabah A.T.  Serya</span>, <span class="hlFld-ContribAuthor ">Mai F.  Tolba</span>, <span class="hlFld-ContribAuthor ">Marawan  Ahmed</span>, <span class="hlFld-ContribAuthor ">Khaled  Barakat</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>82 </em>, 340-359. <a href="https://doi.org/10.1016/j.bioorg.2018.10.071" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.10.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.10.071%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bdynamics%252Bsimulation%252Bof%252Bindazole%252Bderivatives%252Bwith%252Bantiangiogenic%252Band%252Bantiproliferative%252Banticancer%252Bactivity%26aulast%3DElsayed%26aufirst%3DNevine%2BM.Y.%26date%3D2019%26volume%3D82%26spage%3D340%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarosh  Iqbal</span>, <span class="hlFld-ContribAuthor ">Yijun  Lui</span>, <span class="hlFld-ContribAuthor ">Jonathan G.  Moloney</span>, <span class="hlFld-ContribAuthor ">Emily M.  Parker</span>, <span class="hlFld-ContribAuthor ">Minjeong  Suh</span>, <span class="hlFld-ContribAuthor ">John S.  Foord</span>, <span class="hlFld-ContribAuthor ">Mark G.  Moloney</span>. </span><span class="cited-content_cbyCitation_article-title">A comparative study of diaryl carbene insertion reactions at polymer surfaces. </span><span class="cited-content_cbyCitation_journal-name">Applied Surface Science</span><span> <strong>2019,</strong> <em>465 </em>, 754-762. <a href="https://doi.org/10.1016/j.apsusc.2018.09.182" title="DOI URL">https://doi.org/10.1016/j.apsusc.2018.09.182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsusc.2018.09.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsusc.2018.09.182%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Surface%2520Science%26atitle%3DA%252Bcomparative%252Bstudy%252Bof%252Bdiaryl%252Bcarbene%252Binsertion%252Breactions%252Bat%252Bpolymer%252Bsurfaces%26aulast%3DIqbal%26aufirst%3DSarosh%26date%3D2019%26volume%3D465%26spage%3D754%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aml E.-S.  Mghwary</span>, <span class="hlFld-ContribAuthor ">Ehab M.  Gedawy</span>, <span class="hlFld-ContribAuthor ">Aliaa M.  Kamal</span>, <span class="hlFld-ContribAuthor ">Suzan M.  Abuel-Maaty</span>. </span><span class="cited-content_cbyCitation_article-title">Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 838-852. <a href="https://doi.org/10.1080/14756366.2019.1593160" title="DOI URL">https://doi.org/10.1080/14756366.2019.1593160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1593160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1593160%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bthienopyrimidine%252Bderivatives%252Bas%252Bdual%252BEGFR%252Band%252BVEGFR-2%252Binhibitors%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Banticancer%252Bactivity%252Band%252Beffect%252Bon%252Bcell%252Bcycle%252Bprofile%26aulast%3DMghwary%26aufirst%3DAml%2BE.-S.%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D838%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wuji  Sun</span>, <span class="hlFld-ContribAuthor ">Shengquan  Hu</span>, <span class="hlFld-ContribAuthor ">Shubiao  Fang</span>, <span class="hlFld-ContribAuthor ">Hong  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>78 </em>, 393-405. <a href="https://doi.org/10.1016/j.bioorg.2018.04.005" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrimidine-based%252Bderivatives%252Bas%252BVEGFR-2%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DSun%26aufirst%3DWuji%26date%3D2018%26volume%3D78%26spage%3D393%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxuan  Li</span>, <span class="hlFld-ContribAuthor ">Jing-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-Lin  Deng</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Deyan  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00167" title="DOI URL">https://doi.org/10.3389/fchem.2018.00167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00167%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252BBiological%252BEvaluation%25252C%252Band%252BMolecular%252BDocking%252Bof%252BNovel%252BPDE10%252BInhibitors%252BWith%252BAntioxidant%252BActivities%26aulast%3DLi%26aufirst%3DJinxuan%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Alagarsamy</span>, <span class="hlFld-ContribAuthor ">K.  Chitra</span>, <span class="hlFld-ContribAuthor ">G.  Saravanan</span>, <span class="hlFld-ContribAuthor ">V. Raja  Solomon</span>, <span class="hlFld-ContribAuthor ">M.T.  Sulthana</span>, <span class="hlFld-ContribAuthor ">B.  Narendhar</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of quinazolines: Pharmacological significance and recent developments. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 628-685. <a href="https://doi.org/10.1016/j.ejmech.2018.03.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bquinazolines%25253A%252BPharmacological%252Bsignificance%252Band%252Brecent%252Bdevelopments%26aulast%3DAlagarsamy%26aufirst%3DV.%26date%3D2018%26volume%3D151%26spage%3D628%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreia  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Rui M.V.  Abreu</span>, <span class="hlFld-ContribAuthor ">Madalena M.  Dias</span>, <span class="hlFld-ContribAuthor ">Maria Filomena  Barreiro</span>, <span class="hlFld-ContribAuthor ">Isabel C.F.R.  Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Antiangiogenic compounds: well-established drugs versus emerging natural molecules. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2018,</strong> <em>415 </em>, 86-105. <a href="https://doi.org/10.1016/j.canlet.2017.12.006" title="DOI URL">https://doi.org/10.1016/j.canlet.2017.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2017.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DAntiangiogenic%252Bcompounds%25253A%252Bwell-established%252Bdrugs%252Bversus%252Bemerging%252Bnatural%252Bmolecules%26aulast%3DRibeiro%26aufirst%3DAndreia%26date%3D2018%26volume%3D415%26spage%3D86%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seiya  Kitamura</span>, <span class="hlFld-ContribAuthor ">Christophe  Morisseau</span>, <span class="hlFld-ContribAuthor ">Todd R.  Harris</span>, <span class="hlFld-ContribAuthor ">Bora  Inceoglu</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Hammock</span>, . </span><span class="cited-content_cbyCitation_article-title">Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2017,</strong> <em>12 </em>
                                    (5)
                                     , e0176571. <a href="https://doi.org/10.1371/journal.pone.0176571" title="DOI URL">https://doi.org/10.1371/journal.pone.0176571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0176571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0176571%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DOccurrence%252Bof%252Burea-based%252Bsoluble%252Bepoxide%252Bhydrolase%252Binhibitors%252Bfrom%252Bthe%252Bplants%252Bin%252Bthe%252Border%252BBrassicales%26aulast%3DKitamura%26aufirst%3DSeiya%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D5%26spage%3De0176571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. E.  Kassab</span>, <span class="hlFld-ContribAuthor ">E. M.  Gedawy</span>, <span class="hlFld-ContribAuthor ">H. B.  El-Nassan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-Heteroaryl-Quinazoline Derivatives as Potential Anti-breast Cancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (1)
                                     , 624-633. <a href="https://doi.org/10.1002/jhet.2634" title="DOI URL">https://doi.org/10.1002/jhet.2634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B4-Heteroaryl-Quinazoline%252BDerivatives%252Bas%252BPotential%252BAnti-breast%252BCancer%252BAgents%26aulast%3DKassab%26aufirst%3DA.%2BE.%26date%3D2017%26date%3D2016%26volume%3D54%26issue%3D1%26spage%3D624%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajaka  Lingayya</span>, <span class="hlFld-ContribAuthor ">Mari  Vellakkaran</span>, <span class="hlFld-ContribAuthor ">Kommu  Nagaiah</span>, <span class="hlFld-ContribAuthor ">Prabhakar Rao  Tadikamalla</span>, <span class="hlFld-ContribAuthor ">Jagadeesh Babu  Nanubolu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium(
              ii
              )-catalyzed direct O-alkenylation of 2-arylquinazolinones with N-tosylhydrazones: an efficient route to O-alkenylquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (10)
                                     , 1672-1675. <a href="https://doi.org/10.1039/C6CC09445G" title="DOI URL">https://doi.org/10.1039/C6CC09445G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CC09445G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CC09445G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPalladium%252528%252Bii%252B%252529-catalyzed%252Bdirect%252BO-alkenylation%252Bof%252B2-arylquinazolinones%252Bwith%252BN-tosylhydrazones%25253A%252Ban%252Befficient%252Broute%252Bto%252BO-alkenylquinazolines%26aulast%3DLingayya%26aufirst%3DRajaka%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D10%26spage%3D1672%26epage%3D1675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingya  Zhang</span>, <span class="hlFld-ContribAuthor ">Linna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyou  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2016,</strong> <em>77 </em>
                                    (5)
                                     , 905-926. <a href="https://doi.org/10.1007/s00280-016-2961-6" title="DOI URL">https://doi.org/10.1007/s00280-016-2961-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-016-2961-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-016-2961-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Banti-angiogenic%252Btyrosine%252Bkinases%252Binhibitors%25253A%252Bmolecular%252Bstructures%252Band%252Bbinding%252Bmodes%26aulast%3DZhang%26aufirst%3DJingya%26date%3D2016%26date%3D2016%26volume%3D77%26issue%3D5%26spage%3D905%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changyan  Wang</span>, <span class="hlFld-ContribAuthor ">Yajun  Sun</span>, <span class="hlFld-ContribAuthor ">Xingqi  Zhu</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Qiao  Wang</span>, <span class="hlFld-ContribAuthor ">Yuhong  Zhen</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Youwen  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Quinazoline Derivatives Bearing Various 4-Aniline Moieties as Potent EGFR Inhibitors with Enhanced Activity Against NSCLC Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>87 </em>
                                    (4)
                                     , 635-643. <a href="https://doi.org/10.1111/cbdd.12692" title="DOI URL">https://doi.org/10.1111/cbdd.12692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12692%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DNovel%252BQuinazoline%252BDerivatives%252BBearing%252BVarious%252B4-Aniline%252BMoieties%252Bas%252BPotent%252BEGFR%252BInhibitors%252Bwith%252BEnhanced%252BActivity%252BAgainst%252BNSCLC%252BCell%252BLines%26aulast%3DWang%26aufirst%3DChangyan%26date%3D2016%26date%3D2015%26volume%3D87%26issue%3D4%26spage%3D635%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiqing  Yu</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Shanshan  Huang</span>, <span class="hlFld-ContribAuthor ">Yue  Jin</span>, <span class="hlFld-ContribAuthor ">Xu  Han</span>, <span class="hlFld-ContribAuthor ">Yuhong  Zhen</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Youwen  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>110 </em>, 195-203. <a href="https://doi.org/10.1016/j.ejmech.2016.01.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.01.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.01.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.01.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B4-anilinoquinazoline%252Bderivatives%252Bfeaturing%252Ban%252B1-adamantyl%252Bmoiety%252Bas%252Bpotent%252BEGFR%252Binhibitors%252Bwith%252Benhanced%252Bactivity%252Bagainst%252BNSCLC%252Bcell%252Blines%26aulast%3DYu%26aufirst%3DHaiqing%26date%3D2016%26volume%3D110%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Rui  Gao</span>, <span class="hlFld-ContribAuthor ">Meng-Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Cong  Lv</span>, <span class="hlFld-ContribAuthor ">Su-Fen  Cao</span>, <span class="hlFld-ContribAuthor ">Lin-Jiang  Tong</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Wen-Hu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of biphenylurea derivatives as VEGFR-2 kinase inhibitors (II). </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2016,</strong> <em>27 </em>
                                    (2)
                                     , 200-204. <a href="https://doi.org/10.1016/j.cclet.2015.10.004" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbiphenylurea%252Bderivatives%252Bas%252BVEGFR-2%252Bkinase%252Binhibitors%252B%252528II%252529%26aulast%3DGao%26aufirst%3DGuo-Rui%26date%3D2016%26volume%3D27%26issue%3D2%26spage%3D200%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Séverine  Ravez</span>, <span class="hlFld-ContribAuthor ">Stéphane  Arsenlis</span>, <span class="hlFld-ContribAuthor ">Amélie  Barczyk</span>, <span class="hlFld-ContribAuthor ">Anthony  Dupont</span>, <span class="hlFld-ContribAuthor ">Raphaël  Frédérick</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Hesse</span>, <span class="hlFld-ContribAuthor ">Gilbert  Kirsch</span>, <span class="hlFld-ContribAuthor ">Patrick  Depreux</span>, <span class="hlFld-ContribAuthor ">Laurence  Goossens</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (22)
                                     , 7340-7347. <a href="https://doi.org/10.1016/j.bmc.2015.10.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.10.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.10.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdi-aryl%252Burea%252Bderivatives%252Bas%252Bc-Kit%252Binhibitors%26aulast%3DRavez%26aufirst%3DS%25C3%25A9verine%26date%3D2015%26volume%3D23%26issue%3D22%26spage%3D7340%26epage%3D7347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Rui  Gao</span>, <span class="hlFld-ContribAuthor ">Meng-Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Lin-Jiang  Tong</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Wen-Hu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of O-linked indoles as VEGFR-2 kinase inhibitors (I). </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2015,</strong> <em>26 </em>
                                    (9)
                                     , 1165-1168. <a href="https://doi.org/10.1016/j.cclet.2015.07.016" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BO-linked%252Bindoles%252Bas%252BVEGFR-2%252Bkinase%252Binhibitors%252B%252528I%252529%26aulast%3DGao%26aufirst%3DGuo-Rui%26date%3D2015%26volume%3D26%26issue%3D9%26spage%3D1165%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Seon Hee  Seo</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Soon Bang  Kang</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Key-Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 754-768. <a href="https://doi.org/10.1016/j.ejmech.2015.07.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin-vitro%252Bantiproliferative%252Bactivity%252Band%252Bkinase%252Bprofile%252Bof%252Bnew%252Bpicolinamide%252Bbased%252B2-amido%252Band%252Bureido%252Bquinoline%252Bderivatives%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2015%26volume%3D101%26spage%3D754%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Pankaj  Bari</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>, <span class="hlFld-ContribAuthor ">Malleshappa  Noolvi</span>, <span class="hlFld-ContribAuthor ">Neeta  Thapliyal</span>, <span class="hlFld-ContribAuthor ">Sanjay  Surana</span>, <span class="hlFld-ContribAuthor ">Pritam  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screening. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (70)
                                     , 56724-56771. <a href="https://doi.org/10.1039/C5RA05277G" title="DOI URL">https://doi.org/10.1039/C5RA05277G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA05277G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA05277G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252BVEGFR-2%252Btyrosine%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Banticancer%252Bagents%252Bby%252Bvirtual%252Bbased%252Bscreening%26aulast%3DPatel%26aufirst%3DHarun%2BM.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D70%26spage%3D56724%26epage%3D56771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>84 </em>, 698-707. <a href="https://doi.org/10.1016/j.ejmech.2014.07.071" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.071%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525282-phenyl-1H-benzo%25255Bd%25255Dimidazol-5-yl%252529quinolin-4-amine%252Bderivatives%252Bas%252Bnovel%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DShi%26aufirst%3DLei%26date%3D2014%26volume%3D84%26spage%3D698%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Séverine  Ravez</span>, <span class="hlFld-ContribAuthor ">Amélie  Barczyk</span>, <span class="hlFld-ContribAuthor ">Perrine  Six</span>, <span class="hlFld-ContribAuthor ">Aurélie  Cagnon</span>, <span class="hlFld-ContribAuthor ">Antonio  Garofalo</span>, <span class="hlFld-ContribAuthor ">Laurence  Goossens</span>, <span class="hlFld-ContribAuthor ">Patrick  Depreux</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of tumor cell growth and angiogenesis by 7-Aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>79 </em>, 369-381. <a href="https://doi.org/10.1016/j.ejmech.2014.04.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Btumor%252Bcell%252Bgrowth%252Band%252Bangiogenesis%252Bby%252B7-Aminoalkoxy-4-aryloxy-quinazoline%252Bureas%25252C%252Ba%252Bnovel%252Bseries%252Bof%252Bmulti-tyrosine%252Bkinase%252Binhibitors%26aulast%3DRavez%26aufirst%3DS%25C3%25A9verine%26date%3D2014%26volume%3D79%26spage%3D369%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Letícia de Castro  Barbosa</span>, <span class="hlFld-ContribAuthor ">Lídia Moreira  Lima</span>, <span class="hlFld-ContribAuthor ">Roberta  Tesch</span>, <span class="hlFld-ContribAuthor ">Carlos Mauricio R.  Sant'Anna</span>, <span class="hlFld-ContribAuthor ">Frank  Totzke</span>, <span class="hlFld-ContribAuthor ">Michael H.G.  Kubbutat</span>, <span class="hlFld-ContribAuthor ">Christoph  Schächtele</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Eliezer J.  Barreiro</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>71 </em>, 1-14. <a href="https://doi.org/10.1016/j.ejmech.2013.10.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.10.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.10.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.10.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B2-chloro-4-anilino-quinazoline%252Bderivatives%252Bas%252BEGFR%252Band%252BVEGFR-2%252Bdual%252Binhibitors%26aulast%3DBarbosa%26aufirst%3DMaria%2BLet%25C3%25ADcia%2Bde%2BCastro%26date%3D2014%26volume%3D71%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satyanarayana  Battula</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Qazi Naveed  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Cu–benzotriazole-catalyzed electrophilic cyclization of N-arylimines: a methodical tandem approach to O-protected-4hydroxyquinazolines-. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (72)
                                     , 38375. <a href="https://doi.org/10.1039/C4RA07377K" title="DOI URL">https://doi.org/10.1039/C4RA07377K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA07377K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA07377K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCu%2525E2%252580%252593benzotriazole-catalyzed%252Belectrophilic%252Bcyclization%252Bof%252BN-arylimines%25253A%252Ba%252Bmethodical%252Btandem%252Bapproach%252Bto%252BO-protected-4hydroxyquinazolines-%26aulast%3DBattula%26aufirst%3DSatyanarayana%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D72%26spage%3D38375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin-Chuan  Tian</span>, <span class="hlFld-ContribAuthor ">Xing  Huang</span>, <span class="hlFld-ContribAuthor ">Dan  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Eco-Efficient One-Pot Synthesis of Quinazoline-2,4(1H,3H)-diones at Room Temperature in Water. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2014,</strong> <em>62 </em>
                                    (8)
                                     , 824-829. <a href="https://doi.org/10.1248/cpb.c14-00264" title="DOI URL">https://doi.org/10.1248/cpb.c14-00264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c14-00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c14-00264%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DEco-Efficient%252BOne-Pot%252BSynthesis%252Bof%252BQuinazoline-2%25252C4%2525281H%25252C3H%252529-diones%252Bat%252BRoom%252BTemperature%252Bin%252BWater%26aulast%3DTian%26aufirst%3DXin-Chuan%26date%3D2014%26volume%3D62%26issue%3D8%26spage%3D824%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Peng</span>, <span class="hlFld-ContribAuthor ">Xun  Ji</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Mengyuan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (24)
                                     , 7988-7998. <a href="https://doi.org/10.1016/j.bmc.2013.09.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-anilinoquinazolines%252Bwith%252BC-6%252Burea-linked%252Bside%252Bchains%252Bas%252Binhibitors%252Bof%252Bthe%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%26aulast%3DZhang%26aufirst%3DXu%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D7988%26epage%3D7998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lichen  Yang</span>, <span class="hlFld-ContribAuthor ">Ruimao  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Cycloaddition of 1,4-Diaryl-1,3-butadiynes with Nitriles: An Atom-economic One-pot Approach to Benzo[
              f
              ]quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Letters</span><span> <strong>2013,</strong> <em>42 </em>
                                    (7)
                                     , 769-771. <a href="https://doi.org/10.1246/cl.130206" title="DOI URL">https://doi.org/10.1246/cl.130206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/cl.130206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fcl.130206%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Letters%26atitle%3DCycloaddition%252Bof%252B1%25252C4-Diaryl-1%25252C3-butadiynes%252Bwith%252BNitriles%25253A%252BAn%252BAtom-economic%252BOne-pot%252BApproach%252Bto%252BBenzo%25255B%252Bf%252B%25255Dquinazolines%26aulast%3DYang%26aufirst%3DLichen%26date%3D2013%26volume%3D42%26issue%3D7%26spage%3D769%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>, <span class="hlFld-ContribAuthor ">Geng-Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Xu-Liang  Jiang</span>, <span class="hlFld-ContribAuthor ">Hai-Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antitumor Evaluation and Docking Study of Novel 4-Anilinoquinazoline Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 928-933. <a href="https://doi.org/10.1002/cmdc.201300120" title="DOI URL">https://doi.org/10.1002/cmdc.201300120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300120%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%25252C%252BAntitumor%252BEvaluation%252Band%252BDocking%252BStudy%252Bof%252BNovel%252B4-Anilinoquinazoline%252BDerivatives%252Bas%252BPotential%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%26aulast%3DRao%26aufirst%3DGuo-Wu%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D928%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Diao</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Fu</span>, <span class="hlFld-ContribAuthor ">Fei  Tang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Houyuan  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (6)
                                     , 979. <a href="https://doi.org/10.1039/c3md00096f" title="DOI URL">https://doi.org/10.1039/c3md00096f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00096f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00096f%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252B4-anilinoquinazoline%252Bureas%252Bas%252Bmultikinase%252Binhibitors%252Btargeting%252BBRAF%25252C%252BVEGFR-2%252Band%252BEGFR%26aulast%3DZhang%26aufirst%3DQingwen%26date%3D2013%26volume%3D4%26issue%3D6%26spage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Bai</span>, <span class="hlFld-ContribAuthor ">Rui  Xie</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of VEGFR-2/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (14)
                                     , 1839-1852. <a href="https://doi.org/10.4155/fmc.12.121" title="DOI URL">https://doi.org/10.4155/fmc.12.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.121%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BVEGFR-2%25252FKDR%252Binhibitors%26aulast%3DHuang%26aufirst%3DLingyi%26date%3D2012%26volume%3D4%26issue%3D14%26spage%3D1839%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of tyrosine kinase inhibitors undergoing clinical trials or marketed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structures of synthesized carbamic acid esters <b>1a</b> and aryloxy derivatives <b>1b</b>.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Quinazoline Intermediates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Raney nickel, H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, ROH (80–90%); (b) Raney nickel, H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/THF (1/1), ROH (80–90%); (c) isocyanate, CHCl<sub>3</sub> (70–80%); (d) RCOCl, triethylamine, THF, 0–20 °C (70–85%); (e) Raney nickel, H<sub>2</sub>, MeOH (80–90%); (i) anilines, 2-propanol, reflux (60–80%); (j) anilines, NaH, DMF, 50 °C (25–40%).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (Aryloxy)quinazoline Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>, 2-butanone, 20% NaOH, reflux (84%); (b) isocyanate derivatives, NEt<sub>3</sub>, CHCl<sub>3</sub>, room temperature (35–55%).</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking conformation of furo[2,3-<i>d</i>]pyrimidine <b>103</b> synthesized by Y. Miyazaki<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> (colored by atom types) compared with the crystallographic conformation (in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0016.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Docking conformation of <b>91</b>. (b) Docking of <b>92</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0017.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Repartition of the activities of the compounds in the training (blue tilted squares) and test (orange triangles) sets of model 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0018.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Predictions of CoMSIA model 4 for the training (blue tilted squares) and test (orange triangles) sets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0019.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Predictions of CoMFA model 4 for the training (blue tilted squares) and test (orange triangles) sets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0020.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Residuals of the second series of compounds by models 4 and 6 for the CoMFA (orange triangles) and CoMSIA (blue tilted squares) methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0021.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Steric (green, favorable; yellow, unfavorable) and electrostatic (blue, positive charge favorable; red, negative charge favorable) CoMFA fields.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0022.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. CoMSIA fields of <b>91</b> and <b>92</b>: (a) steric (green, favorable; yellow, unfavorable) and electrostatic (blue, positive charge favorable; red, negative charge favorable), (b) hydrophobic (yellow, hydrophobic favorable; white, hydrophilic favorable), (c) hydrogen bond donor (cyan, favorable; purple, unfavorable) and acceptor (magenta, favorable; red, unfavorable).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/medium/jm-2011-013453_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0001.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm2013453/production/images/large/jm-2011-013453_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2013453&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>Bu<sub>4</sub>N<sup>+</sup>Br<sup>–</sup>, 2-butanone, 20% NaOH, reflux (40–70%); (b) isocyanate derivatives, NEt<sub>3</sub>, CHCl<sub>3</sub>, room temperature (10–38%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Barton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeling, A.</span><span> </span><span class="NLM_article-title">Growth factor and their receptors: new targets for prostate cancer therapy</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=114-122&author=J.+Bartonauthor=G.+Blackledgeauthor=A.+Wakeling&title=Growth+factor+and+their+receptors%3A+new+targets+for+prostate+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DJ.%26aulast%3DBlackledge%26aufirst%3DG.%26aulast%3DWakeling%26aufirst%3DA.%26atitle%3DGrowth%2520factor%2520and%2520their%2520receptors%253A%2520new%2520targets%2520for%2520prostate%2520cancer%2520therapy%26jtitle%3DUrology%26date%3D2001%26volume%3D58%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The role of protein phosphorylation in human health and disease</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">5001</span><span class="NLM_x">–</span> <span class="NLM_lpage">5010</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1046%2Fj.0014-2956.2001.02473.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=11589691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1els70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=5001-5010&author=P.+Cohen&title=The+role+of+protein+phosphorylation+in+human+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The role of protein phosphorylation in human health and disease</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5001-5010</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The reversible phosphorylation of proteins regulates almost all aspects of cell life, while abnormal phosphorylation is a cause or consequence of many diseases.  Mutations in particular protein kinases and phosphatases gives rise to a no. of disorders and many naturally occurring toxins and pathogens exert their effects by altering the phosphorylation states of intracellular proteins.  In this lecture, I present an overview of the progress that is being made in developing specific inhibitors of protein kinases for the treatment of cancer and chronic inflammatory diseases and describe how recent advances in our understanding of the specificity and regulation of one particular protein kinase (GSK3) may facilitate the development of drugs to treat diabetes that would not have the potential to be oncogenic.  I also discuss the exploitation of specific protein kinase inhibitors for the study of cell signalling and make recommendations for their effective use in cell-based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjsuAXr4EpLVg90H21EOLACvtfcHk0ljntU1SE5Yyvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1els70%253D&md5=a7b1a0673af6e3d13711c5f972109000</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1046%2Fj.0014-2956.2001.02473.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0014-2956.2001.02473.x%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520role%2520of%2520protein%2520phosphorylation%2520in%2520human%2520health%2520and%2520disease%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D5001%26epage%3D5010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Protein kinase inhibitors as a therapeutic modality</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar0201207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=462-469&author=A.+Levitzki&title=Protein+kinase+inhibitors+as+a+therapeutic+modality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Far0201207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far0201207%26sid%3Dliteratum%253Aachs%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DProtein%2520kinase%2520inhibitors%2520as%2520a%2520therapeutic%2520modality%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2003%26volume%3D36%26spage%3D462%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Protein kinases—the major drug targets of the twenty-first century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=309-315&author=P.+Cohen&title=Protein+kinases%E2%80%94the+major+drug+targets+of+the+twenty-first+century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DProtein%2520kinases%25E2%2580%2594the%2520major%2520drug%2520targets%2520of%2520the%2520twenty-first%2520century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D309%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Zwick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bange, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">Receptor tyrosine kinase as targets for anticancer drugs</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=17-22&author=E.+Zwickauthor=J.+Bangeauthor=A.+Ullrich&title=Receptor+tyrosine+kinase+as+targets+for+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwick%26aufirst%3DE.%26aulast%3DBange%26aufirst%3DJ.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DReceptor%2520tyrosine%2520kinase%2520as%2520targets%2520for%2520anticancer%2520drugs%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: from rational design to clinical trials</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fmed.1022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=11607931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=499-512&author=P.+Traxlerauthor=G.+Boldauthor=E.+Buchdungerauthor=G.+Caravattiauthor=P.+Furetauthor=P.+Manleyauthor=T.+O%E2%80%99Reillyauthor=J.+Woodauthor=J.+Zimmermann&title=Tyrosine+kinase+inhibitors%3A+from+rational+design+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase inhibitors: From rational design to clinical trials</span></div><div class="casAuthors">Traxler, Peter; Bold, Guido; Buchdunger, Elisabeth; Caravatti, Giorgio; Furet, Pascal; Manley, Paul; O'Reilly, Terence; Wood, Jeanette; Zimmermann, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499-512</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms.  The inhibition of growth related kinases, esp. Tyr kinases, might provide new therapies for diseases such as cancer.  The progress made in the crystn. of protein kinases has confirmed that the ATP-binding domain of Tyr kinases is an attractive target for drug design.  Three successful examples of drug design at Novartis using a Tyr kinase as a mol. target are described.  PK1166, a pyrrolo[2,3,-d]pyrimidine deriv., is a dual inhibitor of both the EGFR and the ErbB2 kinases.  The compd. entered clin. trials in 1999, based on its favorable pre-clin. profile: potent inhibition of EGF-mediated signalling in cells, in vivo antitumor activity in several EGFR over-expressing xenograft tumor models in nude mice, long-lasting inhibition of EGF-stimulated EGFR auto-phosphorylation in tumor tissue, good oral bioavailability in animals, and no prohibitive in vitro and in vivo toxicity findings.  The anilino-phthalazine deriv. PTK787/ZK222584 (Phase I, co-developed by Schering AG, Berlin) is a potent and selective inhibitor of both the KDR and Flt-1 kinases with interesting anti-angiogenic and pharmacokinetic properties (orally bioavailable).  STI 571 (Glivec, Gleevec), a phenylamino-pyrimidine deriv., is a potent inhibitor of the Abl Tyr kinase, which is present in 95% of patients with chronic myelogenous leukemia (CML).  The compd. specifically inhibits proliferation of v-Abl and Bcr-Abl expressing cells (including cells from CML patients) and shows anti-tumor activity as a single agent in animal models at well-tolerated doses.  Pharmacol. relevant concns. are achieved in the plasma of animals (oral administration).  Promising data from phase I and II clin. trials in CML patients (98% hematol. response rate in Phase I) support the fact that the STI571 represents a new treatment modality for CML.  In addn., potent inhibition of the PDGFR and c-Kit Tyr kinases also indicates its possible clin. use in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4W1Gy1U-gvLVg90H21EOLACvtfcHk0ljv4HfHXCi9bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D&md5=bc5ca99f96e51da0736842df4fea841e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fmed.1022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1022%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DManley%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520from%2520rational%2520design%2520to%2520clinical%2520trials%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D499%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Traxler, P.</span><span> </span><span class="NLM_article-title">Tyrosine kinases as targets in cancer therapy—successes and failures</span> <span class="citation_source-journal">Exp. Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=499-512&author=P.+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapy%E2%80%94successes+and+failures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase inhibitors: From rational design to clinical trials</span></div><div class="casAuthors">Traxler, Peter; Bold, Guido; Buchdunger, Elisabeth; Caravatti, Giorgio; Furet, Pascal; Manley, Paul; O'Reilly, Terence; Wood, Jeanette; Zimmermann, Juerg</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">499-512</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms.  The inhibition of growth related kinases, esp. Tyr kinases, might provide new therapies for diseases such as cancer.  The progress made in the crystn. of protein kinases has confirmed that the ATP-binding domain of Tyr kinases is an attractive target for drug design.  Three successful examples of drug design at Novartis using a Tyr kinase as a mol. target are described.  PK1166, a pyrrolo[2,3,-d]pyrimidine deriv., is a dual inhibitor of both the EGFR and the ErbB2 kinases.  The compd. entered clin. trials in 1999, based on its favorable pre-clin. profile: potent inhibition of EGF-mediated signalling in cells, in vivo antitumor activity in several EGFR over-expressing xenograft tumor models in nude mice, long-lasting inhibition of EGF-stimulated EGFR auto-phosphorylation in tumor tissue, good oral bioavailability in animals, and no prohibitive in vitro and in vivo toxicity findings.  The anilino-phthalazine deriv. PTK787/ZK222584 (Phase I, co-developed by Schering AG, Berlin) is a potent and selective inhibitor of both the KDR and Flt-1 kinases with interesting anti-angiogenic and pharmacokinetic properties (orally bioavailable).  STI 571 (Glivec, Gleevec), a phenylamino-pyrimidine deriv., is a potent inhibitor of the Abl Tyr kinase, which is present in 95% of patients with chronic myelogenous leukemia (CML).  The compd. specifically inhibits proliferation of v-Abl and Bcr-Abl expressing cells (including cells from CML patients) and shows anti-tumor activity as a single agent in animal models at well-tolerated doses.  Pharmacol. relevant concns. are achieved in the plasma of animals (oral administration).  Promising data from phase I and II clin. trials in CML patients (98% hematol. response rate in Phase I) support the fact that the STI571 represents a new treatment modality for CML.  In addn., potent inhibition of the PDGFR and c-Kit Tyr kinases also indicates its possible clin. use in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4W1Gy1U-gvLVg90H21EOLACvtfcHk0ljba0kIGGD36A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVeht7c%253D&md5=bc5ca99f96e51da0736842df4fea841e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapy%25E2%2580%2594successes%2520and%2520failures%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Targets%26date%3D2001%26volume%3D21%26spage%3D499%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Angiogenesis in health and disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1038%2Fnm0603-653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=12778163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=653-660&author=P.+Carmeliet&title=Angiogenesis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in health and disease</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels constitute the first organ in the embryo and form the largest network in our body but, sadly, are also often deadly.  When dysregulated, the formation of new blood vessels contributes to numerous malignant, ischemic, inflammatory, infectious and immune disorders.  Mol. insights into these processes are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVe6HXO3QPLbVg90H21EOLACvtfcHk0ljba0kIGGD36A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D&md5=501ed35c48dbcc7c9d18b804c996284a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-653%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D653%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Otrock, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarem, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamseddine, A. I.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor family of ligands and receptors: reviews</span> <span class="citation_source-journal">Blood Cells, Mol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.bcmd.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=17344076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFegs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=258-268&author=Z.+K.+Otrockauthor=J.+A.+Makaremauthor=A.+I.+Shamseddine&title=Vascular+endothelial+growth+factor+family+of+ligands+and+receptors%3A+reviews"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor family of ligands and receptors: Review</span></div><div class="casAuthors">Otrock, Zaher K.; Makarem, Jawad A.; Shamseddine, Ali I.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Cells, Molecules, & Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-268</span>CODEN:
                <span class="NLM_cas:coden">BCMDFX</span>;
        ISSN:<span class="NLM_cas:issn">1079-9796</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  VEGF signaling often represents a crit. rate-limiting step in physiol. angiogenesis.  The VEGF family comprises seven secreted glycoproteins that are designated VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, placental growth factor (PlGF) and VEGF-F.  The VEGF family members bind their cognate receptors.  The receptors identified so far are designated VEGFR-1, VEGFR-2, VEGFR-3 and the neuropilins (NP-1 and NP-2).  We review in this article the biol. of the VEGF ligands and the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEwGCsSDNpgLVg90H21EOLACvtfcHk0liEG1mHGc8xDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFegs7s%253D&md5=1533d087c198c9b3298171dae6d59927</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bcmd.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcmd.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DOtrock%26aufirst%3DZ.%2BK.%26aulast%3DMakarem%26aufirst%3DJ.%2BA.%26aulast%3DShamseddine%26aufirst%3DA.%2BI.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520family%2520of%2520ligands%2520and%2520receptors%253A%2520reviews%26jtitle%3DBlood%2520Cells%252C%2520Mol.%2520Dis.%26date%3D2007%26volume%3D38%26spage%3D258%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bishop-Bailey, D.</span><span> </span><span class="NLM_article-title">Tumour vascularisation: a druggable target</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.coph.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19056315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFaht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=96-101&author=D.+Bishop-Bailey&title=Tumour+vascularisation%3A+a+druggable+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour vascularisation: a druggable target</span></div><div class="casAuthors">Bishop-Bailey, David</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">96-101</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tumor growth, spreading and metastasis require the development of a local vasculature.  There have been great advances in the understanding of how this new vasculature arises, particularly in our increased knowledge of the process of angiogenesis, although, a vast no. of pro-angiogenic and anti-angiogenic mediators have been identified, one of the key signaling processes in the development of the tumor vasculature is the hypoxia-induced stimulation of vascular endothelial cell growth factors (VEGFs) prodn.  Anti-VEGF therapy therefore not only provides a new paradigm for limiting tumor growth via targeting angiogenesis, but also provides prototypic agents to test the hypothesis that by controlling the development of the tumor vasculature we are able to limit, and potentially stop, tumor growth and spreading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqccdJORGSeBrVg90H21EOLACvtfcHk0liEG1mHGc8xDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFaht7s%253D&md5=f7dde53a0196024b99ab009270fd6fe9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DBishop-Bailey%26aufirst%3DD.%26atitle%3DTumour%2520vascularisation%253A%2520a%2520druggable%2520target%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2009%26volume%3D9%26spage%3D96%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindoh, M.</span><span> </span><span class="NLM_article-title">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1111%2Fj.1349-7006.2007.00704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=18167133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=459-466&author=K.+Hidaauthor=Y.+Hidaauthor=M.+Shindoh&title=Understanding+tumor+endothelial+cell+abnormalities+to+develop+ideal+anti-angiogenic+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span></div><div class="casAuthors">Hida, Kyoko; Hida, Yasuhiro; Shindoh, Masanobu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor angiogenesis is necessary for solid tumor progression and metastasis.  Tumor blood vessels were shown to differ from their normal counterparts, for example, by changes in morphol.  An important concept in tumor angiogenesis is that tumor endothelial cells are assumed to be genetically normal, even though these endothelial cells are structurally and functionally abnormal.  To date, many anti-angiogenic drugs were developed, but, their therapeutic efficacy is not dramatic and they were also reported to cause toxic side effects.  To develop ideal antiangiogenic therapies, understanding tumor endothelial cell abnormalities is important.  The authors have isolated tumor endothelial cells from mouse tumor xenografts and have shown that tumor-assocd. endothelial cells are abnormal.  Tumor-assocd. endothelial cells upregulate many genes, such as epidermal growth factor receptor (EGFR).  Tumor-assocd. endothelial cells are also more sensitive to EGF.  They also have relatively large, heterogeneous nuclei.  Unexpectedly, tumor endothelial cells are cytogenetically abnormal.  Fluorescence in situ hybridization (FISH) anal. showed that freshly isolated uncultured tumor endothelial cells were aneuploid and had abnormal multiple centrosomes.  The degree of aneuploidy was exacerbated by passage in culture.  In marked contrast, freshly isolated normal skin and adipose endothelial cells were diploid.  They had normal centrosomes and remained cytogenetically stable in culture even up to 20 passages.  The authors conclude that tumor endothelial cells can acquire cytogenetic abnormalities while in the tumor microenvironment.  Questions as to whether or not tumor endothelial cells become resistant to antiangiogenic drugs are thus raised.  The authors' preliminary data show that tumor endothelial cells are more resistant to certain chemotherapeutic drugs.  Studies to evaluate the mechanism for cytogenetic abnormalities in tumor endothelial cells are underway.  It is becoming quite clear that the tumor vasculature is much more complex and unpredictable than initially perceived.  Here, the authors provide an overview of the current studies on tumor endothelial cell abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6NvCQ0OhH7Vg90H21EOLACvtfcHk0liEG1mHGc8xDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D&md5=eca837a1371c1d0ff455fd3c3d523403</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00704.x%26sid%3Dliteratum%253Aachs%26aulast%3DHida%26aufirst%3DK.%26aulast%3DHida%26aufirst%3DY.%26aulast%3DShindoh%26aufirst%3DM.%26atitle%3DUnderstanding%2520tumor%2520endothelial%2520cell%2520abnormalities%2520to%2520develop%2520ideal%2520anti-angiogenic%2520therapies%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Otrock, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahfouz, R. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarem, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamseddine, A. I.</span><span> </span><span class="NLM_article-title">Understanding the biology of angiogenesis: review of the most important molecular mechanisms</span> <span class="citation_source-journal">Blood Cells, Mol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.bcmd.2007.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=17553709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFKisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=212-220&author=Z.+K.+Otrockauthor=R.+A.+R.+Mahfouzauthor=J.+A.+Makaremauthor=A.+I.+Shamseddine&title=Understanding+the+biology+of+angiogenesis%3A+review+of+the+most+important+molecular+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the biology of angiogenesis: Review of the most important molecular mechanisms</span></div><div class="casAuthors">Otrock, Zaher K.; Mahfouz, Rami A. R.; Makarem, Jawad A.; Shamseddine, Ali I.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Cells, Molecules, & Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-220</span>CODEN:
                <span class="NLM_cas:coden">BCMDFX</span>;
        ISSN:<span class="NLM_cas:issn">1079-9796</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is an important process for forming new blood vessels.  It is fundamental in many biol. processes including development, reprodn. and wound repair.  Under these conditions, angiogenesis is a highly regulated process.  Numerous inducers of angiogenesis have been identified, including the members of the vascular endothelial growth factor family, angiopoietins, transforming growth factors, platelet-derived growth factor, tumor necrosis factor-α, interleukins and members of the fibroblast growth factor family.  Vascular endothelial growth factor-A is the most potent pro-angiogenic protein described to date.  It induces proliferation, sprouting and tube formation of endothelial cells.  Angiogenesis is therefore a putative target for therapy.  The potential application of different angiogenesis inhibitors is currently under intense clin. investigation.  A better understanding of the biol. of angiogenesis may reveal new targets for treating many diseases that are assocd. with this complex process.  In this review, we summarize the most important mol. mechanisms mediating angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri3qfVcA9RsbVg90H21EOLACvtfcHk0lgHFBl-lgQlRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFKisrg%253D&md5=abe32c8a9a792ddf45cf8e78a634998e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bcmd.2007.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcmd.2007.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DOtrock%26aufirst%3DZ.%2BK.%26aulast%3DMahfouz%26aufirst%3DR.%2BA.%2BR.%26aulast%3DMakarem%26aufirst%3DJ.%2BA.%26aulast%3DShamseddine%26aufirst%3DA.%2BI.%26atitle%3DUnderstanding%2520the%2520biology%2520of%2520angiogenesis%253A%2520review%2520of%2520the%2520most%2520important%2520molecular%2520mechanisms%26jtitle%3DBlood%2520Cells%252C%2520Mol.%2520Dis.%26date%3D2007%26volume%3D39%26spage%3D212%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Senger, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Water, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berse, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, H. F.</span><span> </span><span class="NLM_article-title">Vascular permeability factor (VPF, VEGF) in tumor biology</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1007%2FBF00665960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=8281615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2cXnsVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=303-324&author=D.+R.+Sengerauthor=L.+Van+de+Waterauthor=L.+F.+Brownauthor=J.+A.+Nagyauthor=K.+T.+Yeoauthor=T.+K.+Yeoauthor=B.+Berseauthor=R.+W.+Jackmanauthor=A.+M.+Dvorakauthor=H.+F.+Dvorak&title=Vascular+permeability+factor+%28VPF%2C+VEGF%29+in+tumor+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular permeability factor (VPF,VEGF) in tumor biology</span></div><div class="casAuthors">Senger, Donald R.; Van De Water, Livingston; Brown, Lawrence F.; Nagy, Janice A.; Yeo, Kiang Teck; Yeo, Tet Kin; Berse, Brygida; Jackman, Robert W.; Dvorak, Ann M.; Dvorak, Harold F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">303-24</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    </div><div class="casAbstract">A review with 89 refs.  Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a multifunctional cytokine expressed and secreted at high levels by many tumor cells of animal and human origin.  As secreted by tumor cells, VPF/VEGF is a 34-42 kDa heparin-binding, dimeric, disulfide-bonded glycoprotein that acts directly on endothelial cells (EC) by way of specific receptors to activate phospholipase C and induce [Ca2+]i transients.  Two high affinity VPF/VEGF receptors, both tyrosine kinases, have thus far been described.  VPF/VEGF is likely to have a no. of important roles in tumor biol. related, but not limited to, the process of tumor angiogenesis.  As a potent permeability factor, VPF/VEGF promotes extravasation of plasma fibrinogen, leading to fibrin deposition which alters the tumor extracellular matrix.  This matrix promotes the ingrowth of macrophages, fibroblasts, and endothelial cells.  Moreover, VPF/VEGF is a selective endothelial cell (EC) growth factor in vitro, and it presumably stimulates EC proliferation in vivo.  Furthermore, VPF/VEGF has been found in animal and human tumor effusions by immunoassay and by functional assays and very likely accounts for the induction of malignant ascites.  In addn. to its role in tumors, VPF/VEGF has recently been found to have a role in wound healing and its expression by activated macrophages suggest that it probably also participates in certain types of chronic inflammation.  VPF/VEGF is expressed in normal development and in certain normal adult organs, notably kidney, heart, adrenal gland and lung.  Its functions in normal adult tissues are under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoypXw29msdV7Vg90H21EOLACvtfcHk0lgHFBl-lgQlRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXnsVejug%253D%253D&md5=bf7d474ad681de62f1cc73029a90e376</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2FBF00665960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00665960%26sid%3Dliteratum%253Aachs%26aulast%3DSenger%26aufirst%3DD.%2BR.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DL.%2BF.%26aulast%3DNagy%26aufirst%3DJ.%2BA.%26aulast%3DYeo%26aufirst%3DK.%2BT.%26aulast%3DYeo%26aufirst%3DT.%2BK.%26aulast%3DBerse%26aufirst%3DB.%26aulast%3DJackman%26aufirst%3DR.%2BW.%26aulast%3DDvorak%26aufirst%3DA.%2BM.%26aulast%3DDvorak%26aufirst%3DH.%2BF.%26atitle%3DVascular%2520permeability%2520factor%2520%2528VPF%252C%2520VEGF%2529%2520in%2520tumor%2520biology%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D1993%26volume%3D12%26spage%3D303%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Roy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ylä-Herttuala, S.</span><span> </span><span class="NLM_article-title">Biology of vascular endothelial growth factors</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">2879</span><span class="NLM_x">–</span> <span class="NLM_lpage">2887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=2879-2887&author=H.+Royauthor=S.+Bhardwajauthor=S.+Yl%C3%A4-Herttuala&title=Biology+of+vascular+endothelial+growth+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DH.%26aulast%3DBhardwaj%26aufirst%3DS.%26aulast%3DYl%25C3%25A4-Herttuala%26aufirst%3DS.%26atitle%3DBiology%2520of%2520vascular%2520endothelial%2520growth%2520factors%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D2879%26epage%3D2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, S. D.</span><span> </span><span class="NLM_article-title">Roles of main pro- and anti-angiogenic factors in tumor angiogenesis</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.3748%2Fwjg.v10.i4.463" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=463-470&author=Z.+Huangauthor=S.+D.+Bao&title=Roles+of+main+pro-+and+anti-angiogenic+factors+in+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v10.i4.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v10.i4.463%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBao%26aufirst%3DS.%2BD.%26atitle%3DRoles%2520of%2520main%2520pro-%2520and%2520anti-angiogenic%2520factors%2520in%2520tumor%2520angiogenesis%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2004%26volume%3D4%26spage%3D463%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gleadle, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratcliffe, P. J.</span><span> </span><span class="NLM_article-title">Hypoxia and the regulation of gene expression</span> <span class="citation_source-journal">Mol. Med. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2FS1357-4310%2897%2901198-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=9575495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK1cXisVOqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=122-129&author=J.+M.+Gleadleauthor=P.+J.+Ratcliffe&title=Hypoxia+and+the+regulation+of+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia and the regulation of gene expression</span></div><div class="casAuthors">Gleadle, Jonathan M.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">122-129</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 45 refs.  The optimal delivery of oxygen to tissues is essential both to ensure adequate energy provision and to avoid the toxic effects of higher oxygen concns.  For this to occur, organisms must be able to sense oxygen and respond to changes in oxygen tension by altering gene expression.  The anal. of the regulation of erythropoiesis has provided important insights into the mechanisms of oxygen-regulated gene expression.  These mechanisms have a role in the regulation of many genes, in many cell types and appear to be of relevance to many common pathologies in which disturbances of oxygen supply are central.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXyEtSoI4bQrVg90H21EOLACvtfcHk0lgHFBl-lgQlRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVOqu7c%253D&md5=31840c786a6c7214fcfc95c08ea4b16d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2897%2901198-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252897%252901198-2%26sid%3Dliteratum%253Aachs%26aulast%3DGleadle%26aufirst%3DJ.%2BM.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DHypoxia%2520and%2520the%2520regulation%2520of%2520gene%2520expression%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1998%26volume%3D4%26spage%3D122%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Smyth, T.</span><span> </span><span class="NLM_article-title">The biology of vascular endothelial growth factor</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1210%2Fer.18.1.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=9034784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=4-25&author=N.+Ferraraauthor=T.+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of vascular endothelial growth factor</span></div><div class="casAuthors">Ferrara, Napoleone; Davis-Smyth, Terri</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-25</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 250 refs., on: biol. activities of vascular endothelial growth factor (VEGF); organization of the VEGF gene; properties of the VEGF isoforms; regulation of VEGF gene expression; the VEGF receptors; VEGF-related mols.; role of VEGF and its receptors in physiol. angiogenesis; role of VEGF in pathol. angiogenesis; and therapeutic applications of VEGF-induced angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5imhPXJtxxrVg90H21EOLACvtfcHk0ljST4Z8YK52IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsFCiu7s%253D&md5=22796890fbe49a721d330447396aea8b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1210%2Fer.18.1.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.18.1.4%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DDavis-Smyth%26aufirst%3DT.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocr.%2520Rev.%26date%3D1997%26volume%3D18%26spage%3D4%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Roskoski, R.,  Jr.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor (VEGF) signaling in tumor progression</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.critrevonc.2007.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=17324579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ns1OgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=179-213&author=R.+Roskoski&title=Vascular+endothelial+growth+factor+%28VEGF%29+signaling+in+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor (VEGF) signaling in tumor progression</span></div><div class="casAuthors">Roskoski Robert Jr</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-213</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Vascular endothelial cells are ordinarily quiescent in adult humans and divide less than once per decade.  When tumors reach a size of about 0.2-2.0mm in diameter, they become hypoxic and limited in size in the absence of angiogenesis.  There are about 30 endogenous pro-angiogenic factors and about 30 endogenous anti-angiogenic factors.  In order to increase in size, tumors undergo an angiogenic switch where the action of pro-angiogenic factors predominates, resulting in angiogenesis and tumor progression.  One mechanism for driving angiogenesis results from the increased production of vascular endothelial growth factor (VEGF) following up-regulation of the hypoxia-inducible transcription factor.  The human VEGF family consists of VEGF (VEGF-A), VEGF-B, VEGF-C, VEGF-D, and placental growth factor (PlGF).  The VEGF family of receptors consists of three protein-tyrosine kinases and two non-protein kinase receptors (neuropilin-1 and -2).  Owing to the importance of angiogenesis in tumor progression, inhibition of VEGF signaling represents an attractive cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHS2jvhIW2-BBrI9DTGjC0fW6udTcc2eZJrI8OYEjd5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ns1OgtA%253D%253D&md5=cf49919265b5bdef75791ea02b4bb99e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2007.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2007.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520signaling%2520in%2520tumor%2520progression%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2007%26volume%3D62%26spage%3D179%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Roskoski, R,  Jr.</span><span> </span><span class="NLM_article-title">VEGF receptor protein-tyrosine kinases: structure and regulation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=287-291&author=R+Roskoski&title=VEGF+receptor+protein-tyrosine+kinases%3A+structure+and+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR%26atitle%3DVEGF%2520receptor%2520protein-tyrosine%2520kinases%253A%2520structure%2520and%2520regulation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D375%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Shibuya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson-Welsh, L.</span><span> </span><span class="NLM_article-title">Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.yexcr.2005.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16336962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=549-560&author=M.+Shibuyaauthor=L.+Claesson-Welsh&title=Signal+transduction+by+VEGF+receptors+in+regulation+of+angiogenesis+and+lymphangiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis</span></div><div class="casAuthors">Shibuya, Masabumi; Claesson-Welsh, Lena</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The VEGF/VPF (vascular endothelial growth factor/vascular permeability factor) ligands and receptors are crucial regulators of vasculogenesis, angiogenesis, lymphangiogenesis and vascular permeability in vertebrates.  VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).  VEGFR1, which occurs in transmembrane and sol. forms, neg. regulates vasculogenesis and angiogenesis during early embryogenesis, but it also acts as a pos. regulator of angiogenesis and inflammatory responses, playing a role in several human diseases such as rheumatoid arthritis and cancer.  The sol. VEGFR1 is overexpressed in placenta in preeclampsia patients.  VEGFR2 has crit. functions in physiol. and pathol. angiogenesis through distinct signal transduction pathways regulating proliferation and migration of endothelial cells.  VEGFR3, a receptor for the lymphatic growth factors VEGF-C and VEGF-D, but not for VEGF-A, regulates vascular and lymphatic endothelial cell function during embryogenesis.  Loss-of-function variants of VEGFR3 have been identified in lymphedema.  Formation of tumor lymphatics may be stimulated by tumor-produced VEGF-C, allowing increased spread of tumor metastases through the lymphatics.  Mapping the signaling system of these important receptors may provide the knowledge necessary to suppress specific signaling pathways in major human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6TrItSz12JLVg90H21EOLACvtfcHk0ljST4Z8YK52IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWltbo%253D&md5=7e59aaa57fe5a35b1b44e7f4d7bb552b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2005.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2005.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DShibuya%26aufirst%3DM.%26aulast%3DClaesson-Welsh%26aufirst%3DL.%26atitle%3DSignal%2520transduction%2520by%2520VEGF%2520receptors%2520in%2520regulation%2520of%2520angiogenesis%2520and%2520lymphangiogenesis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2006%26volume%3D312%26spage%3D549%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rahimi, N.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.exer.2006.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16713597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1005-1016&author=N.+Rahimi&title=Vascular+endothelial+growth+factor+receptors%3A+molecular+mechanisms+of+activation+and+therapeutic+potentials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor receptors: Molecular mechanisms of activation and therapeutic potentials</span></div><div class="casAuthors">Rahimi, Nader</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis-assocd. eye diseases are among the most common cause of blindness in the United States and worldwide.  Recent advances in the development of angiogenesis-based therapies for treatment of angiogenesis-assocd. diseases have provided new hope in a wide variety of human diseases ranging from eye diseases to cancer.  One group of growth factor receptors critically implicated in angiogenesis is vascular endothelial growth factor receptors (VEGFR), a subfamily of receptor tyrosine kinases (RTKs).  VEGFR-1 and VEGFR-2 are closely related receptor tyrosine kinases and have both common and specific ligands.  VEGFR-1 is a kinase-impaired RTK and its kinase activity is suppressed by a single amino acid substitution in its kinase domain and by its carboxyl terminus.  VEGFR-2 is highly active kinase, stimulates a variety of signaling pathways and broad biol. responses in endothelial cells.  The mechanisms that govern VEGFR-2 activation, its ability to recruit signaling proteins and to undergo downregulation are highly regulated by phosphorylation activation loop tyrosines and its carboxyl terminus.  Despite their differential potentials to undergo tyrosine phosphorylation and kinase activation, both VEGFR-1 and VEGFR-2 are required for normal embryonic development and pathol. angiogenesis.  VEGFR-1 regulates angiogenesis by mechanisms that involve ligand trapping, receptor homodimerization and heterodimerization.  This review highlights recent insights into the mechanism of activation of VEGFR-1 and VEGFR-2, and focuses on the signaling pathways employed by VEGFR-1 and VEGFR-2 that regulate angiogenesis and their therapeutic potentials in angiogenesis-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Df0usV5jvLVg90H21EOLACvtfcHk0lhz7M5XRkzXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGnsrg%253D&md5=cdcb6127f3a97f5665e4992f54a88476</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DRahimi%26aufirst%3DN.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520receptors%253A%2520molecular%2520mechanisms%2520of%2520activation%2520and%2520therapeutic%2520potentials%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2006%26volume%3D83%26spage%3D1005%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Cell signaling by receptor tyrosine kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2FS0092-8674%2800%2900114-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=11057895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2000&pages=211-225&author=J.+Schlessinger&title=Cell+signaling+by+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cell signaling by receptor tyrosine kinases</span></div><div class="casAuthors">Schlessinger, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-225</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 109 refs.  The purpose of this review is to describe general concepts underlying the mechanism of action of RTKs and the signaling pathways that they regulate, while attempting to shed light on the question of how specificity is defined by the action of RTKs, and how a specific biol. response can be generated by the diverse array of signaling pathways activated by all RTKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0AvjN2PpaVbVg90H21EOLACvtfcHk0lhz7M5XRkzXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1Cltrs%253D&md5=7b4cacd2513290f3b3e6120b58647654</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900114-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900114-8%26sid%3Dliteratum%253Aachs%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DCell%2520signaling%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCell%26date%3D2000%26volume%3D103%26spage%3D211%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Tyrosine phosphorylation: thirty years and counting</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.ceb.2009.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19269802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=140-146&author=T.+Hunter&title=Tyrosine+phosphorylation%3A+thirty+years+and+counting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine phosphorylation: thirty years and counting</span></div><div class="casAuthors">Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-146</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging.  Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a no. of which were approved for clin. use.  The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozf_yslNwApbVg90H21EOLACvtfcHk0lhz7M5XRkzXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClurs%253D&md5=ef5dbec53a41f9691317cc5b1b47b3cb</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DTyrosine%2520phosphorylation%253A%2520thirty%2520years%2520and%2520counting%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gibson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodburn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarlett, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. S.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor tyrosine kinase: structure-activity relationships and antitumour activity of novel quinazolines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2723</span><span class="NLM_x">–</span> <span class="NLM_lpage">2728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2723-2728&author=K.+H.+Gibsonauthor=W.+Grundyauthor=A.+Godfreyauthor=J.+R.+Woodburnauthor=S.+E.+Ashtonauthor=B.+J.+Curryauthor=L.+Scarlettauthor=A.+J.+Barkerauthor=D.+S.+Brown&title=Epidermal+growth+factor+receptor+tyrosine+kinase%3A+structure-activity+relationships+and+antitumour+activity+of+novel+quinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DK.%2BH.%26aulast%3DGrundy%26aufirst%3DW.%26aulast%3DGodfrey%26aufirst%3DA.%26aulast%3DWoodburn%26aufirst%3DJ.%2BR.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DCurry%26aufirst%3DB.%2BJ.%26aulast%3DScarlett%26aufirst%3DL.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DD.%2BS.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%253A%2520structure-activity%2520relationships%2520and%2520antitumour%2520activity%2520of%2520novel%2520quinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2723%26epage%3D2728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouyssegur, J.</span><span> </span><span class="NLM_article-title">Targeting the Erk signalling pathway in cancer therapy</span> <span class="citation_source-journal">Ann. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1080%2F07853890600551037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16720434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVyms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=200-211&author=M.+Kohnoauthor=J.+Pouyssegur&title=Targeting+the+Erk+signalling+pathway+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the ERK signaling pathway in cancer therapy</span></div><div class="casAuthors">Kohno, Michiaki; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Medicine (Basingstoke, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">200-211</span>CODEN:
                <span class="NLM_cas:coden">ANMDEU</span>;
        ISSN:<span class="NLM_cas:issn">0785-3890</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  The extracellular signal-regulated kinase (ERK) signaling pathway is a major determinant in the control of diverse cellular processes such as proliferation, survival, differentiation and motility.  This pathway is often up-regulated in human tumors and as such represents an attractive target for the development of anticancer drugs.  Because of its multiple roles in the acquisition of a complex malignant phenotype, specific blockade of the ERK pathway is expected to result in not only an anti-proliferative effect but also in anti-metastatic and anti-angiogenic effects in tumor cells.  Recently potent small-mol. inhibitors targeting the components of the ERK pathway have been developed.  Among them, BAY 43-9006 (Raf inhibitor), and PD184352, PD0325901 and ARRY-142886 (MEK1/2 inhibitors) have reached the clin. trial stage.  We briefly discuss the possibility that combination of ERK pathway inhibitors (cytostatic agents) and conventional anticancer drugs (cytotoxic agents) provides an excellent basis for the development of new chemotherapeutic strategies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC9mDu6Gn4nrVg90H21EOLACvtfcHk0lhz7M5XRkzXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVyms7c%253D&md5=64efca43e25a60c2396842beef7559aa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F07853890600551037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07853890600551037%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520Erk%2520signalling%2520pathway%2520in%2520cancer%2520therapy%26jtitle%3DAnn.%2520Med.%26date%3D2006%26volume%3D38%26spage%3D200%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Djordjevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, P. C.</span><span> </span><span class="NLM_article-title">Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=426-432&author=S.+Djordjevicauthor=P.+C.+Driscoll&title=Structural+insight+into+substrate+specificity+and+regulatory+mechanisms+of+phosphoinositide+3-kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDjordjevic%26aufirst%3DS.%26aulast%3DDriscoll%26aufirst%3DP.%2BC.%26atitle%3DStructural%2520insight%2520into%2520substrate%2520specificity%2520and%2520regulatory%2520mechanisms%2520of%2520phosphoinositide%25203-kinases%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2002%26volume%3D27%26spage%3D426%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gourley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, J. S.</span><span> </span><span class="NLM_article-title">Angiogenesis: new targets for the development of anticancer chemotherapies</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.2174%2F1381612003400867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=10788590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjt1Cltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=417-439&author=M.+Gourleyauthor=J.+S.+Williamson&title=Angiogenesis%3A+new+targets+for+the+development+of+anticancer+chemotherapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis: new targets for the development of anticancer chemotherapies</span></div><div class="casAuthors">Gourley, Maralea; Williamson, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">417-439</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 120 refs.  Angiogenesis is the process by which new blood vessels are formed from preexisting microvasculature.  To ensure an adequate blood supply, tumor cells release angiogenic factors that are capable of promoting nearby blood vessels to extend vascular branches to the tumor.  In addn., larger tumors have been shown to release angiogenic inhibitory factors that prevent blood vessels from sending branches to smaller, more distant tumors that compete for oxygen and nutrients.  Angiogenesis is a complex multistep biochem. process, and offers several potential mol. targets for non-cytotoxic anticancer therapies.  Strategies for exploiting tumor angiogenesis for novel cancer drug discovery include: (i) inhibition of proteolytic enzymes that breakdown the extracellular matrix surrounding existing capillaries; (ii) inhibition of endothelial cell migration; (iii) inhibition of endothelial cell proliferation; (iv) enhancement of tumor endothelial cell apoptosis.  There is also a host of misc. agents that inhibit angiogenesis for which the specific mechanisms are not clear.  Several methods have been developed for measuring antiangiogenic activity both in vitro and in vivo.  Although there has been intensive research efforts focused at the phenomena of angiogenesis, as well as the search for antiangiogenic agents for more than two decades, many questions remain unanswered with regard to the overall biochem. mechanisms of the angiogenesis process and the potential therapeutic utility of angiogenic inhibitors.  Nevertheless potent angiogenic inhibitors capable of blocking tumor growth have been discovered, and appear to have potential for development into novel anticancer therapeutics.  However there are still hurdles to be overcome before these inhibitors become mainstream therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozUc0mX-Ip9rVg90H21EOLACvtfcHk0ljDK4tk6_y3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjt1Cltb0%253D&md5=9eba84a10096c9a95e513187c745de37</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1381612003400867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612003400867%26sid%3Dliteratum%253Aachs%26aulast%3DGourley%26aufirst%3DM.%26aulast%3DWilliamson%26aufirst%3DJ.%2BS.%26atitle%3DAngiogenesis%253A%2520new%2520targets%2520for%2520the%2520development%2520of%2520anticancer%2520chemotherapies%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2000%26volume%3D6%26spage%3D417%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Brunella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanza, E.</span><span> </span><span class="NLM_article-title">Possible novel targets for therapeutic angiogenesis</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1016%2Fj.coph.2008.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19071062" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=102-108&author=C.+Brunellaauthor=E.+Costanza&title=Possible+novel+targets+for+therapeutic+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrunella%26aufirst%3DC.%26aulast%3DCostanza%26aufirst%3DE.%26atitle%3DPossible%2520novel%2520targets%2520for%2520therapeutic%2520angiogenesis%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2009%26volume%3D9%26spage%3D102%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Raffetto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalil, R. A.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=346-359&author=J.+D.+Raffettoauthor=R.+A.+Khalil&title=Matrix+metalloproteinases+and+their+inhibitors+in+vascular+remodeling+and+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaffetto%26aufirst%3DJ.%2BD.%26aulast%3DKhalil%26aufirst%3DR.%2BA.%26atitle%3DMatrix%2520metalloproteinases%2520and%2520their%2520inhibitors%2520in%2520vascular%2520remodeling%2520and%2520vascular%2520disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D346%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindoh, M.</span><span> </span><span class="NLM_article-title">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1111%2Fj.1349-7006.2007.00704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=18167133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=459-466&author=K.+Hidaauthor=Y.+Hidaauthor=M.+Shindoh&title=Understanding+tumor+endothelial+cell+abnormalities+to+develop+ideal+anti-angiogenic+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies</span></div><div class="casAuthors">Hida, Kyoko; Hida, Yasuhiro; Shindoh, Masanobu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor angiogenesis is necessary for solid tumor progression and metastasis.  Tumor blood vessels were shown to differ from their normal counterparts, for example, by changes in morphol.  An important concept in tumor angiogenesis is that tumor endothelial cells are assumed to be genetically normal, even though these endothelial cells are structurally and functionally abnormal.  To date, many anti-angiogenic drugs were developed, but, their therapeutic efficacy is not dramatic and they were also reported to cause toxic side effects.  To develop ideal antiangiogenic therapies, understanding tumor endothelial cell abnormalities is important.  The authors have isolated tumor endothelial cells from mouse tumor xenografts and have shown that tumor-assocd. endothelial cells are abnormal.  Tumor-assocd. endothelial cells upregulate many genes, such as epidermal growth factor receptor (EGFR).  Tumor-assocd. endothelial cells are also more sensitive to EGF.  They also have relatively large, heterogeneous nuclei.  Unexpectedly, tumor endothelial cells are cytogenetically abnormal.  Fluorescence in situ hybridization (FISH) anal. showed that freshly isolated uncultured tumor endothelial cells were aneuploid and had abnormal multiple centrosomes.  The degree of aneuploidy was exacerbated by passage in culture.  In marked contrast, freshly isolated normal skin and adipose endothelial cells were diploid.  They had normal centrosomes and remained cytogenetically stable in culture even up to 20 passages.  The authors conclude that tumor endothelial cells can acquire cytogenetic abnormalities while in the tumor microenvironment.  Questions as to whether or not tumor endothelial cells become resistant to antiangiogenic drugs are thus raised.  The authors' preliminary data show that tumor endothelial cells are more resistant to certain chemotherapeutic drugs.  Studies to evaluate the mechanism for cytogenetic abnormalities in tumor endothelial cells are underway.  It is becoming quite clear that the tumor vasculature is much more complex and unpredictable than initially perceived.  Here, the authors provide an overview of the current studies on tumor endothelial cell abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6NvCQ0OhH7Vg90H21EOLACvtfcHk0ljDK4tk6_y3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ehsro%253D&md5=eca837a1371c1d0ff455fd3c3d523403</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2007.00704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2007.00704.x%26sid%3Dliteratum%253Aachs%26aulast%3DHida%26aufirst%3DK.%26aulast%3DHida%26aufirst%3DY.%26aulast%3DShindoh%26aufirst%3DM.%26atitle%3DUnderstanding%2520tumor%2520endothelial%2520cell%2520abnormalities%2520to%2520develop%2520ideal%2520anti-angiogenic%2520therapies%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Masood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P. S.</span><span> </span><span class="NLM_article-title">Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fijc.10996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=12594815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVehtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2003&pages=603-610&author=R.+Masoodauthor=A.+Kundraauthor=S.+Zhuauthor=G.+Xiaauthor=P.+Scaliaauthor=D.+L.+Smithauthor=P.+S.+Gill&title=Malignant+mesothelioma+growth+inhibition+by+agents+that+target+the+VEGF+and+VEGF-C+autocrine+loops"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops</span></div><div class="casAuthors">Masood, Rizwan; Kundra, Ajay; Zhu, SuTao; Xia, Guangbin; Scalia, Pierluigi; Smith, D. Lynne; Gill, Parkash S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">603-610</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Malignant mesothelioma (MM) is a locally aggressive tumor that originates from the mesothelial cells of the pleural and sometimes peritoneal surface.  Conventional treatments for MM, consisting of chemotherapy or surgery give little survival benefit to patients, who generally die within 1 yr of diagnosis.  Hence, there is an urgent need for the development of alternative therapies.  Vascular endothelial growth factor (VEGF) is an autocrine growth factor for MM.  The closely related mol., VEGF-C, is also implicated in malignant mesothelioma growth.  VEGF-C and its cognate receptor VEGFR-3 are co-expressed in mesothelioma cell lines.  A functional VEGF-C autocrine growth loop was demonstrated in mesothelioma cells by targeting VEGF-C expression and binding to VEGFR-3.  The ability of novel agents that reduce the levels of VEGF and VEGF-C to inhibit mesothelioma cell growth in vitro was assessed.  Antisense oligonucleotide (ODN) complementary to VEGF that inhibited VEGF and VEGF-C expression simultaneously specifically inhibited mesothelioma cell growth.  Similarly, antibodies to VEGF receptor (VEGFR-2) and VEGF-C receptor (VEGFR-3) were synergistic in inhibiting mesothelioma cell growth.  In addn., a diphtheria toxin-VEGF fusion protein (DT-VEGF), which is toxic to cells that express VEGF receptors was very effective in inhibiting mesothelioma cell growth in vitro.  These results indicate that targeting VEGF and VEGF-C simultaneously may be an effective therapeutic approach for malignant mesothelioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplulg_0LcHdrVg90H21EOLACvtfcHk0ljDK4tk6_y3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVehtLw%253D&md5=edeb814f312d7b37c16ce1ab68d2a53a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fijc.10996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10996%26sid%3Dliteratum%253Aachs%26aulast%3DMasood%26aufirst%3DR.%26aulast%3DKundra%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DScalia%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DGill%26aufirst%3DP.%2BS.%26atitle%3DMalignant%2520mesothelioma%2520growth%2520inhibition%2520by%2520agents%2520that%2520target%2520the%2520VEGF%2520and%2520VEGF-C%2520autocrine%2520loops%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2003%26volume%3D104%26spage%3D603%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Booy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirzada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahib, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehrke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadkhoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, M.</span><span> </span><span class="NLM_article-title">Monoclonal and bispecific antibodies as novel therapeutics</span> <span class="citation_source-journal">Arch. Immunol. Ther. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1007%2Fs00005-006-0011-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16648969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvF2kt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=85-101&author=E.+P.+Booyauthor=D.+Joharauthor=S.+Maddikaauthor=H.+Pirzadaauthor=M.+M.+Sahibauthor=I.+Gehrkeauthor=S.+Loewenauthor=S.+F.+Louisauthor=K.+Kadkhodaauthor=M.+Mowatauthor=M.+Los&title=Monoclonal+and+bispecific+antibodies+as+novel+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal and bispecific antibodies as novel therapeutics</span></div><div class="casAuthors">Booy, Evan P.; Johar, Dina; Maddika, Srilekha; Pirzada, Hasan; Sahib, Mickey M.; Gehrke, Iris; Loewen, Shauna; Louis, Sherif F.; Kadkhoda, Kamran; Mowat, Michael; Los, Marek</div><div class="citationInfo"><span class="NLM_cas:title">Archivum Immunologiae et Therapiae Experimentalis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-101</span>CODEN:
                <span class="NLM_cas:coden">AITEAT</span>;
        ISSN:<span class="NLM_cas:issn">0004-069X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Gene amplification, over-expression, and mutation of growth factors, or the receptors themselves, causes increased signaling through receptor kinases, which has been implicated in many human cancers and is assocd. with poor prognosis.  Tumor growth has been shown to be decreased by interrupting this process of extensive growth factor-mediated signaling by directly targeting either the surface receptor or the ligand and thereby preventing cell survival and promoting apoptosis.  Monoclonal antibodies have long been eyed as a potential new class of therapeutics targeting cancer and other diseases.  Antibody-based therapy initially entered clin. practice when trastuzumab/Herceptin became the first clin. approved drug against an oncogene product as a well-established blocking reagent for tumors with hyperactivity of epidermal growth factor signaling pathways.  In the first part of this review we explain basic terms related to the development of antibody-based drugs, give a brief historic perspective of the field, and also touch on topics such as the "humanization of antibodies" or creation of hybrid antibodies.  The second part of the review gives an overview of the clin. usage of bispecific antibodies and antibodies "armed" with cytotoxic agents or enzymes.  Further within this section, cancer-specific, site-specific, or signaling pathway-specific therapies are discussed in detail.  Among other antibody-based therapeutic products, we discuss: Avastin (bevacizumab), CG76030, Theragyn (pemtumomab), daclizumab (Zenapax), TriAb, MDX-210, Herceptin (trastuzumab), panitumumab (ABX-EGF), mastuzimab (EMD-72000), Erbitux (certuximab, IMC225), Panorex (edrecolomab), STI571, CeaVac, Campath (alemtuizumab), Mylotarg (gemtuzumab, ozogamicin), and many others.  The end of the review deliberates upon potential problems assocd. with cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI2od5G6SCK7Vg90H21EOLACvtfcHk0ljo6Otk_cyBeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvF2kt7s%253D&md5=614a7b672981ad6db344aabcbcfbee7f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00005-006-0011-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00005-006-0011-5%26sid%3Dliteratum%253Aachs%26aulast%3DBooy%26aufirst%3DE.%2BP.%26aulast%3DJohar%26aufirst%3DD.%26aulast%3DMaddika%26aufirst%3DS.%26aulast%3DPirzada%26aufirst%3DH.%26aulast%3DSahib%26aufirst%3DM.%2BM.%26aulast%3DGehrke%26aufirst%3DI.%26aulast%3DLoewen%26aufirst%3DS.%26aulast%3DLouis%26aufirst%3DS.%2BF.%26aulast%3DKadkhoda%26aufirst%3DK.%26aulast%3DMowat%26aufirst%3DM.%26aulast%3DLos%26aufirst%3DM.%26atitle%3DMonoclonal%2520and%2520bispecific%2520antibodies%2520as%2520novel%2520therapeutics%26jtitle%3DArch.%2520Immunol.%2520Ther.%2520Exp.%26date%3D2006%26volume%3D54%26spage%3D85%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2005&pages=328-335&author=N.+Ferraraauthor=K.+J.+Hillanauthor=W.+Novotny&title=Bevacizumab+%28Avastin%29%2C+a+humanized+anti-VEGF+monoclonal+antibody+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DBevacizumab%2520%2528Avastin%2529%252C%2520a%2520humanized%2520anti-VEGF%2520monoclonal%2520antibody%2520for%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D333%26spage%3D328%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Scanga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowdley, K.</span><span> </span><span class="NLM_article-title">Sorafenib: a glimmer of hope for unresectable hepatocellular carcinoma?</span> <span class="citation_source-journal">Hepathology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fhep.22756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=19115217" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=332-334&author=A.+Scangaauthor=K.+Kowdley&title=Sorafenib%3A+a+glimmer+of+hope+for+unresectable+hepatocellular+carcinoma%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fhep.22756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22756%26sid%3Dliteratum%253Aachs%26aulast%3DScanga%26aufirst%3DA.%26aulast%3DKowdley%26aufirst%3DK.%26atitle%3DSorafenib%253A%2520a%2520glimmer%2520of%2520hope%2520for%2520unresectable%2520hepatocellular%2520carcinoma%253F%26jtitle%3DHepathology%26date%3D2009%26volume%3D49%26spage%3D332%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Escudier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczylik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negrier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevreau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demkow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowski, R. M.</span><span> </span><span class="NLM_article-title">Sorafenib in advanced clear-cell renal-cell carcinoma</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=332-334&author=B.+Escudierauthor=T.+Eisenauthor=W.+M.+Stadlerauthor=C.+Szczylikauthor=S.+Oudardauthor=M.+Siebelsauthor=S.+Negrierauthor=C.+Chevreauauthor=E.+Solskaauthor=A.+A.+Desaiauthor=F.+Rollandauthor=T.+Demkowauthor=T.+E.+Hutsonauthor=M.+Goreauthor=S.+Freemanauthor=B.+Schwartzauthor=M.+Shanauthor=R.+Simantovauthor=R.+M.+Bukowski&title=Sorafenib+in+advanced+clear-cell+renal-cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEscudier%26aufirst%3DB.%26aulast%3DEisen%26aufirst%3DT.%26aulast%3DStadler%26aufirst%3DW.%2BM.%26aulast%3DSzczylik%26aufirst%3DC.%26aulast%3DOudard%26aufirst%3DS.%26aulast%3DSiebels%26aufirst%3DM.%26aulast%3DNegrier%26aufirst%3DS.%26aulast%3DChevreau%26aufirst%3DC.%26aulast%3DSolska%26aufirst%3DE.%26aulast%3DDesai%26aufirst%3DA.%2BA.%26aulast%3DRolland%26aufirst%3DF.%26aulast%3DDemkow%26aufirst%3DT.%26aulast%3DHutson%26aufirst%3DT.%2BE.%26aulast%3DGore%26aufirst%3DM.%26aulast%3DFreeman%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DShan%26aufirst%3DM.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DBukowski%26aufirst%3DR.%2BM.%26atitle%3DSorafenib%2520in%2520advanced%2520clear-cell%2520renal-cell%2520carcinoma%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2009%26volume%3D49%26spage%3D332%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Motzer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redman, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudes, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figlin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePrimo, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bello, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theuer, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1200%2FJCO.2005.02.2574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=16330672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1ChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=16-24&author=R.+J.+Motzerauthor=M.+D.+Michaelsonauthor=B.+G.+Redmanauthor=G.+R.+Hudesauthor=G.+Wildingauthor=R.+A.+Figlinauthor=M.+S.+Ginsbergauthor=S.+T.+Kimauthor=C.+M.+Baumauthor=S.+E.+DePrimoauthor=J.+Z.+Liauthor=C.+L.+Belloauthor=C.+P.+Theuerauthor=D.+J.+Georgeauthor=B.+I.+Rini&title=Activity+of+SU11248%2C+a+multitargeted+inhibitor+of+vascular+endothelial+growth+factor+receptor+and+platelet-derived+growth+factor+receptor%2C+in+patients+with+metastatic+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Motzer, Robert J.; Michaelson, M. Dror; Redman, Bruce G.; Hudes, Gary R.; Wilding, George; Figlin, Robert A.; Ginsberg, Michelle S.; Kim, Sindy T.; Baum, Charles M.; DePrimo, Samuel E.; Li, Jim Z.; Bello, Carlo L.; Theuer, Charles P.; George, Daniel J.; Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-24</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Renal cell carcinoma (RCC) is characterized by loss of von Hippel Lindau tumor suppressor gene activity, resulting in high expression of pro-angiogenic growth factors: vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).  SU11248 (sunitinib malate), a small mol. inhibitor with high binding affinity for VEGF and PDGF receptors, was tested for clin. activity in patients with metastatic RCC.  Patients and Methods: Patients with metastatic RCC and progression on first-line cytokine therapy were enrolled onto a multicenter phase II trial.  SU11248 monotherapy was administered in repeated 6-wk cycles of daily oral therapy for 4 wk, followed by 2 wk off.  Overall response rate was the primary end point, and time to progression and safety were secondary end points.  Results: Twenty-five (40%) of 63 patients treated with SU11248 achieved partial responses; 17 addnl. patients (27%) demonstrated stable disease lasting ≥ 3 mo.  Median time to progression in the 63 patients was 8.7 mo.  Dosing was generally tolerated with manageable toxicities.  Conclusion: SU11248, a multitargeted receptor tyrosine kinase inhibitor of VEGF and PDGF receptors, demonstrates antitumor activity in metastatic RCC as second-line therapy, a setting where no effective systemic therapy is presently recognized.  The genetics of RCC and these promising clin. results support the hypothesis that VEGF and PDGF receptor-mediated signaling is an effective therapeutic target in RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCep3NZbaojLVg90H21EOLACvtfcHk0litnIqsshSIoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1ChtA%253D%253D&md5=f3304eba449f0ff4ac20ac0cf8a878c5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.02.2574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.02.2574%26sid%3Dliteratum%253Aachs%26aulast%3DMotzer%26aufirst%3DR.%2BJ.%26aulast%3DMichaelson%26aufirst%3DM.%2BD.%26aulast%3DRedman%26aufirst%3DB.%2BG.%26aulast%3DHudes%26aufirst%3DG.%2BR.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DFiglin%26aufirst%3DR.%2BA.%26aulast%3DGinsberg%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BT.%26aulast%3DBaum%26aufirst%3DC.%2BM.%26aulast%3DDePrimo%26aufirst%3DS.%2BE.%26aulast%3DLi%26aufirst%3DJ.%2BZ.%26aulast%3DBello%26aufirst%3DC.%2BL.%26aulast%3DTheuer%26aufirst%3DC.%2BP.%26aulast%3DGeorge%26aufirst%3DD.%2BJ.%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DActivity%2520of%2520SU11248%252C%2520a%2520multitargeted%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%252C%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span> </span><span class="NLM_article-title">ZD6474—a novel inhibitor of VEGFR and EGFR tyrosine kinase</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">S6</span><span class="NLM_x">–</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=S6-S13&author=A.+J.+Ryanauthor=S.+R.+Wedge&title=ZD6474%E2%80%94a+novel+inhibitor+of+VEGFR+and+EGFR+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DZD6474%25E2%2580%2594a%2520novel%2520inhibitor%2520of%2520VEGFR%2520and%2520EGFR%2520tyrosine%2520kinase%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3DS6%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ciardiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troiani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vita, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Placido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortora, G.</span><span> </span><span class="NLM_article-title">Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1158%2F1078-0432.CCR-1100-03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=14760102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=784-793&author=F.+Ciardielloauthor=R.+Biancoauthor=R.+Caputoauthor=R.+Caputoauthor=V.+Damianoauthor=T.+Troianiauthor=D.+Melisiauthor=F.+De+Vitaauthor=S.+De+Placidoauthor=A.+R.+Biancoauthor=G.+Tortora&title=Antitumor+activity+of+ZD6474%2C+a+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+in+human+cancer+cells+with+acquired+resistance+to+antiepidermal+growth+factor+receptor+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy</span></div><div class="casAuthors">Ciardiello, Fortunato; Bianco, Roberto; Caputo, Roberta; Caputo, Rosa; Damiano, Vincenzo; Troiani, Teresa; Melisi, Davide; De Vita, Ferdinando; De Placido, Sabino; Bianco, A. Raffaele; Tortora, Giampaolo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">784-793</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) autocrine signaling pathway is involved in cancer development and progression.  EGFR inhibitors such as C225 (cetuximab), a chimeric human-mouse anti-EGFR monoclonal antibody, and ZD1839 (gefitinib), a small mol. EGFR-selective tyrosine kinase inhibitor, are in advanced clin. development.  The potential emergence of cancer cell resistance in EGFR-expressing cancers treated with EGFR inhibitors could det. lack of activity of these drugs in some cancer patients.  Vascular endothelial growth factor (VEGF) is secreted by cancer cells and plays a key role in the regulation of tumor-induced endothelial cell proliferation and permeability.  ZD6474 is a small mol. VEGF flk-1/KDR (VEGFR-2) tyrosine kinase inhibitor that also demonstrates inhibitory activity against EGFR tyrosine kinase.  The antitumor activity of ZD1839, C225, and ZD6474 was tested in athymic mice bearing human GEO colon cancer xenografts.  GEO cell lines resistant to EGFR inhibitors were established from GEO xenografts growing in mice treated chronically with ZD1839 or C225.  Expression of EGFR was evaluated by flow cytometry.  Expression of various proteins involved in intracellular cell signaling was assessed by Western blotting.  Tumor growth data were evaluated for statistical significance using the Student's t test.  All Ps were two-sided.  Although chronic administration of optimal doses of C225 or ZD1839 efficiently blocked GEO tumor growth in the majority of mice, tumors slowly started to grow within 80-90 days, despite continuous treatment.  In contrast, continuous treatment of mice bearing established GEO xenografts with ZD6474 resulted in efficient tumor growth inhibition for the entire duration of dosing (up to 150 days).  ZD6474 activity was also detd. in mice pretreated with ZD1839 or C225.  When GEO growth was apparent after 4 wk of treatment with EGFR inhibitors, mice were either re-treated with EGFR inhibitors or treated with ZD6474.  GEO tumor growth was blocked only in mice treated with ZD6474, whereas tumor progression was obsd. in mice re-treated with C225 or ZD1839.  GEO tumors growing during treatment with C225 or with ZD1839 were established as cell lines (GEO-C225-RES and GEO-ZD1839-RES, resp.).  Cell membrane-assocd. EGFR expression was only slightly reduced in these cell lines compared with parental GEO cells.  Western blotting revealed no major change in the expression of the EGFR ligand transforming growth factor α of bcl-2, bcl-xL, p53, p27, MDM-2, akt, activated phospho-akt, or mitogen-activated protein kinase.  However, both GEO-C225-RES and GEO-ZD1839-RES cells exhibited a 5-10-fold increase in activated phospho-mitogen-activated protein kinase and in the expression of cyclooxygenase-2 and of VEGF compared with GEO cells.  GEO-C225-RES and GEO-ZD1839-RES growth as xenografts in nude mice was not significantly affected by treatment with either C225 or ZD1839 but was efficiently inhibited by ZD6474.  Long-term treatment of GEO xenografts with selective EGFR inhibitors results in the development of EGFR inhibitor-resistant cancer cells.  Growth of EGFR inhibitor-resistant tumors can be inhibited by ZD6474.  These data indicate that inhibition of VEGF signaling has potential as an anticancer strategy, even in tumors that are resistant to EGF inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXQ5DOhiBGb7Vg90H21EOLACvtfcHk0litnIqsshSIoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKitw%253D%253D&md5=cabb04fc66ce376a26ed101f9717e376</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-1100-03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-1100-03%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DBianco%26aufirst%3DR.%26aulast%3DCaputo%26aufirst%3DR.%26aulast%3DCaputo%26aufirst%3DR.%26aulast%3DDamiano%26aufirst%3DV.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DMelisi%26aufirst%3DD.%26aulast%3DDe%2BVita%26aufirst%3DF.%26aulast%3DDe%2BPlacido%26aufirst%3DS.%26aulast%3DBianco%26aufirst%3DA.%2BR.%26aulast%3DTortora%26aufirst%3DG.%26atitle%3DAntitumor%2520activity%2520of%2520ZD6474%252C%2520a%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520human%2520cancer%2520cells%2520with%2520acquired%2520resistance%2520to%2520antiepidermal%2520growth%2520factor%2520receptor%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D784%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Morabito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccirillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falasconi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Feo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normanno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, F.</span><span> </span><span class="NLM_article-title">Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=378-390&author=A.+Morabitoauthor=M.+C.+Piccirilloauthor=F.+Falasconiauthor=G.+De+Feoauthor=A.+Del+Giudiceauthor=J.+Bryceauthor=M.+Di+Maioauthor=E.+De+Maioauthor=N.+Normannoauthor=F.+Perrone&title=Vandetanib+%28ZD6474%29%2C+a+dual+inhibitor+of+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+and+epidermal+growth+factor+receptor+%28EGFR%29+tyrosine+kinases%3A+current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorabito%26aufirst%3DA.%26aulast%3DPiccirillo%26aufirst%3DM.%2BC.%26aulast%3DFalasconi%26aufirst%3DF.%26aulast%3DDe%2BFeo%26aufirst%3DG.%26aulast%3DDel%2BGiudice%26aufirst%3DA.%26aulast%3DBryce%26aufirst%3DJ.%26aulast%3DDi%2BMaio%26aufirst%3DM.%26aulast%3DDe%2BMaio%26aufirst%3DE.%26aulast%3DNormanno%26aufirst%3DN.%26aulast%3DPerrone%26aufirst%3DF.%26atitle%3DVandetanib%2520%2528ZD6474%2529%252C%2520a%2520dual%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520and%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520tyrosine%2520kinases%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlot, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.3109%2F14756360903169485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=20222760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVygtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=158-171&author=A.+Garofaloauthor=L.+Goossensauthor=A.+Lemoineauthor=A.+Farceauthor=Y.+Arlotauthor=P.+Depreux&title=Quinazoline-urea%2C+new+protein+kinase+inhibitors+in+treatment+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer</span></div><div class="casAuthors">Garofalo, Antonio; Goossens, Laurence; Lemoine, Amelie; Farce, Amaury; Arlot, Yannick; Depreux, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">158-171</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor-2 (VEGFR-2), two protein tyrosine kinases, are involved in pathol. disorders and the progression of different types of carcinomas.  Concomitant inhibition of both tyrosine kinase activities appears to be an attractive target for cancer chemotherapy.  A series of new quinazolines I (R1, R2 = MeO, Et2NCH2CH2O; R3 = Me, MeO, EtO, EtNH, PhNH, 2,4-F2C6H3NH, etc.) substituted by amide, urea, or carbamate groups has been synthesized.  The biol. activities of these new compds. have been evaluated for their enzyme inhibition and antiproliferative activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPsXFXwjxLrVg90H21EOLACvtfcHk0lh0PH_DdVeEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVygtbc%253D&md5=5eba33689803516f1f1ba8c3bda6b5b6</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.3109%2F14756360903169485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756360903169485%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DArlot%26aufirst%3DY.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DQuinazoline-urea%252C%2520new%2520protein%2520kinase%2520inhibitors%2520in%2520treatment%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2010%26volume%3D25%26spage%3D158%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkots, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroogy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambing, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchaleelaha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbach, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span> </span><span class="NLM_article-title">Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3772</span><span class="NLM_x">–</span> <span class="NLM_lpage">3793</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020143r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3772-3793&author=A.+Pandeyauthor=D.+L.+Volkotsauthor=J.+M.+Seroogyauthor=J.+W.+Roseauthor=J.+C.+Yuauthor=J.+L.+Lambingauthor=A.+Hutchaleelahaauthor=S.+J.+Hollenbachauthor=K.+Abeauthor=N.+A.+Gieseauthor=R.+M.+Scarborough&title=Identification+of+orally+active%2C+potent%2C+and+selective+4-piperazinylquinazolines+as+antagonists+of+the+platelet-derived+growth+factor+receptor+tyrosine+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fjm020143r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020143r%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DVolkots%26aufirst%3DD.%2BL.%26aulast%3DSeroogy%26aufirst%3DJ.%2BM.%26aulast%3DRose%26aufirst%3DJ.%2BW.%26aulast%3DYu%26aufirst%3DJ.%2BC.%26aulast%3DLambing%26aufirst%3DJ.%2BL.%26aulast%3DHutchaleelaha%26aufirst%3DA.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26atitle%3DIdentification%2520of%2520orally%2520active%252C%2520potent%252C%2520and%2520selective%25204-piperazinylquinazolines%2520as%2520antagonists%2520of%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3772%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Six, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howsam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">(4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl) carbamic acid ester: a novel series of dual EGFR/VEGFR-2 receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=65-72&author=A.+Garofaloauthor=L.+Goossensauthor=A.+Lemoineauthor=P.+Ravezauthor=P.+Sixauthor=M.+Howsamauthor=A.+Farceauthor=P.+Depreux&title=%284-%286%2C7-Disubstituted+quinazolin-4-ylamino%29phenyl%29+carbamic+acid+ester%3A+a+novel+series+of+dual+EGFR%2FVEGFR-2+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DRavez%26aufirst%3DP.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DHowsam%26aufirst%3DM.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3D%25284-%25286%252C7-Disubstituted%2520quinazolin-4-ylamino%2529phenyl%2529%2520carbamic%2520acid%2520ester%253A%2520a%2520novel%2520series%2520of%2520dual%2520EGFR%252FVEGFR-2%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Six, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2106</span><span class="NLM_x">–</span> <span class="NLM_lpage">2112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2106-2112&author=A.+Garofaloauthor=L.+Goossensauthor=A.+Farceauthor=A.+Lemoineauthor=P.+Ravezauthor=P.+Sixauthor=P.+Depreux&title=Impact+of+aryloxy-linked+quinazolines%3A+a+novel+series+of+selective+VEGFR-2+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DRavez%26aufirst%3DP.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DImpact%2520of%2520aryloxy-linked%2520quinazolines%253A%2520a%2520novel%2520series%2520of%2520selective%2520VEGFR-2%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2106%26epage%3D2112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Furuta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, A.</span><span> </span><span class="NLM_article-title">Identification of potent and selective inhibitors of PDGF Receptor autophosphorylation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2186</span><span class="NLM_x">–</span> <span class="NLM_lpage">2192</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0506423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2186-2192&author=T.+Furutaauthor=T.+Sakaiauthor=T.+Sengaauthor=T.+Osawaauthor=K.+Kuboauthor=T.+Shimizuauthor=R.+Suzukiauthor=T.+Yoshinoauthor=M.+Endoauthor=A.+Miwa&title=Identification+of+potent+and+selective+inhibitors+of+PDGF+Receptor+autophosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0506423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0506423%26sid%3Dliteratum%253Aachs%26aulast%3DFuruta%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DSenga%26aufirst%3DT.%26aulast%3DOsawa%26aufirst%3DT.%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DYoshino%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DMiwa%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520PDGF%2520Receptor%2520autophosphorylation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2186%26epage%3D2192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Desroses, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconde, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hénichart, J. P.</span><span> </span><span class="NLM_article-title">Synthesis of unsymmetrical dialkoxy quinazolines</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1080%2F00304940409356628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=445-452&author=M.+Desrosesauthor=G.+Lacondeauthor=P.+Depreuxauthor=J.+P.+H%C3%A9nichart&title=Synthesis+of+unsymmetrical+dialkoxy+quinazolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of unsymmetrical dialkoxy quinazolines</span></div><div class="casAuthors">Desroses, Matthieu; Laconde, Guillaume; Depreux, Patrick; Henichart, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-452</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">The prepn. of title compds. is described.  Thus, alkylation of Me 3,4-dihydroxybenzoate with 1-iodobutane gave Me 4-butoxy-3-hydroxybenzoate which on alkylation with 2-(diethylamino)ethyl chloride hydrochloride gave Me 4-butoxy-3-(2-diethylaminoethoxy)benzoate hydrochloride.  Nitration of the later followed by redn. and cyclization with HCO2NH4/HCONH2 gave title 7-butoxy-6-(2-diethylaminoethoxy)-3H-quinazolin-4-one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKN6iNOhB0rVg90H21EOLACvtfcHk0lh0PH_DdVeEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOmtb4%253D&md5=cf115709ad66a7a7e54d6356876d0934</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1080%2F00304940409356628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304940409356628%26sid%3Dliteratum%253Aachs%26aulast%3DDesroses%26aufirst%3DM.%26aulast%3DLaconde%26aufirst%3DG.%26aulast%3DDepreux%26aufirst%3DP.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.%2BP.%26atitle%3DSynthesis%2520of%2520unsymmetrical%2520dialkoxy%2520quinazolines%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2004%26volume%3D36%26spage%3D445%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Telliez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desroses, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommery, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconde, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hénichart, J. P.</span><span> </span><span class="NLM_article-title">Derivatives of Iressa, a specific epidermal growth factor receptor inhibitor, are powerful apoptosis inducers in PC3 prostatic cancer cells</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=318-332&author=A.+Telliezauthor=M.+Desrosesauthor=N.+Pommeryauthor=O.+Briandauthor=A.+Farceauthor=G.+Lacondeauthor=A.+Lemoineauthor=P.+Depreuxauthor=J.+P.+H%C3%A9nichart&title=Derivatives+of+Iressa%2C+a+specific+epidermal+growth+factor+receptor+inhibitor%2C+are+powerful+apoptosis+inducers+in+PC3+prostatic+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTelliez%26aufirst%3DA.%26aulast%3DDesroses%26aufirst%3DM.%26aulast%3DPommery%26aufirst%3DN.%26aulast%3DBriand%26aufirst%3DO.%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DLaconde%26aufirst%3DG.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DDepreux%26aufirst%3DP.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.%2BP.%26atitle%3DDerivatives%2520of%2520Iressa%252C%2520a%2520specific%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%252C%2520are%2520powerful%2520apoptosis%2520inducers%2520in%2520PC3%2520prostatic%2520cancer%2520cells%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D318%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebegue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span> </span><span class="NLM_article-title">A novel and efficient one-pot synthesis of (aminophenyl)carbamic acid ester</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1080%2F00397911.2010.494818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVChtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=2007-2016&author=A.+Garofaloauthor=L.+Goossensauthor=N.+Lebegueauthor=P.+Depreux&title=A+novel+and+efficient+one-pot+synthesis+of+%28aminophenyl%29carbamic+acid+ester"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and efficient one-pot synthesis of (aminophenyl)carbamic acid esters</span></div><div class="casAuthors">Garofalo, Antonio; Goossens, Laurence; Six, Perrine; Lebegue, Nicolas; Depreux, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2007-2016</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A novel and efficient protocol was developed for the synthesis of various (aminophenyl)carbamic acid esters from the redn. and condensation of nitrophenyl isocyanate derivs.  The reaction takes place in various hydroxy derivs. such as alcs. or phenols under a hydrogen atm. using Raney nickel as catalyst.  Products are obtained by a convenient one-pot synthesis with excellent yields and short reaction times.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAAz1E5Y0vTrVg90H21EOLACvtfcHk0ljUptF-sod3qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVChtrY%253D&md5=82317ba16da12969fec07fd0329dc47a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1080%2F00397911.2010.494818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2010.494818%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DLebegue%26aufirst%3DN.%26aulast%3DDepreux%26aufirst%3DP.%26atitle%3DA%2520novel%2520and%2520efficient%2520one-pot%2520synthesis%2520of%2520%2528aminophenyl%2529carbamic%2520acid%2520ester%26jtitle%3DSynth.%2520Commun.%26date%3D2011%26volume%3D41%26spage%3D2007%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Elliott, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaddix, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riordan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">Nitrosoureido nucleosides as potential inhibitors of nucleotide biosynthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=250-254&author=R.+D.+Elliottauthor=H.+J.+Thomasauthor=S.+C.+Shaddixauthor=D.+J.+Adamsonauthor=R.+W.+Brockmanauthor=J.+M.+Riordanauthor=J.+A.+Montgomery&title=Nitrosoureido+nucleosides+as+potential+inhibitors+of+nucleotide+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a039%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DR.%2BD.%26aulast%3DThomas%26aufirst%3DH.%2BJ.%26aulast%3DShaddix%26aufirst%3DS.%2BC.%26aulast%3DAdamson%26aufirst%3DD.%2BJ.%26aulast%3DBrockman%26aufirst%3DR.%2BW.%26aulast%3DRiordan%26aufirst%3DJ.%2BM.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DNitrosoureido%2520nucleosides%2520as%2520potential%2520inhibitors%2520of%2520nucleotide%2520biosynthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D250%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldyrou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Six, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Cordonnier, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonte, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depreux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, J. F.</span><span> </span><span class="NLM_article-title">Design, synthesis and DNA-binding of N-alkyl(anilino)quinazoline derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8089</span><span class="NLM_x">–</span> <span class="NLM_lpage">8103</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1009605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8089-8103&author=A.+Garofaloauthor=L.+Goossensauthor=B.+Baldyrouauthor=A.+Lemoineauthor=S.+Ravezauthor=P.+Sixauthor=M.+H.+David-Cordonnierauthor=J.+P.+Bonteauthor=P.+Depreuxauthor=A.+Lansiauxauthor=J.+F.+Goossens&title=Design%2C+synthesis+and+DNA-binding+of+N-alkyl%28anilino%29quinazoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm1009605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009605%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DL.%26aulast%3DBaldyrou%26aufirst%3DB.%26aulast%3DLemoine%26aufirst%3DA.%26aulast%3DRavez%26aufirst%3DS.%26aulast%3DSix%26aufirst%3DP.%26aulast%3DDavid-Cordonnier%26aufirst%3DM.%2BH.%26aulast%3DBonte%26aufirst%3DJ.%2BP.%26aulast%3DDepreux%26aufirst%3DP.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DGoossens%26aufirst%3DJ.%2BF.%26atitle%3DDesign%252C%2520synthesis%2520and%2520DNA-binding%2520of%2520N-alkyl%2528anilino%2529quinazoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8089%26epage%3D8103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span> <span class="citation_source-book">SYBYL 6.9.1</span>; <span class="NLM_publisher-name">Tripos Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL+6.9.1%3B+Tripos+Inc.%3A+St.+Louis%2C+MO%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSYBYL%25206.9.1%26pub%3DTripos%2520Inc%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Clark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, R. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Opdenbosch, N.</span><span> </span><span class="NLM_article-title">Validation of the general purpose Tripos 5.2 force field</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fjcc.540100804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK3cXhtlygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1989&pages=982-1012&author=M.+Clarkauthor=R.+D.+Cramerauthor=N.+van+Opdenbosch&title=Validation+of+the+general+purpose+Tripos+5.2+force+field"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the general purpose Tripos 5.2 force field</span></div><div class="casAuthors">Clark, Matthew; Cramer, Richard D., III; Van Opdenbosch, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">982-1012</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    </div><div class="casAbstract">A mol. mechanics force field implemented in the Sybyl program is described along with a statistical evaluation of its efficiency on a variety of compds. by anal. of internal coordinates and thermodn. barriers.  The goal of the force field is to provide good quality geometries and relative energies for a large variety of org. mols. by energy minimization.  Performance in protein modeling was tested by minimizations starting from crystallog. coordinates for three cyclic hexapeptides in the crystal lattice.  Accuracy in calcg. thermodn. barriers was tested for 17 energy differences between conformers, 12 stereoisomers, and 15 torsional barriers.  Performance in general purpose applications was assessed by minimizing 76 diverse complex org. crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk84YWRXYBF7Vg90H21EOLACvtfcHk0lhlck41vhTUKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtlygsbk%253D&md5=b855270284acf42c6f03c495326aeda8</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjcc.540100804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.540100804%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%26aulast%3DCramer%26aufirst%3DR.%2BD.%26aulast%3Dvan%2BOpdenbosch%26aufirst%3DN.%26atitle%3DValidation%2520of%2520the%2520general%2520purpose%2520Tripos%25205.2%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1989%26volume%3D10%26spage%3D982%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Garyauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lhlck41vhTUKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGary%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, R. T.</span><span> </span><span class="NLM_article-title">Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2203-2207&author=Y.+Miyazakiauthor=S.+Matsunagaauthor=J.+Tangauthor=Y.+Maedaauthor=M.+Nakanoauthor=R.+J.+Philippeauthor=M.+Shibaharaauthor=W.+Liuauthor=H.+Satoauthor=L.+Wangauthor=R.+T.+Nolte&title=Novel+4-amino-furo%5B2%2C3-d%5Dpyrimidines+as+Tie-2+and+VEGFR2+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DPhilippe%26aufirst%3DR.%2BJ.%26aulast%3DShibahara%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26atitle%3DNovel%25204-amino-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tie-2%2520and%2520VEGFR2%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2203%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lhlck41vhTUKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. J.</span><span> </span><span class="NLM_article-title">Further development and validation of empirical scoring functions for structure-based binding affinity prediction</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1023%2FA%3A1016357811882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm2013453&amp;key=12197663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlSqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=11-26&author=R.+Wangauthor=L.+Laiauthor=S.+J.+Wang&title=Further+development+and+validation+of+empirical+scoring+functions+for+structure-based+binding+affinity+prediction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Further development and validation of empirical scoring functions for structure-based binding affinity prediction</span></div><div class="casAuthors">Wang, Renxiao; Lai, Luhua; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">New empirical scoring functions have been developed to est. the binding affinity of a given protein-ligand complex with known three-dimensional structure.  These scoring functions include terms accounting for van der Waals interaction, hydrogen bonding, deformation penalty, and hydrophobic effect.  A special feature is that three different algorithms have been implemented to calc. the hydrophobic effect term, which results in three parallel scoring functions.  All three scoring functions are calibrated through multivariate regression anal. of a set of 200 protein-ligand complexes and they reproduce the binding free energies of the entire training set with std. deviations of 2.2 kcal/mol, 2.1 kcal/mol, and 2.0 kcal/mol, resp.  These three scoring functions are further combined into a consensus scoring function, X-CSCORE.  When tested on an independent set of 30 protein-ligand complexes, X-CSCORE is able to predict their binding free energies with a std. deviation of 2.2 kcal/mol.  The potential application of X-CSCORE to mol. docking is also investigated.  Our results show that this consensus scoring function improves the docking accuracy considerably when compared to the conventional force field computation used for mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqULje6PqR73rVg90H21EOLACvtfcHk0liWrlxYC8m0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlSqs7k%253D&md5=f77fd72d168df67d7fb66a88bc3b6cd9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1023%2FA%3A1016357811882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1016357811882%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%2BJ.%26atitle%3DFurther%2520development%2520and%2520validation%2520of%2520empirical%2520scoring%2520functions%2520for%2520structure-based%2520binding%2520affinity%2520prediction%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2002%26volume%3D16%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Oprea, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2215</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00040a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2206-2215&author=T.+I.+Opreaauthor=C.+L.+Wallerauthor=G.+R.+Marshall&title=Three-dimensional+quantitative+structure-activity+relationship+of+human+immunodeficiency+virus+%28I%29+protease+inhibitors.+2.+Predictive+power+using+limited+exploration+of+alternate+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm00040a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00040a013%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DWaller%26aufirst%3DC.%2BL.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DThree-dimensional%2520quantitative%2520structure-activity%2520relationship%2520of%2520human%2520immunodeficiency%2520virus%2520%2528I%2529%2520protease%2520inhibitors.%25202.%2520Predictive%2520power%2520using%2520limited%2520exploration%2520of%2520alternate%2520binding%2520modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2206%26epage%3D2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Cramer, R. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunce, J. D.</span><span> </span><span class="NLM_article-title">Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">5959</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00226a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=5959-5967&author=R.+D.+Cramerauthor=D.+E.+Pattersonauthor=J.+D.+Bunce&title=Comparative+molecular+field+analysis+%28CoMFA%29.+1.+Effect+of+shape+on+binding+of+steroids+to+carrier+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative molecular field analysis (CoMFA).  1.  Effect of shape on binding of steroids to carrier proteins</span></div><div class="casAuthors">Cramer, Richard D., III; Patterson, David E.; Bunce, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5959-67</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Comparative mol. field anal. (CoMFA) which represents ligand mols. by their steric and electrostatic fields was used to analyze the affinity of 21 steroids to corticosteroid- and testosterone-binding globulins and then to predict the binding consts. of 10 more, structurally diverse, steroids.  QSAR obtained with CoMFA parameters had greater predictive, and also correlative, power then QSAR obtained by other parameters combinations.  The predicted affinities of the addnl. 10 steroids were highly correlated with the actual binding data with the poorest predictions being for steroids that were most dissimilar from the original 21 steroids analyzed.  The CoMFA methodol is characterized by inherent generality, ease of use, superior anal. power, and predictive utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkkJZS5v2zRrVg90H21EOLACvtfcHk0liWrlxYC8m0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVCqsbs%253D&md5=8829e9efd71a65faa7c9397c9eb13cc7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja00226a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00226a005%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DR.%2BD.%26aulast%3DPatterson%26aufirst%3DD.%2BE.%26aulast%3DBunce%26aufirst%3DJ.%2BD.%26atitle%3DComparative%2520molecular%2520field%2520analysis%2520%2528CoMFA%2529.%25201.%2520Effect%2520of%2520shape%2520on%2520binding%2520of%2520steroids%2520to%2520carrier%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D5959%26epage%3D5967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mietzner, T.</span><span> </span><span class="NLM_article-title">Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4130</span><span class="NLM_x">–</span> <span class="NLM_lpage">4146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00050a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=4130-4146&author=G.+Klebeauthor=U.+Abrahamauthor=T.+Mietzner&title=Molecular+similarity+indices+in+a+comparative+analysis+%28CoMSIA%29+of+drug+molecules+to+correlate+and+predict+their+biological+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity</span></div><div class="casAuthors">Klebe, Gerhard; Abraham, Ute; Mietzner, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4130-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">An alternative approach is reported to compute property fields based on similarity indexes of drug mols. that have been brought into a common alignment.  The fields of different physicochem. properties use a Gaussian-type distance dependence, and no singularities occur at the at. positions.  Accordingly, no arbitrary definitions of cutoff limits and deficiencies due to different slopes of the fields are encountered.  The fields are evaluated by a PLS anal. similar to the CoMFA formalism.  Two data sets of steroids binding to the corticosteroid-binding-globulin and thermolysin inhibitors were analyzed in terms of the conventional CoMFA method (Lennard-Jones and Coulomb potential fields) and the new comparative mol. similarity indexes anal. (CoMSIA).  Models of comparative statistical significance were obtained.  Field contribution maps were produced for the different models.  Due to cutoff settings in the CoMFA fields and the steepness of the potentials close to the mol. surface, the CoMFA maps are often rather fragmentary and not contiguously connected.  This makes their interpretation difficult.  The maps obtained by the new CoMSIA approach are superior and easier to interpret.  Whereas the CoMFA maps denote regions apart from the mols. where interactions with a putative environment are to be expected, the CoMSIA maps highlight those regions within the area occupied by the ligand skeletons that require a particular physicochem. property important for activity.  This is a more significant guide to trace the features that really matter esp. with respect to the design of novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprb-_Wx0SAN7Vg90H21EOLACvtfcHk0liWrlxYC8m0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWhu7Y%253D&md5=f0b5d27f6556fc93d4a1007c245a4d6a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm00050a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00050a010%26sid%3Dliteratum%253Aachs%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DAbraham%26aufirst%3DU.%26aulast%3DMietzner%26aufirst%3DT.%26atitle%3DMolecular%2520similarity%2520indices%2520in%2520a%2520comparative%2520analysis%2520%2528CoMSIA%2529%2520of%2520drug%2520molecules%2520to%2520correlate%2520and%2520predict%2520their%2520biological%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D4130%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Clark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, R. D.,  III.</span><span> </span><span class="NLM_article-title">The probability of chance correlation using partial least squares (PLS)</span> <span class="citation_source-journal">Quant. Struct.-Act. Relat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2013453&amp;key=10.1002%2Fqsar.19930120205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2013453&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=137-145&author=M.+Clarkauthor=R.+D.+Cramer&title=The+probability+of+chance+correlation+using+partial+least+squares+%28PLS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The probability of chance correlation using partial least squares (PLS)</span></div><div class="casAuthors">Clark, Matthew; Cramer, Richard D. III</div><div class="citationInfo"><span class="NLM_cas:title">Quantitative Structure-Activity Relationships</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-45</span>CODEN:
                <span class="NLM_cas:coden">QSARDI</span>;
        ISSN:<span class="NLM_cas:issn">0931-8771</span>.
    </div><div class="casAbstract">The frequency of chance correlation using partial least squares (PLS) has been measured exptl. for variously dimensioned data, comprising either completely random nos., random nos. contg. a perfect correlation within, and comparative mol. field anal. (CoMFA) field descriptors, esp. for QSAR of drugs.  This frequency, much lower than that for stepwise multiple regression, is maximal for datasets in which the no. of descriptors equals the no. of compds., and surprisingly decreases indefinitely as the no. of descriptors becomes much greater than the no. of compds.  However, perfect correlations involving descriptor subsets are not detected by PLS if the no. of irrelevant descriptors is excessive.  In CoMFA applications, the probability of chance correlation is usually negligible.  For example with 21 compds. a cross-validated r2 value greater than 0.25 will occur by chance in less than 5% of trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre8G_RM6wwULVg90H21EOLACvtfcHk0lgWZqzs8x_cFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFaqurY%253D&md5=9f296f29b7e328db12bcba97f26b9a81</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fqsar.19930120205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqsar.19930120205%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%26aulast%3DCramer%26aufirst%3DR.%2BD.%26atitle%3DThe%2520probability%2520of%2520chance%2520correlation%2520using%2520partial%2520least%2520squares%2520%2528PLS%2529%26jtitle%3DQuant.%2520Struct.-Act.%2520Relat.%26date%3D1993%26volume%3D12%26spage%3D137%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn','PDB','1ywn'); return false;">PDB: 1ywn</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2013453&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm2013453%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-3%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2013453" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a7d9a4b643d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
